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Abstract
Xylose is the major pentose and the second most abundant sugar in lignocellulosic
feedstocks. Therefore, the efficient utilization of xylose is required for the cost-effective
bioconversion of lignocellulose. Rational and combinatorial metabolic engineering
approaches coupled with transcriptomic and proteomic studies have been extensively
exploited on the yeast Saccharomyces cerevisiae for improved xylose utilization.
However, the resulting strains remain inapplicable for industrial ethanolic fermentation,
although basic engineering approaches have been established and targets have been
identified for further modification.
In this study, we started with the rational genetic engineering of a laboratory S.
cerevisiae strain to express the xylose metabolic pathways, including the xylose
reductase/xylitol dehydrogenase (XR/XDH) and xylose isomerase (XI) pathways. The
xylulokinase (XK) and the non-oxidative pentose phosphate pathway (PPP) were also
overexpressed to facilitate pentose assimilation. The resulting strains, H131 -XYL 123 and
H13 1-XYLA3 1, exhibited slow but significant aerobic growth (p.1ma=0.031+0.022 h~1 and
0.081+0.052 h-1, respectively), establishing a baseline for further advancement.
These engineered strains mentioned above were then used to initiate a three-stage
evolutionary engineering, through aerobic and oxygen-limited sequential batch
cultivation followed by xylose-limited anaerobic chemostat cultivation. We aborted the
development of the XR/XDH-based strain after the first stage of aerobic evolution, owing
to the intrinsic cofactor imbalance of the two enzymes. In contrast, continuous
improvement was observed during adaption of the XI-based H131-XYLA31, when
strains were isolated from the evolved populations periodically and evaluated in terms of
growth and fermentation. The final isolated strain, H131E8-XYLA31, displayed a
significantly increased anaerobic growth rate (0.120+0.004 h-1) and xylose consumption
rate (0.916 g-g h ) compared to its parent strain.
Upon successful evolutionary engineering, the H131E8-XYLA31 was further
modified by complementing the auxotrophic markers arg4 and leu2, resulting in
H153E10-XYLA31 with greatly boosted aerobic growth. Moreover, adding the
anaerobic growth factors ergosterol and Tween 80 to the medium enabled a maximum
anaerobic growth rate of 0.199 h-1 and a specific xylose consumption rate of 1.647g-g-lh-1
in batch fermentation, 65% and 37% higher than those of the best reported xylose-
fermenting strain RWB 218, respectively. In chemostat cultivation, the strains exhibit
specific performance more than 50% better than in the batch cultivation, implying the
potential for further improvement of the strains in extended evolution.
In order to identify the genotypes responsible for quick xylose utilization in the
evolutionarily engineered strain, an inverse inverse metabolic engineering approach was
applied to the evolved strain, based on functional complementation of the evolved
H131E5-XYLA31 genomic library to an unevolved background strain. A high-
throughput micro-fluidic screening method was used to screen the library, revealing the
tandem duplication of XYLA in the H131E5-XYLA31 genome. The structure of XYLA
integration, coupled with qPCR, DNA/RNA blotting, and enzyme activity assay results,
suggests that the high expression level of XI is a major recombination event during the
evolution and is necessary for efficient xylose assimilation. However, high XI expression
does not necessarily imply the tandem multi-copy integration of XYLA into the genome.
The XYLA expansion could originate from different initial constructions, subject to
recombination/rearrangement, and produce different configurations.
The effects of other metabolic engineering targets were also investigated,
including other heterologous XIs, XK (XYL3), aldose reductase (GRE3), NADP-
dependent G3P dehydrogenase (gapN), and heterologous xylose transporters. Most
results verified the previous hypothesis, leaving room for future strain improvements.
In this study, we successfully applied rational and combinatorial metabolic
engineering approaches for both constructing rapid xylose-fermenting strains and
identifying novel genetic characteristics. We demonstrated the use of evolutionary
engineering to achieve superior strains, as well as the inverse metabolic engineering
approach based on micro-fluidic screening for both strain improvement and genotype
identification. As such, the work of this thesis serves as a practical milestone in
lignocellulose conversions. The constructed strains can be used as hosts for further
advancement, and the metabolic engineering techniques have proven to be effective tools
for future strain evolution.
Thesis Supervisor: Gregory N. Stephanopoulos
W.H. Dow Professor of Chemical Engineering and Biotechnology
Acknowledgements
I would like to thank my thesis advisor, Prof. Greg Stephanopoulos, for his
guidance and encouragement, for his patience when I struggled with my little bugs, and
for the freedom he granted me to pursue my own ideas. My entire thesis committee also
provided essential ideas and critical feedback. Thanks to Professor Gerry Fink and
Narendra Maheshri for insights in yeast research. Thanks to Professor Daniel Wang for
willingness to share both his expertise in fermentation and his laboratory resources.
Professor Graham Walker, although not technically on my committee, offered help in
searching for sugar transporters.
I have been lucky to work closely with many brilliant and dedicated researchers.
Thanks to Yong-Su Jin and Hal Alper for being good teachers helping me to initiate my
own project. Thanks to Benjamin Wang for working together with me in the library
screening, and Chapter 4 was written in close collaboration with Ben. Thanks to
Jingsheng Cheng, for his help in those exhausting biochemical and fermentation studies.
Thanks to Kang Zhou for his expertise in qPCR. To Simon Carlsen, Mitchell Tai, Jose
Avalos and Felix Lam, for sharing their experiences and advice in yeast research. To
Keith Tyo, Christine Santos, and Adel Ghaderi for patiently reminding me to label all my
bottles. To Rosangela dos Santos for her continuous administrative help. Also, many
thanks go to other members of the Stephanopoulos lab, especially Curt Fischer, Jason
Walther, Daniel Klein, Ajikumar Parayil, Hussain Abidi, Vikram Yadav, Tom
Wasylenko, and so many others, for sharing the great times with me in the lab.
My gratitude goes to Huimin Yu, Hui Luo, Wenhai Xiao, Xiaobing Huang, Wen-
chi Yang, Peipei Han, Claire Li and many others, for making my lunch time in a relaxing
Chinese speaking community. Thanks to all my friends at MIT and elsewhere, too many
to list here, for making my days at MIT and in US very enjoyable.
An extra sincere thank goes to my parents, Jinkun and Xiufang, who never stop
their unconditional love and support throughout my entire life, and encourage me to
always think independently, practice boldly and strive for excellence. I'm so happy to
welcome my lovely boy Alex, who constantly surprises me by showing his new skills and
becomes an extra reason that I enjoy every single day of my life. And finally, I would
like to express my most hearty gratitude to my wife, Wei Guo, for her love,
comprehension and encouragement, and it is to you that I dedicate this thesis.
6
Table of Contents
List of Figures.................................................................................................................. 10
List of Tables ................................................................................................................... 12
CHAPTER 1. Introduction..................................................................................... 13
1.1 Research background and motivation........................................................... 13
1.2 Xylose reductase (XR) and xylitol dehydrogenase (XDH) ........................... 17
1.3 Xylose isomerase (XI) .................................................................................. 19
1.4 Xylulokinase (XK)......................................................................................... 21
1.5 Pentose Phosphate Pathway (PPP)................................................................ 21
1.6 G RE 3 D eletion .............................................................................................. 22
1.7 Evolutionary engineering.............................................................................. 23
1.8 Xylose transporters ...................................................................................... 24
1.9 Thesis objective and overview....................................................................... 27
CHAPTER 2. Construction of Xylose-utilizing Strains....................................... 29
2.1 Introduction .................................................................................................. 29
2.2 Materials and Methods.................................................................................. 30
2.2.1 Strains and maintenance ........................................................................... 30
2.2.2 Enzymes, primers and chemicals.............................................................. 32
2.2.3 Yeast transformation.................................................................................. 34
2.2.4 Determination of nucleotides, metabolites, cell density and culture dry
weight 35
2.2.5 Quantitative PCR for determining gene copy number and expression......... 36
2.3 Results and discussion .................................................................................. 37
2.3.1 Measuring of nucleic acids, metabolites and OD 600 and DCW ................ 37
2.3.2 Pentose phosphate pathway over-expression strain construction............. 40
2.3.3 Xylose metabolic pathway based on XI..................................................... 42
2.3.4 Xylose metabolic pathway based on XR-XDH ......................................... 44
2.3.5 Xylose-utilizing strains construction and characterization........................ 45
2.3.6 Verification of genes integration and transformation ................................ 46
2.4 C onclusions..................................................................................................... 47
CHAPTER 3. Evolutionary Engineering of Xylose-utilizing Strains................. 49
3.1 Introduction .................................................................................................... . 49
3.2 Materials and Methods.................................................................................. 50
3.2.1 Shake flask batch cultivation .................................................................... 50
3.2.2 Chemostat cultivation ............................................................................... 50
3.2.3 Anaerobic fermentation of xylose.............................................................. 51
3.2.4 Strains, other materials and methods ......................................................... 51
3.3 Results and Discussion .................................................................................. 52
3.3.1 Aerobic sequential batch cultivation for improved growth on xylose..... 53
3.3.2 Evolution by oxygen-limited sequential batch cultivation ....................... 56
3.3.3 Evolution by xylose-lim ited chem ostat cultivation .................................. 60
3.3.4 Discussion................................................................................................... 62
3.4 Conclusions................................................................................................... 66
CHAPTER 4. Inverse Metabolic Engineering for Identification of Key Genotypes
in the Evolutionarily Engineered Strains .................................................................. 67
4.1 Introduction................................................................................................... 67
4.2 M aterials and M ethods................................................................................... 68
4.2.1 Construction of genomic library ................................................................ 68
4.2.2 M icrofluidic high-throughput screening.................................................. 68
4.2.3 Strains, plasm ids, and other m aterials and methods .................................. 70
4.3 Results and Discussion .................................................................................. 71
4.3.1 Genom ic library construction .................................................................... 71
4.3.2 Genom ic library screening......................................................................... 72
4.3.3 Validation of the selected clones .............................................................. 73
4.3.4 Analysis of selected mutants..................................................................... 74
4.3.5 Copy number of genes from the xylose metabolism pathway.......... 77
4.3.6 Discussion................................................................................................... 78
4.4 Conclusions................................................................................................... 81
CHAPTER 5. Biochemical and Genetic Characterization of the Evolutionarily
Engineered Strains....................................................................................................... 83
5.1 Introduction................................................................................................... 83
5.2 M aterials and M ethods................................................................................... 84
5.2.1 Southern blot.............................................................................................. 84
5.2.2 Northern blot.............................................................................................. 86
5.2.3 Pulsed field gel electrophoresis (PFGE) and chromosome blot ................ 86
5.2.4 XI activity assay.......................................................................................... 87
5.2.5 XK activity assay ....................................................................................... 88
5.2.6 Plasm ids, strains and other m aterials and methods.................................... 88
5.3 Results and Discussion .................................................................................. 90
5.3.1 Verification of tandem gene duplication of XYLA .................. 90
5.3.2 Southern blot.............................................................................................. 95
5.3.3 Transcription of key enzymes in the xylose metabolic pathway ............... 96
5.3.4 Enzym atic activity of XYLA and XYL3..................................................... 98
5.3.5 Chrom osom e blotting.................................................................................. 100
5.3.6 GRE3 mutations in the evolved strains....................................................... 103
5.4 Conclusions..................................................................................................... 106
CHAPTER 6. Optimization of Fermentation and Other Metabolic Engineering of
Xylose-ferm enting S. cerevisiae Strains ...................................................................... 109
6.1 Introduction..................................................................................................... 109
6.2 M aterials and M ethods.................................................................................... 110
6.2.1 Plasm ids and strains.................................................................................... 110
6.2.2 Anaerobic ferm entation of xylose............................................................... 111
6.3 Results and Discussion ................................................................................... 111
6.3.1 M edium comparison ................................................................................ 111
6.3.2 Complem ent of arg4 and leu2 .................................................................... 113
6.3.3 Strictly anaerobic fermentation with growth factors ergosterol and Tween 80
117
6.3.4 Expression of other heterologous XIs......................................................... 121
6.3.5 NADP-dependent glyceraldehyde-3-phosphate dehydrogenase (gapN) .... 123
6.3.6 Expression of heterologous xylose transporters ......................................... 126
6.3.7 Chemostat cultivation of H 153E1O -XYLA31 ............................................ 127
6.3.8 Discussion................................................................................................... 129
6.4 Conclusions..................................................................................................... 131
CHAPTER 7. Conclusions and Recom m endations................................................ 133
7.1 Conclusions..................................................................................................... 133
7.2 Recomm endations and future work ................................................................ 136
References...................................................................................................................... 139
Appendix........................................................................................................................ 145
A. 1. Heterologous xylose isom erases ..................................................................... 145
A.2. Putative xylose transporters ............................................................................ 155
A.3. Xylitol inhibitory effect estimation................................................................. 157
List of Figures
Figure 1-1. Metabolic network of xylose metabolism in the recombinant S. cerevisiae.. 17
Figure 1-2. Topology of yeast sugar transporters[80] .................................................. 25
Figure 2-1. HPLC chromatogram .................................................................................. 38
Figure 2-2. HPLC standard curves................................................................................. 38
Figure 2-3. Dry cell weight calibration curve................................................................ 39
Figure 2-4. Integration plasmid pRS404-RPEJ-RKIJ .................................................. 41
Figure 2-5. Integration plasmids pUCHI2-TKL1 and pUCAD2-PsTAL1..................... 41
Figure 2-6. Cloning of PsXYL3..................................................................................... 43
Figure 2-7. Plasmid pRS426-XYLA3 ............................................................................. 44
Figure 2-8. Cloning of XYLJ-XYL2-XYL3..................................................................... 45
Figure 2-9. Expression of transformed genes ................................................................ 46
Figure 3-1. Scheme of strain evolution......................................................................... 52
Figure 3-2. Evolution process of strains under aerobic condition ................................ 53
Figure 3-3. Fermentation profiles of H131E l-XYL123 ................................................ 54
Figure 3-4. Fermentation profiles of H131E1-XYLA31 ............................................. 55
Figure 3-5. Fermentation profiles of H13 1E3-XYLA31 ............................................... 57
Figure 3-6. Fermentation profiles of H13 1E5-XYLA31 ............................................... 58
Figure 3-7. Fermentation profiles of H13 1E8-XYLA31 ............................................... 61
Figure 4-1. Schematic of the microfluidic high-throughput screening platform.......... 69
Figure 4-2. Schematic of the xylose assay reactions .................................................... 70
Figure 4-3. Genomic library construction and screening.............................................. 71
Figure 4-4. Xylose consumption of strain H13 1-A3 1 transformed with plasmids [107]. 73
Figure 4-5. Sequencing results of plasmid pRS415-geno-W2..................................... 74
Figure 4-6. Restriction enzymes digestion of plasmid pRS415-geno-W2 and control
p R S 4 15 ...................................................................................................................... 7 5
Figure 4-7. Map of plasmid pRS415-geno-W2 ........................................................... 76
Figure 4-8. Copy number of genes XYLA and XYL3 .................................................. 77
Figure 4-9. Scheme of unequal crossover of pRS426-XYLA-XYL3............................. 80
Figure 5-1. X ylose isom erase assay.............................................................................. 87
Figure 5-2. X ylulokinase assay..................................................................................... 88
Figure 5-3. Expression of yECitrine under various promoters...................................... 91
Figure 5-4. Micro-aerobic growth of H13 1E/H142E strains ......................................... 92
Figure 5-5. (XYLA)2 integration in LEU2 of H142-p405A2 ....................................... 93
Figure 5-6. (XYLA)2 integration in URA3 of H142-p406A2....................................... 93
Figure 5-7. Sequencing of URA3 context in H142-p406A2......................................... 94
Figure 5-8. qPCR for XYLA copy numbers in H142/H142E strains.............................. 94
Figure 5-9. Southern blot of XYLA in H131/11142 strains........................................... 95
Figure 5-10. Structure of tandem XYLA duplication after Xba I digestions ......... 96
Figure 5-11. Transcription of the key xylose metabolic genes.................................... 97
Figure 5-12. Northern blot results of XYLA in H131E strains ....................................... 98
Figure 5-13. Activity of XI and XK in H131/H131E strains......................................... 99
Figure 5-14. DNA copy number, expression and activity of XI and XK in H131/H131 E
strain s ........................................................................................................................ 9 9
Figure 5-15. PFGE and chromosome blot of H131/H131E/H142E ............................... 101
Figure 5-16. Mutations of GRE3 in the evolved strains ................................................. 104
Figure 5-17. Effect of gre3z on aerobic growth in glucose medium ............................. 106
Figure 6-1. Fermentation of H 131 E3-XYLA3 1 on different media............................... 112
Figure 6-2. Effect of ARG4 and LEU2 on aerobic growth ............................................. 113
Figure 6-3. Comparison of H131E8-XYLA31 and H153E10-XYLA31........................ 115
Figure 6-4. Fermentation of H153E10-XYLA31 with 8% xylose ................................. 116
Figure 6-5. Effect of strictly anaerobic condition with ergosterol and Tween 80 .......... 119
Figure 6-6. Effect of ergosterol and Tween 80 on H153E10-XYLA31 fermentation.... 120
Figure 6-7. C lustering of X I............................................................................................ 122
Figure 6-8. Aerobic growth of S. cerevisiae containing Bacteroides thetaiotaomicron
X Y L A ....................................................................................................................... 12 3
Figure 6-9. NADP-dependent non-phosphorylating G3P dehydrogenase pathway ....... 124
Figure 6-10. Effect of gapN on xylose fermentation ...................................................... 125
Figure 6-11. Performance of strain with selected transporters ....................................... 127
List of Tables
Table 1-1 Major sugars of common agricultural lignocellulosic feedstocks................. 14
Table 1-2 Characteristics of xylose-fermenting S. cerevisiae strains ........................... 16
Table 1-3 Biochemical characteristics of pentose transporting proteins [95]............... 26
Table 2-1. Strains used in this chapter ........................................................................... 30
Table 2-2. Yeast Synthetic defined media.................................................................... 31
Table 2-3. Plasmids used in this chapter....................................................................... 32
Table 2-4. Prim ers used in this study............................................................................ 33
Table 2-5. HPLC peaks annotation and HPLC standard curves coefficients ............... 37
Table 3-1. S. cerevisiae strains used in this chapter ...................................................... 51
Table 3-2. Characteristics of H131EI-XYL123 and H131EI-XYLA31 fermentation.... 55
Table 3-3. Characteristics of H 131 E3-XYLA3 1 fermentation..................................... 58
Table 3-4. Characteristics of H13 1E5-XYLA3 1 fermentation..................................... 59
Table 3-5. Characteristics of H131E8-XYLA31 fermentation..................................... 61
Table 3-6. Characteristics of xylose-fermenting strains ................................................ 65
Table 4-1. Genomic library cloning strategy ................................................................ 68
Table 4-2. S. cerevisiae strains used in this chapter ...................................................... 70
Table 4-3. Restriction enzyme digestion of plasmid pRS415-geno-W2 and control
p R S 4 15 ...................................................................................................................... 7 6
Table 5-1. Strains and plasmids used in this chapter .................................................... 89
Table 5-2. Putative xylose reductases in S. cerevisiae.................................................... 104
Table 6-1. Plasm ids used in this chapter......................................................................... 110
Table 6-2. S. cerevisiae strains used in this chapter ....................................................... 111
Table 6-3. Characteristics of H131E8-XYLA31 and H153E10-XYLA31 fermentation 115
Table 6-4. Characteristics of H153E 1 0-XYLA3 1 fermentation with 8% xylose........... 117
Table 6-5. Characteristics of H153E10-XYLA31 fermentation under strictly anaerobic
condition with ergosterol and Tween 80................................................................. 119
Table 6-6. Characteristics of H153E10-XYLA31 fermentation with ergosterol and Tween
8 0 ............................................................................................................................. 12 0
Table 6-7. Characteristics of H141E5-XYLA31 fermentation....................................... 125
Table 6-8. Characteristics of H141E5-XYLA31 in chemostat....................................... 128
Table 6-9. Characteristics of recombinant S. cerevisiae strains ..................................... 130
Table A -1. Putative xylose transporters.......................................................................... 155
CHAPTER 1. Introduction
CHAPTER 1. Introduction
1.1 Research background and motivation
Developments in petrochemistry have greatly boosted industrial and societal
progress in the 2 0 th century. The ever-increasing rate of exploration and exploitation of
oil reserves has, for a long time, supplied an abundant and cheap raw material for
transport fuels as well as the production of bulk and fine chemicals. However, in the past
decade, several factors such as the increasing demand for fossil resources, the short- and
long-term uncertainties generated by geopolitical issues, and rapid increase of the CO 2
levels in the Earth's atmosphere and oceans which is related to the use of fossil resources
and affects the global climate via the well-publicized "greenhouse effect"[1], are
contributing to create an urgent need for alternatives to an economy that predominantly
depends on fossil resources. Plant biomass offers an attractive alternative, and it would be
extremely attractive to have cost-effective, sustainable means of producing transport fuels
from plant biomass. One of the most promising processes in this respect is the production
of fuel ethanol. Ethanol can be blended with conventional fuels or used alone, and
modifications to conventional car motors are either limited or not required. Although CO 2
is emitted during fermentation, the net effect is offset by the uptake of carbon gases by
the plants grown to produce ethanol. When compared to gasoline, ethanol releases less
greenhouse gases [2].
Fuel ethanol production from plant biomass hydrolysates by Saccharomyces
cerevisiae is of great economic significance. Wild-type S. cerevisiae strains readily
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ferment glucose, mannose and fructose via the Embden-Meyerhof pathway of glycolysis,
while galactose is fermented via the Leloir pathway [3]. However, consensus has been
reached in the past decades that, in the long run, cost-effective production of ethanol from
plant biomass should not only be based on the readily fermentable starch and sucrose
fractions of plant carbohydrates, but also on the much more resistant lignocellulosic
fractions. Lignocellulosic crop residues comprise more than half of the world's
agricultural phytomass [4] and significant fractions of the total can be recovered without
competing with other uses [5]. Xylose constitutes about 10-20% of the total dry weight in
woody common agricultural lignocellulosic feedstocks (Table 1-1) [3].
Table 1-1 Major sugars of common agricultural lignocellulosic feedstocks
Corn stover Wheat straw Bagasse Cotton gin Sugar beet pulp Switch grass
Carbohydrate (%)
Glucose 34.6 32.6 39,0 37. 24.1 31.0
Mannose 0.4 0.3 0.4 1.1 4.6 0.2
Galactose to0 0.8 0.5 2.4 0.9 0.9
Xylose 19,3 19.2 22.1 94 18.2 0.4
Arabinose 2.5 2.4 2.1 2.3 1.5 2.8
Uronic acids 3.2 2.2 2.2 NA 20.7 1.2
Non-carbohydrate (%)
Lignin 17.7 16.9 23.1 28. L5 17.6
Extractives 7.7 13.0 3.8 7.7 NA 17.0
Ash 10.4 10.2 3.7 10.5 8.2 5.8
One source of xylose is the sulfite-pulping of hardwood [6]. Depending on the
substrate and reaction conditions, dilute acid pretreatments of lignocellulosic residues can
recover 80-95% of the xylose from the feedstock [7]. However, the efficient utilization of
xylose presents a technical barrier to the commercial bioconversion, and therefore a
major challenge in metabolic engineering.
Some yeasts, like Candida utilis, will grow on xylose but do not produce ethanol.
In the 1980s, intensive screening efforts rapidly revealed that some yeasts, such as
Pachysolen tannophilus, Pichia stipitis, Candida shehatae [8] and Candida tropicalis [9],
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can convert xylose to ethanol directly under aerobic or oxygen-limiting conditions Many
improvements have been made in the genetic engineering of yeasts and bacteria for the
fermentation of xylose to ethanol. However, the bioconversion of pentoses to ethanol still
presents a considerable economic and technical challenge [7].
The cost-effective production of ethanol requires several key factors:
1. The high-yield, high-rate fermentation of biomass hydrolysates to ethanol;
2. The tolerance to numerous compounds in the plant hydrolysates that inhibit
microbial growth [10], as well as to high concentrations of ethanol;
3. The ability to grow under strictly anaerobic conditions. Overaeration leads to
increased respiration and suboptimal ethanol yields, while an accurate level of
oxygen in large-scale processes with viscous two-phase feedstocks is not only
economically undesired, but also virtually impossible [11];
4. High resistance to contaminations. It is almost impossible to maintain aseptic
conditions in industrial-scale ethanol production. In general, the combined use of
low pH and high ethanol concentrations suffices to keep contaminations at bay in
large-scale yeast-based ethanol production processes.
Based on its widespread, large-scale application for bioethanol production from
hexoses, S. cerevisiae appears to be the most promising metabolic-engineering platform
for bioethanol production from plant hydrolysates. Although native strains of S.
cerevisiae do not use xylose as a carbon source, recent metabolic and evolutionary
engineering studies on S. cerevisiae strains have greatly improved fermentation of this
pentose.
Table 1-2 Characteristics of xylose-fermenting S. cerevisiae strains
Strain Strain description Fermentation condition Ethanold Xylitol g/g h g/gh h
1400 (pLNH32)[12]
424A(LNH-ST)[ 13]
TMB 3255[14]
TMB 3271[15]
TMB3057[16]
TMB3066[16]
FPL-YSX3C[17]
FPL-YSX3
TAL1M[18]
RW 202-AFX[19]
RWB 217[20]
RWB 218[3, 21]
INVSc1/pRS406XKS/
pILSUT1/pWOXYLA[22]
ADAP8[23]
BWY1OXyl[24]
XYL1, XYL2, XKS1
XYL1, XYL2, XKSJ
XYL1, XYL2, XKS1, Azwfl
XYLJm(K270M), XYL2, XKS1
XYL1, XYL2, XKS1, TALI, TKL1,
RPEJ, RKIJ, Agre3
Piromyces XYLA, XKSJ, TALI,
TKLJ, RPEJ, RKIJ, Agre3
XYL1, XYL2, XYL3
XYL1, XYL2, XYL3, TALI
Piromyces XYLA evolved isolate
Piromyces XYLA, XKS1, TAL1,
TKLJ, RPEJ, RKIJ, Agre3
Selection of RWB 217
Orpinomyces XYLA,
XKS1, SUT1
Orpinomyces XYLA XKSI, PsSUT1,
evolved isolate
Clostridium phytofermentans XYLA
in industrial strain
Fermentative batch,
YPEX
Fermentative batch
Oxygen limited, batch,
synthetic medium
Oxygen limited, batch,
synthetic medium
Anaerobic batch,
synthetic medium
Anaerobic batch,
synthetic medium
Aerobic batch, minimal
medium
Aerobic batch, minimal
medium
Anaerobic batch,
synthetic medium
Anaerobic batch,
synthetic medium
Anaerobic batch,
synthetic medium
Aerobic batch
Aerobic batch, complex
medium
Anaerobic batch,
synthetic medium
0.30
0.43
0.41
0.31
0.33
0.43
0.19
0.21
0.42
0.43
0.41
0.39
0.48
0.43
0.08 0.36 g/L h 1.07 g/L-h 0.29
0.10 N/A
0.05 0.01
0.09 0.07
0.33 0.04
0.04 0.02
0.20 0.019
0.31 0.033
N/A
0.02
0.226
0.13
0.05
0.10
0.16
0.021 0.14 0.34
0.003 0.46 1.06
0.001 0.49 1.2
0.08 0.043 g/L-h 0.11 g/L-h
N/A 0.038 0.079
0.18 0.03 0.065
* growth on D-xylose medium was tested under aerobic conditions
N/A
0.05
0.06
0.16*
0.02*
0.058
0.123
0.03
0.09
0.12
0.025
0.04
0.04*
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Pentose Phosphate Pathway
D-Glucose D-Glucono- SOL D-Xylose
ATp 1 1 -5-lactone + Gluconate-6-P ~-A()
AP GLK, HXK NADPH NADPPH XYLCO2
ADP GND xGNDXYL2 *NAD(P)-
ZWI NADPH NADPH :: *C0 2  D-Xylulose 4 j.-Xylitol
Glycolysis Glucose-6-P NADP' Ribulose-5-P ATP NADH NAD
Embden-Meyerhof pathway Fructose-6-P 
3r _RPE1
ATP RKI1 L-Xylulose
PFK
ADP ' Ribose-5-P Xylulose-5-P L-Ribulose-5-P
Fructose-1,6-P % L-Arabinitol
FBA1 TKL1I
Dihydroxyacetone-P Glyceraldehyde-3-P Sedoheptulose-7-P
I TAL1
Pi+NAD + L-Arabinose
P+NAD + TDH1,2,3
NADH NADP NADH Fructose-6-P Erythrose-4-P
NAD. gapN Glyceraldehyde-1,3-P
NADPH ADP
ATP
Glycerol Glycerate-3-P
I GPM1,Z3
Glycerate-2-P
I ENO2
Phosphoenolpyruvate Acetate
ADP-,,ND
------------ PYK1 ALD6
Mitochondria ATP C02  NAD NADH NAD
TCA 4-Acetyl-CoAk-- Pyruvate -2 -- Acetaldehyde Ethanol
I PDC1 ADHI
- - - -
- - - -
I
Figure 1-1. Metabolic network of xylose metabolism in the recombinant S. cerevisiae
1.2 Xylose reductase (XR) and xylitol dehydrogenase (XDH)
The assimilation of xylose requires two oxidoreductase steps, which are not
available in S. cerevisiae. One of the best xylose-fermenting yeasts, P. stipitis, has served
as the source of genes for engineering xylose metabolism in S. cerevisiae. The XYL1 and
XYL2 (Figure 1-1) genes coding for xylose reductase (XR) and xylitol dehydrogenase
(XDH) from P. stipitis have been expressed in S. cerevisiae [12, 25-27]. The resulting
transformants can use xylose oxidatively and produce xylitol without the addition of a co-
metabolizable carbon source, but only produce significant amounts of ethanol in low
yield. The xylitol accumulation is mainly due to a cofactor imbalance, caused by the
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different requirements for XR and XDH activities. XR from P. stipitis has a high affinity
for NADPH even though it can use NADH as a cofactor. However, P. stipitis XDH only
uses NAD' as a cofactor [28]. This difference results in cofactor imbalance in the cytosol
during xylose metabolism, since no route is available for their regeneration. Respiration
can alleviate the redox imbalance engineered S. cerevisiae. Under aerobic conditions the
NADH can be reoxidized via the respiratory chain with molecular oxygen, and therefore,
for optimal ethanol production, low aeration rates are required [29, 30]. But the exact
aeration may be too costly to achieve in industrial-scale fermentation. To alleviate the
redox imbalance and reduce the xylitol production, various attempts have been made to
alter the cofactor specificity for XR and/or XDH [15, 31].
P. stipitis XR has about a twofold higher affinity for NADPH than for NADH [32,
33] and the intracellular ratio of NADPH/NADH is about 3 [34], so both facts favor the
use of NADPH by XR. Watanabe et al. reported a mutated NADH-preferring PsXR
(R276H), which was improved 52-fold in the ratio of NADH/NADPH in catalytic
efficiency [(kcat/Km with NADH)/(kcat/Km with NADPH)][34, 35]. The Km for NADH
dropped by 45% while the Km for NADPH went up more than 1000-fold, the Km for
xylose doubled and the Kcat with NADH stayed about the same. S. cerevisiae expressing
PsXR R276H mutant showed a 20% increase in ethanol and a 52% decrease in xylitol
production. Combinatorial approaches such as active site saturation (CASTing) is another
empirical method for the protein engineering [36]. Selected amino acid residues were
targeted with saturating mutagenesis in several successive rounds with high-throughput
screening in each round to identify the best mutant. The best P. stipitis XYL1 mutant, 2-
2C12(K270S, N272P, S271G, and R276F) showed a NADH/NADPH activity ratio of
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about 13, and a 73% Kcat with NADH. However, the Km for NADH rose about 7-fold, but
growth and fermentation characteristics were not reported [32]. A Candida tenuis XYL1
K274R, N276D double mutant decreased xylitol production 52% while improving the
ethanol yield 42% [37].
The cofactor imbalance also has been addressed by altering the preference of
XDH from NAD* to NADP*, albeit the reported NAD*/NADP* ratio of 4.9 [34] favors
NAD* usage by XDH. A double mutant of Gluconobacter oxydans XDH showed
completely reversed specificity for NADP* and Km for xylitol increased from 13.7 to 100
mM [38]. By substituting an XDH containing four mutations, xylitol production
decreased 86% and ethanol production increased 41% [39]; increased specific xylose
consumption and specific ethanol production rates in hydrolysate were also observed [40].
Fusion of XR and XDH has also been used in an attempt to get around cofactor
imbalance. This resulted in a low ethanol yield, but the strain was capable of growth and
ethanol production from xylose [41].
High levels of XR and XDH activity are important during xylose utilization [42,
43] and a higher level of XDH than XR reduces xylitol formation [39]. However,
anaerobic xylose fermentation by engineered strains was inevitably accompanied by
considerable xylitol production (Table 1-2) [3, 15].
1.3 Xylose isomerase (XI)
Functional expression of a heterologous xylose isomerase in S. cerevisiae, which
converts xylose to xylulose directly (Figure 1-1), is another logical approach to engineer
this yeast to ferment xylose, bypassing the cofactor imbalance problem in XR-XDH
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pathway. However, attempts to introduce a xylose isomerase in S. cerevisiae were
unsuccessful[3, 44-46] until 2003, when the first fungal xylose isomerase that could be
functionally expressed in S. cerevisiae at high levels was discovered, which is encoded
by the XYLA gene of the anaerobic fungus Piromyces sp E2 [47]. The introduction of the
XYLA resulted in a strain (RWB 202-AFX) capable of anaerobic growth on xylose
producing mainly ethanol, C0 2, glycerol and biomass and notably little xylitol (Table 1-2)
[19].
XI from another anaerobic fungus Orpinomyces, which shows 94.3% amino acid
sequence homology to Piromyces XI, have also been successfully expressed in S.
cerevisiae [22]. Further evolutionary engineering increased the growth rate and ethanol
yield of this strain but they are still not comparable to those of the evolved strain with
Piromyces XI [23].
The cloning and successful expression of Clostridium phytofermentans XI in S.
cerevisiae was also reported recently [24]. After a very short period of optimization, the
industrial strain BWY1OXyl exhibited noticeable growth and fermentation on xylose,
with an unusual high xylitol yield of 0.18 g/g of D-xylose consumed (Table 1-2). As an
advantage, the XI from C. phytofermentans is significantly less susceptible to inhibition
by xylitol (Ki=14.51±1.08 mM) than is the XI from the Piromyces strain (Ki=4.67±1.77
mM).
The XI pathway and the XR/XDH pathway were compared in the same
background [16]. S. cerevisiae engineered with the XR/XDH pathway (TMB3057 in
Table 1-2) had much higher aerobic growth and anaerobic xylose consumption rates than
the XI strain (TMB3066 in Table 1-2), but the ethanol yield was lower due to the cofactor
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imbalance. In hydrolysates, the XR/XDH pathway may have an advantage by detoxifying
5-hydroxymethyl-furfural (HMF) [48].
1.4 Xylulokinase (XK)
To obtain a higher specific rate of ethanol production, it is helpful to overexpress
genes involved in the conversion of xylose into intermediates of glycolysis [17, 18, 20,
49, 50], including xylulokinase and the Pentose Phosphate Pathway (PPP).
The S. cerevisiae genome contains the gene XKS1 coding for XK [51, 52], but the
XK activity in wild-type S. cerevisiae is too low to support ethanolic xylose fermentation
in strains engineered with a xylose pathway [30, 51, 53]. It is only when additional copies
of XKS1 are expressed that recombinant xylose-utilizing S. cerevisiae produce ethanol
from xylose [54]. However, nonphysiological or unregulated kinase activity may cause a
metabolic disorder [55]. It was indeed experimentally demonstrated that only fine-tuned
overexpression of XKS] in S. cerevisiae led to improved xylose fermentation to ethanol
[17, 56]. XYL3 from P. stipitis was reported to have higher xylulokinase activity than
endogenous XKS1 [17], and also have high specific activity on xylulose than xylitol,
avoiding any possible toxic xylitol-5P production[57].
1.5 Pentose Phosphate Pathway (PPP)
The main metabolic function of the PPP is to provide anabolic intermediates such
as ribulose 5-phosphate, erythrose 4-phosphate, and NADPH for biosynthesis and cell
growth. The flux through the nonoxidative PPP in S. cerevisiae was found to be much
lower than in other yeasts [58], which is sometimes interpreted to be a result of
prolonged selection of S. cerevisiae for carbon dioxide and ethanol production from
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hexose sugars. However, PPP activity is a crucial part of pentose metabolism, since it is
virtually the only way to introduce xylulose into the central metabolism.
The insufficient flux through the nonoxidative PPP in S. cerevisiae has been
confirmed by the superior pentose utilization by strains in which the enzymes of the
nonoxidative PPP [ribulose 5-phosphate isomerase (RKIl), ribulose 5-phosphate
epimerase (RPEl), transketolase (TKL1) and transaldolase (TALl)] have been
overexpressed. Overexpression of the endogenous S. cerevisiae transaldolase (TAL1)
resulted in improved growth on xylose [49]. It has been shown that the transaldolase from
P. stipitis is a better gene target, and gene overexpression of PsTAL1 did not cause
growth inhibition when cells were grown on glucose, unlike that of the S. cerevisiae
TALI [18].
Later, the overexpression of all four nonoxidative PPP genes was shown to
improve xylulose consumption by S. cerevisiae [59, 60]. Moreover, the improvement
resulting from the overexpression of the four genes was higher than when each gene was
overexpressed alone [61]. The simultaneous overexpression of the whole nonoxidative
PPP, together with GRE3 deletion, allowed growth on xylose in strains carrying a
bacterial XI [62] and in a strain carrying the Piromyces XI (strain RWB217, Table 1-2)
[20]. PPP overexpression also allowed superior xylose fermentation rates in combination
with high levels of XR and XDH (strains TMB3057, Table 1-2) [42, 62].
1.6 GRE3 Deletion
S. cerevisiae strains reduce xylose to xylitol with an endogenous xylose (aldose)
reductase encoded by the GRE3 gene [63] and other genes putatively encoding enzymes
CHAPTER 1. Introduction
capable of xylose reduction (GCY1, YPR1, YDL124W YJR096W) [64]. Xylitol strongly
inhibits the activity of XI [24, 65], and therefore deleting the GRE3 gene minimizes
xylitol production and improves xylose assimilation in S. cerevisiae strains using the XI
pathway [66]. Ethanol yields were also noticed to improve for XI-carrying strains with
reduced xylitol yields [20] (strain RWB217 v.s. RW 202-AFX in Table 1-2). However,
the aldose reductase endoded by GRE3 belongs to a group of generally stress-induced
proteins [63] and the deletion of it reduces the growth by 30% [67], which makes GRE3
deletion unfavorable in industrial applications.
1.7 Evolutionary engineering
Evolution through adaptation and natural selection is an iterative process of
genetic diversification and functional selection. It is nature's design algorithm, and is
believed that all natural biological structures were "designed" through this process so that
they would best "fit" in certain conditions. Evolutionary engineering is simply the
application of this first principle of biological design [68]. The use of evolutionary
engineering has proven to be very valuable for obtaining phenotypes of microorganisms
with improved properties, such as an expanded substrate range, increased stress tolerance,
and efficient substrate utilization [69]. Also, for S. cerevisiae, evolutionary engineering
has been extensively used to select for industrially relevant phenotypes in addition to
rational metabolic engineering, by prolonged cultivation of recombinant S. cerevisiae
strains in either anaerobic chemostat or sequential batch cultures.
Evolutionary engineering have been successfully emplcyed to obtain improved
xylose-utilizing strains (TMB3400[70], Cl, C5[71], BH42[62], RWB202-AFX[19],
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RWB218[21]), arabinose-utilizing [72, 73] and xylose-arabinose co-utilizing [74, 75] S.
cerevisiae strains. The best reported xylose-utilizing strain RWB218 was evolved from
engineered strain RWB 217(Table 1-2) through two stages: 85 generations in a xylose-
limited chemostat for xylose-uptake kinetics, followed by 35 cycles of sequential batch
reactor on mixtures of glucose and xylose. A single colony, RWB 218, was then isolated
from the sequential batch cultivation and on xylose alone it has the highest reported
specific anaerobic growth rate, xylose consumption and ethanol production rate to date
(Table 1-2).
Some of the resultant strains have been analyzed in order to identify molecular
traits related to the improved ethanolic fermentation of pentose sugars. High-throughput
technologies, such as transcription analysis [28, 72, 76], enzyme and metabolite analysis
[77] and inverse metabolic engineering [18] have been used. In many cases, the
mutations and alterations observed in mutant strains match the rational engineering
approach, confirming previous knowledge and hypotheses about control and regulation of
pentose metabolism. So far, no novel information has been obtained from high-
throughput molecular analyses that would greatly expand our knowledge about pentose
metabolism.
1.8 Xylose transporters
S. cerevisiae takes up xylose via its hexose transporters (Hxtlp-Hxtl7p, Gal2p,
Snf3p), which function by facilitated diffusion [78-80]. Many hexose transporters share a
similar structure, consisting of the most conserved 12 putative transmembrane domains,
and the most divergent in length and sequence are the cytosolic amino- and carboxyl-
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terminal regions [81-83] (Figure 1-2), And some of them show significant sequence
homology [84].
Figure 1-2. Topology of yeast sugar transporters80]
Engineered S. cerevisiae mainly uses the high-affinity system, e.g., Hxt4, Hxt5,
Hxt7 and Gal2, for xylose transport [85], but the HXTs exhibit a significantly lower
affinity for xylose (Km=49-300 mM) than for glucose (Km=1-28 mM) [7, 86]. Therefore,
glucose strongly inhibits the transport of xylose and restricts xylose assimilation [86, 87].
A metabolic control analysis study demonstrated that transport controlled xylose
conversion only at low xylose concentrations [88]. Overexpression of S. cerevisiae
hexose transporters in a xylose-utilizing yeast strain did not result in faster growth or
enhanced xylose fermentation, when the strain was not thoroughly engineered in the
xylose metabolism pathway [85]. However, during the evolutionary engineering of RWB
217, all the known enzymes for xylose assimilation overexpressed [21], and the improved
xylose uptake characteristics (vm doubled and Km decreased by 25%) had significantly
contributed to xylose fermentation of the resulting strain, RWB 218.
It was predicted that transporters with higher affinity to xylose exist in native
xylose-metabolizing yeasts, but few reports exist on expression of pentose transporters in
S. cerevisiae strains with limited success, although substantial research effort has been
made in attempting to isolate fungal xylose transporters [84, 85, 89-94]. This is in part
due to the difficulty in actively expressing heterologous membrane proteins. The first
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active heterologous expression of a glucose/xylose facilitated diffusion transporter
(GXF1, Km for xylose -0.4 mM, Table 1-3) and a glucose/xylose symporter (GXS1) from
Candida intermedia in S. cerevisiae was reported [84]. But neither transporter was able to
support vigorous growth of the S. cerevisiae strain on xylose. However, the expression of
Gxflp in recombinant S. cerevisiae was recently shown to improve xylose fermentation
[94].
Table 1-3 Biochemical characteristics of pentose transporting proteins [95]
Orgmism Transportar Type" Subrate(s) Ku (mM)f Reference
Prokaryote
&chr*ia rCO AraE Symp am 150-320 x10' Daruwalla et al. 1481
AraFGH ABC ar 4.J-6.1 x 10
XyIE Synp xyl 63- 170x 10 lienderson 1990
XyIFGH ABC xyl 0.2-4.0x 10 Sumiya et at 1995
Bacilus subdlis AaE am, gal. xyl ND Krispa and
Alhnansberger 1998
Eukaryote
Saxhamnyce cervisa Ga2 Unip ara, gal glu. xyl ND (xyl) Hamacher et at 2002;
Kou et at 1970
Hxtl Unip fm. glu, mn, xyl 880 (xyD Saloheimo et al. 2007
Hxt2 Unip fr% giu, man, xyl 260 (xyl)
Hxt4 Unip fru. glu, ma, xyl 170 (xy)
Hxt5 Unip fru, glu, mn, xyl ND (xyl)
Hxt7 Unip fm, gl mn, xyl 130 (xyD
cha spiriv SUTI Unip fro glu, xyl 1.5 (glu), 145 (xyb, 36 (fm) Weierstall et al. 1499
SUT2 Unip gia, xyl 1.1155 (glut, 49 (xyl)
SUT3 Unip fn, gal, gIn, xyl 0V31(glu)d, 103 (xyl). 49(fi), 176 (ga)
Canfbia inennakia GXSI Symp gin, xyl 0.2 (gIu), 0.4 (xyl) Leandr ct at. 21006
GXFI Unip giu, xyl 2 (g), 49 (xyl)
Heterologous sugar transporters from organisms other than yeast may also
function in yeast, if properly expressed and targeted to the plasma membrane. C. kessleri
HupI and A. thaliana Stp2 and Stp3 were functionally expressed in the plasma membrane,
as they supported growth of the hexose-transport-deficient yeast strain on glucose but not
on xylose [96]. None of the E. coli xylE and the predicted A. thaliana xylose-proton
symporters were able to support growth on xylose, most likely because these transporters
are not correctly targeted to the plasma membrane in a functional form [85]. Nevertheless,
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the expression of heterologous xylose transporters remains a feasible metabolic
engineering strategy to further increase the rate of xylose.
1.9 Thesis objective and overview
Efficient utilization of xylose is critical for the cost-effective bioconversion of
lignocelluloses. The primary objective of this thesis is to construct S. cerevisiae strains
that ferment xylose rapidly and thoroughly with a high yield of ethanol, to solve the
current limitations in biofuel production from lignocellulosic biomass.
In Chapter 2, xylose metabolism pathways were established in S. cerevisiae
together with the amplification of the downstream pentose phosphate pathway. The
performance of the resulting strains was evaluated in xylose batch cultivation, in order to
compare the two pathways and identify any limitation of xylose utilization.
In Chapter 3, evolutionary engineering approaches were used to obtain S.
cerevisiae strains with promoted xylose-utilization. The multiple-stage evolution
included aerobic and oxygen-limited batch cultivations, followed by anaerobic chemostat.
Xylose consumption was correlated to the growth rate during the process and quick
xylose-utilizing strains were isolated from the evolution, for further evaluation.
In Chapter 4, inverse metabolic engineering approach was designed and employed
in the metabolic and evolutionary engineered xylose-utilizing strains, to identify
genotypes that limit xylose fermentation. This was done by complementing the
unevolved S. cerevisiae strain with the genomic library of an evolved strain, and
screening on a xylose medium either by growth or a microfluidic-device-based screening
system.
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In Chapter 5, the engineered xylose-utilizing strains were genomically and
biochemically characterized. An in-depth study on the gene duplication of xylose
isomerase (XI) was launched to confirm the importance of XI expression in xylose-
utilizing strains.
In Chapter 6, the xylose fermentation was optimized on the metabolically and
evolutionarily engineered strain. Several other issues were also addressed that could
potentially improve the xylose fermentation, such as xylose transporters, other xylose
isomerases and a non-phosphorylating GAP dehydrogenase (gapN).
Chapter 7 concludes this thesis and discusses the significance of current and
future work.
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2.1 Introduction
To enter the central carbon metabolism, xylose must first be converted to xylulose
5-phosphate, an intermediate compound of the pentose phosphate pathway (PPP) (Figure
1-1). Two different pathways can be introduced in S. cerevisiae to provide xylose
utilization: the xylose reductase/xylitol dehydrogenase (XR-XDH) and xylose isomerase
(XI) pathways. The xylulokinase (XK) and the non-oxidative pentose phosphate pathway
(PPP) are also necessary for quick pentose assimilation.
In this Chapter, xylose-utilizing strains were successfully constructed, starting
from a haploid lab strain BF264-15D. Genes encoding the non-oxidative PPP were over-
expressed through integrating an extra copy of each gene into the chromosomes. The two
different xylose metabolic pathways, XR-XDH-XK (XYL1-XYL2-XYL3) and XI-XK
(XYLA-XYL3), were introduced via a multiple-copy 2p plasmid. The resulting strains,
H 131 -XYL 123 and H 131 -XYLA3 1, were verified through PCR and qRT-PCR in terms
of the expression of the key genes for xylose metabolism. However, both strains showed
only a slow aerobic growth rate (0.031±0.022 h- for H131-XYLA31 and 0.081±0.052 h-
'for H13 1-XYL 123), leaving room for further improvement.
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2.2 Materials and Methods
2.2.1 Strains and maintenance
Yeast and bacterial strains (summarized in Table 2-1) were stored in 15% glycerol
at -80'C. E. coli was grown in Luria-Bertani medium, and 100 mg/L of ampicillin was
added to the medium when required.
Table 2-1. Strains used in this chapter
Strains Characteristics Reference
Escherichia coli F <80lacZAM15 A(lacZYA-argF)U 169 deoR recAl endA1 Invitrogen
DH5a hsdR17(rk-, mk')phoA supE44 thi-I gyrA96 relA1 IX 18265-017
Pichia stipitis Wild type ATCC 58376
S. cerevisiae
BF264-15Dau MA Ta, adel, his2, leu2-3,112, trpJ-1, ura3, arg4 [97]
HI 10 BF264-15Dau, TRPJ::TDH3p-RK1-CYC~t-TDH3p-RPEJ-CYC]t This study
H120 H 110, HIS2::TDH3p-TKLI-CYCIt This study
H131 H120, ADEJ::TDH3p-PsTALJ-CYC~t This study
H131-XYL123 H131 (pRS426-XYL123) This study
H131-XYLA31 H131 (pRS426-XYLA3) This study
Wild-type yeast strains were routinely cultivated at 30'C in YPD or YPX
mediums (10g/L Yeast Extract, 20g/L Peptone and 20g/L D-glucose or D-xylose). SD
(Synthetic Defined, Table 2-2) media with appropriate drop-out and glucose (SDG) or
xylose (SDX) were used as selective media for cultivation and screening during strain
construction. For strain characterization, a minimum Dropout Base (DOB) medium with
glucose (YNBG) or xylose (YNBX) and a mixture of appropriate nucleotides and amino
acids were used. To select for yeast transformants with the auxotrophic markers or isolate
colonies, 20g/L Agar was added to appropriate mediums to make Petri dishes. All yeast
media were from Becton, Dickinson and Company, D-glucose (AR-ACS) was from
Mallinckrodt Baker, and D-xylose (>99%, cat#: X1500) was from Sigma-Aldrich.
30
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Table 2-2. Yeast Synthetic defined media
Description mg/l Product
Potassium Phosphate Mono 1000.000
Magnesium Sulfate 500.000
Sodium Chloride 100.000
Calcium Chloride 100.000
Biotin 0.002
Calcium Pantothenate 0.400
Folic Acid 0.002
inositol 2.000
Niacin 0.400
p-Aminobenzoic Acid 0.200
Pyridoxine Hydrochloride 0.400 c
Riboflavin 0.200
Thiamine HCI 0.400
BoricAcid 0.500
Copper Sulfate 0.040
Potassium iodide 0.100 0
Ferric Chloride 0.200
Manganese Sulfate 0.400
Sodium Molybdate 0.200
Zinc Sulfate 0.400
TOTAL 1705.844
Ammonium Sulfate 5000.000
Dextrose 20000.000
TOTAL 26705.844
Adenine 10,000
L-Arginine HCI 50.000
L-Aspartic Acid 80.000
L-Histidine HCI 20.000
L-Isoleucine 50.000
L-Leucine 100.000
L-Lysire HCI 50.000
L-Methionine 20.000
L-Phenylalanine 50.000
L-Threonine 100.000
L-Tryptophan 50.000
L-Tyrosine 50.000
Uracil 20,000
L-Valine 140.000
TOTAL 790.000
TOTAL 27495.844
Strains from frozen stock were usually streaked out on a plate and single colonies
were picked for further cultivation. Colonies picked from Petri dishes, for either strain
activation or transformation, were inoculated into 5mL of appropriate medium in a 14 mL
BD FalconTM Round-Bottom Tube using a sterile toothpick. For shake flask cultivation,
cells were grown in 50 mL of medium in a 250 mL Erlenmeyer flask shaken at 200 rpm,
with sponge plugs used for aerobic growth, and 100 mL of medium and rubber stoppers
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(size 6, with 23G1 syringe needle to release CO2 pressure during fermentation) were used
for micro-aerobic or anaerobic growth
Table 2-3. Plasmids used in this chapter
Plasmids Characteristics
pRS404
pRS404-RKIJ-RPEJ
pRS416GPD
pRS416GPD-RPE1
pRS416GPD-RKIJ
pRS416GPD-TKLJ
pRS416GPD-PsTAL1
pRS416GPD-XYL1
pRS416GPD-XYL2
pRS416GPD-XYL3
pRS426
pRS426GPD
pRS426GPD-GPDXYL3
pRS426-XYLJ-XYL2
pRS426-XYL123
pRS426-XYLA31
pUC19
pUCAD2
pUCAD2-PsTALJ
pUCHI2
pUCHI2-TKL1
YIp, TRP
TRP], TDH3p-RKIJ-CYCit, TDH3p-RPEJ-CYCIt
CEN, URA3, TDH3p-MCS-CYCt
pRS416GPD, Xba I/SpeI - ScRPE1 - Xho I*
pRS416GPD, Xba I - ScRKII -Xho I
pRS416GPD, Xba I - ScRPEI - Xho I
pRS416GPD, Xba I/SpeI - Ps TALI - Xho I
pRS416GPD, Xba I/SpeI - PsXYL1 - Xho I
pRS416GPD, Xba I/SpeI - PsXYL2 -Xho I
pRS416GPD, Xba I/SpeI - PsXYL3 -Xho I
2p, URA3
2p, URA3, TDH3p-MCS-CYC~t
pRS426GPD, Xba I-XYLA-Xho I
pRS426, TDH3p-Spe I-PsXYLJ-Xho I-CYCt-Pst I -
TDH3p-Xba I/Spel -PsXYL2-Hind III-CYCt
pRS426-XYLJ-XYL2, Kpn I-TDH3p-PsXYL3-CYCIt-Kpn I
pRS426, TDH3p-XYLA-CYC t, TDH3p-PsXYL3-CYC~t
Cloning vector, Ampr
pUC19, HindlII-ADH1-HindIII
pUCAD2, Pst I-TDH3p-PsTALJ-CYCit-Sac I
pUC19, HindlI-HIS2-HindlII
pUCHI2, Pst I-TDH3p-TKL]-CYC~t-Kpn I
*vector was digested with Xba I and insert digested with Spe I, Xba I and Spe I are compatible
2.2.2 Enzymes, primers and chemicals
Restriction enzymes, polymerase, DNA-modifying enzymes and other molecular
reagents were obtained from New England Biolabs. All general chemicals were
purchased from Sigma-Aldrich unless otherwise stated. Synthesized primers for PCR and
sequencing were purchased from Invitrogen (Table 2-4). Qiaprep spin miniprep kit was
Reference
[98]
This study
[99]
This study
This study
This study
This study
This study
This study
This study
[99]
[99]
This study
This study
This study
This study
ATCC 37254
This study
This study
This study
This study
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used for E .coli plasmid extraction. Zymoprep TM Yeast Plasmid Miniprep I kit with
Zymolyase from Zymo Research were used for yeast DNA preparation. Subcloning
efficiency or MAX efficiency DH5a chemically competent E. coli were from Invitrogen.
Table 2-4. Primers used in this study
Oligo name
RPEl-F-Spe I
RPEl-R-Xho I
RKIl-F-Xba I
RKI 1 -R-Xho I
TKL1-F-Xba I
TKL 1 -R Xho I
PsTAL1-F-Spe I
PsTAL1-R-Xho I
PsXYL1-F-Spe I
PsXYL1-R-Xho I
PsXYL2-F-Spe I
PsXYL2-R-Xho I
PsXYL2-R-Hind I
PsXYL3-F-Spe I
PsXYL3-R-Xho I
XYLA-F-Xba I
XYLA-R-Xho I
PsXYL3-F-Spe I
PsXYL3-R-Xho I
TDH3p-F-Sac I
TDH3p-F-EcoR I
TDH3p-F-Pst I
TDH3p-F-Kpn I
CYCIt-R-EcoR I
CYClt-R-KpnI
CYCIt-R-Pst I
Underline indicates restriction site
Sequence
AAAAACTAGTATGGTCAAACCAATTATAGC
ATACTCGAGCTAATCTAGCAAATCTCTAGAA
ATTATCTAGAATGGCTGCCGGTGTCCCAA
ATAACTCGAGTCACTTTTCGGTAACTTCA
ATTATCTAGAATGACTCAATTCACTGACAT
ATATCTCGAGTTAGAAAGCTTTTTTCAAAGG
GGACTAGTATGTCCTCCAACTCCCTTGA
TACTCGAGTTAGAATCTGGCTTCCAATTGT
CCACTAGTATGCCTTCTATTAAGTTGAACTCTG
AACTCGAGCAACCTTCTTAGACGAAGATAG
ATACTAGTATGACTGCTAACCCTTCCTTGGTG
TTCTCGAGCCAAGCGGTTGACTTACTCA
AAAAAAAAGCTTGACTTACTCAGGGCCGTCAATG
AAGTTTACTAGTAAAATGACCACTACCCCATTTG
TTCTCGAGTTAGTGTTTCAATTCACTTTCCATCTT
AATCTAGAATGGCTAAAGAGTACTTCCCA
TTCTCGAGTTATTGATACATTGCGACAATAG
AAGTTTACTAGTAAAATGACCACTACCCCATTTG
TTCTCGAGTTAGTGTTTCAATTCACTTTCCATCTT
GCTGGAGCTCAGTTTATCATTATCA
GCTGGAATTCAGTTTATCATTATCAATACTC
GCTGCTGCAGAGTTTATCATTATCAATACTC
GCTGGGTACCAGTTTATCATTATCAATACTC
ACTATGAATTCGGCCGCAAATTAAAGCCTT
TGGGTACCGGCCGCAAATTAAA
TTGCTGCAGGGCCGCAAATTAAAGCCT
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2.2.3 Yeast transformation
Yeast strains were transformed with lithium acetate/PEG transformation method.
1) Buffers:
a) PLI buffer: 1mL LiAc (IM), 1mL H20 and 8mL PEG 3350 (50%);
b) ssDNA: salmon sperm (1mg/mL) denatured at 950 C for 5 minutes, and placed
immediately on ice;
c) 0.1 M LiAc prepared fresh from 1 M LiAc stock.
2) Procedure:
a) Grow cells overnight in 5mL YP or selective medium, in 14 mL BD FalconTM.
Round-Bottom Tube;
b) Day 2, inoculate in 50 mL in 250 mL Erlenmeyer flask at OD 600 0.1-0.2, grow for
2-3 generations or until OD 6 00 reached 0.5-1;
c) Centrifuge culture in a 50mL falcon tube, aspirate medium;
d) Add 200-400 piL of 0.1 M LiAc, depending on the number of cells;
e) Re-suspend gently and leave at room temperature for 10 minutes, flick tubes 2-3
times;
f) Prepare solution in an Eppendorf tube in the following order:
i) 50pL of cells;
ii) <20 pL DNA (>1 ug, PCR or digestion products don't have to be purified);
iii) 300 pL of PLI
iv) 5 pL of ssDNA
g) Vortex briefly to mix;
h) Incubate at 42 'C for 25 minutes;
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i) Centrifuge at 2000xg for 3 minutes;
j) Aspirate supernatant, re-suspend in sterile PBS and then plate. (If cells need to
build resistance to antibiotic, incubate with YPD for at least 5 hours up to
overnight, wash with sterile PBS, then plate.)
Usually transformed yeast strains form colonies within 48 hrs on SDG plates; on
YNBG plates one more night might be required. On xylose plates (SDX and YNBX)
colony forming could take 3-10 days, depending on the xylose-utilizing ability of the
strain. If more than 4 days incubation were required, plates were put in another semi-
airtight container with an adequate amount of free water (emulate of a moist air incubator)
to avoid allowing the agar to dry up. The typical transformation efficiency is 102-104
CFU/ug DNA transformed, depending on the size and quality of DNA transformed as
well as the nature of recombination (plasmid or chromosomal integration, length of
homologous sequence, etc.).
2.2.4 Determination of nucleotides, metabolites, cell density and culture dry weight
The concentration and purity of DNA and RNA were determined by using a
NanoDrop 1000 Spectrophotometer (Thermo Scientific).
The main metabolites D-glucose, D-xylose, xylitol, ethanol, glycerol and acetic
acid were detected by a Waters Alliance 2695 HPLC with a Waters 410 Differential
Refractometer and a Bio-Rad HPX-87H column. The column was eluted at 50'C with 14
mM of sulfuric acid at a flow rate of 0.7 mL/min.
Cell density was determined by measuring absorbance at 600 nm (OD 600) against
a medium blank in a 10 mm cell using an Ultrospec 2100 pro UV/Visible
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Spectrophotometer (GE). Specific growth rate (plmax) was calculated using cell growth
data points from the early exponential growth phase:
p d ln(D 600) Equation 2-1dt
For dry cell weight (DCW), culture samples (1-10 mL) were filtered with pre-
weighed cellulose acetate syringe filters (diameter 25mm, pore size 0.2 pm; VWR). After
filtration of the broth, the cells were washed twice with de-ionized water, dried in a
microwave oven for 15 minutes at 500 W, desiccated in a 60'C oven for another 15
minutes, and then weighed. Duplicate determinations varied by less than 2%. DCW was
further correlated to OD600 for typical strains.
2.2.5 Quantitative PCR for determining gene copy number and expression
Genomic DNA was isolated using Promega Wizard Genomic DNA Purification
Kit. Quantitative PCR was performed by using a Bio-Rad iCycler iQ Real-Time PCR
Detection System and iQ SYBR Green Supermix. Quantitative PCR conditions were as
recommended by the supplier: 400 nM of each primer was used in one step of 95'C for 3
min, and 40 cycles of 95'C for 10 s, 550 C for 15 s and 72'C for 15 s. Endogenous PGK1
and ACT] were used as reference to quantify the copy number of genes of interest; 12.8,
3.2, 0.8, 0.2, and 0.05 ng of DNA template were used.
Quantitative RT-PCR was carried out similarly using the iScript One-Step RT-
PCR Kit with SYBR Green (Bio-Rad), under conditions recommended by the supplier.
PGK1 and ACT] were also used as reference and 10, 1, 0.1 and 0.01 ng of total RNA
template were used. All reactions were performed in triplicate.
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2.3 Results and discussion
2.3.1 Measuring of nucleic acids, metabolites and OD 600 and DCW
1) Nucleic acid analysis
At a wavelength of 260 nm, the extinction coefficient of 0.020 (pg/mL)~1-cm 1 was
used for double-stranded DNA and 0.027 (gg/mL)-cm' used for single-stranded DNA
and RNA[100]. Thus, an OD 260 of 1 corresponds to a concentration of 50 pg/mL for
dsDNA and 37 pg/mL for ssDNA or RNA. This method of calculation is valid for an OD
of up to 2. For a pure DNA sample, the OD260/OD 280 should be -2 and OD260/OD 230 ~1.8.
Lower OD 260/OD 280 is usually caused by protein contamination and lower OD 260/OD 230 is
common for gel extracted DNA.
2) HPLC chromatogram and standard curves
Usually HPLC assay is able to return reproducible data with <3% error at 95%
confidence. With the refractive index detector, the limits of detection (LOD) are ~0.5 g/L
for ethanol and acetate, while for glucose, xylose, xylitol and glycerol the LOD are -0.2
g/L. Table 2-5 and Figure 2-1 show typical chromatogram and retention times for the
major metabolites of interest.
Table 2-5. HPLC peaks annotation and HPLC standard curves coefficients
Metabolites Retention time (min) a b
Solvent 5.83 / / /
D-glucose 8.08 1.07522E-05 -0.018 0.99999
D-xylose 8.62 1.0648E-05 -0.131 0.99991
Xylitol 9.82 1.0583E-05 0.009 0.99998
Glycerol 11.77 9.60647E-06 -0.027 0.99989
Acetate 13.19 2.6206E-05 0.162 0.99692
Ethanol 18.99 2.61686E-05 0.104 0.99992
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Figure 2-1. HPLC chromatogram
Figure 2-2 and Table 2-5 are the standard curves and coefficients of each
metabolite of interest, based on linear regression.
[Metabolite](g/L) = a x peaksize + b Equation 2-2
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Figure 2-2. HPLC standard curves
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The coefficients of the standard curves are usually constant in one batch of
samples if the column is well conditioned. They were checked when the new mobile
phase solution was made or after a longer period of sampling (over a week), and re-done
if necessary.
3) Dry cell weight and OD600 correlation
The absorbance at 600 nm of the samples measured in a spectrophotometer is
correlated to the dry cell weight. Samples were diluted to appropriate concentrations with
absorbance between 0.1 and 0.5 for the highest accuracy. The optical density is also a
function of cell morphology such as size and shape, which are dependent on the nutrient
composition and the cell growth phase. Consequently, an independent calibration curve is
required for each condition in accurate research work.
0.03
y 0.271x - 0.0008
R2 = 0.9543 -
0 .0 2 5 ....- - ....... ... .... -
00. . .. . . . . . . . ..................................
A Yi
~0.015 ..................... ...  . . . . .
0
0.01A,
0 0.05 0.1 0.15
OD600-L
Figure 2-3. Dry cell weight calibration curve
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As shown in Figure 2-3, an optical density of 1 unit corresponds to approximately
0.2-0.3 g/L of dry cell, depending on the medium and growth phase. In this research a
coefficient of 0.267 g DCW/L-OD600 is used for the calculation.
2.3.2 Pentose phosphate pathway over-expression strain construction
Plasmids used in this study are summarized in Table 2-3. All S. cerevisiae strains
in this study were constructed from the BF264-15Dau parent strain (kindly provided by
Gerald R. Fink, Whitehead Institute). In order to integrate the genes of the non-oxidative
pentose phosphate pathway, several plasmids were constructed. To put the endogenous
RPEJ, RKIJ, TKLJ and Pichia stipitis TALI under the strong constitutive
glyceraldehydes-3 -phosphate dehydrogenase promoter (TDH3p), the genes were
amplified from S. cerevisiae or P. stipitis genomic DNA using appropriate primers (Table
2-4), digested by Xba I-Xho I or Spe I-Xho I, and ligated into Xba I-Xho I sites of
pRS416GPD, resulting in pRS416GPD-RPE], pRS416GPD-RKIJ, pRS416GPD-TKL1
and pRS416GPD-PsTAL1 (Table 2-3).
4) Integration of RPEJ and RKJJ
Expression cassettes TDH3p-RKIJ-CYCt and TDH3p-RPEJ-CYCit were then
PCR amplified from the above plasmids using appropriate primers, digested accordingly
and inserted to the Sac I-EcoR I and EcoR I-Kpn I sites of pRS404 to yield the integration
plasmid pRS404-RKI1-RPE1.
The plasmid was linearized by Hind III in TRP1 and transformed to BF264-
15Dau. After selection on tryptophan drop-out medium, Hi 10 was achieved.
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Pro-TRP
TRP1 Amp R
Ter-TRP 0
Fi ori COLElori
pRS404-RPE1-RKI1T7P -
751i619
P-GPD
T-CYC
ScRPEI
XbalSpel
T-CYC P-GPD
Figure 2-4. Integration plasmid pRS404-RPEJ-RKIJ
5) Integration of TKL1
pUCHI2-TKL1 (Figure 2-5) was constructed in a similar way, TDH3p-TKL1-
CYCt was amplified by PCR from pRS416GPD-TKL1 using primers TDH3p-F-Pst I and
CYClt-R-Kpn I, digested and ligated into Pst I-Kpn I sites of pUCHI2. The plasmid was
linearized by Hpa I in HIS2 auxotrophic marker and transformed to H110 to yield H120
after selection on a histidine drop-out medium.
P-seq-F
pUCHI2-GPDScTKL1
314
So-TKLI
COLEI
P(BLA)
pUCAD2-GPDPs
6050 ip
P-1
TAL1
P-lac
P-seq-R
P-lac,
P-seq-R P-
HIS2' P GPD Bmr HI (3"
y I(38;) N 1(3381) ADEI
Figure 2-5. Integration plasmids pUCHI2-TKLI and pUCAD2-PsTALI
T CYC
COLEI ori
eq-F
..SA 1(47)
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6) Integration of PsTAL]
For the transaldolase (TAL1), it has been shown that the TAL1 from P. stipitis is a
better gene target than S. cerevisiae TALl. It has higher specific activity and over-
expression of PsTAL1 did not cause growth inhibition when cells were grown on glucose,
unlike that of the S. cerevisiae TALl [18].
pUCAD2-PsTALJ (Figure 2-5) containing TDH3p-PsTALJ-CYC~t at Sac I- Pst I
sites was similarly constructed using pRS416GPD-PsTAL1 as template, linearized with
BamH I, and then integrated into the genome of H120 to form the PPP over-expression
background strain H131 (MA Ta, TRPJ::TDH3p-RKIJ-CYCit-TDH3p-RPEJ-
CYCNt,HIS2::TDH3p-TKLJ-CYClt, ADEJ::TDH3p-PsTALJ-CYClt, leu2, ura3, arg4).
2.3.3 Xylose metabolic pathway based on XI
For the xylose metabolic pathway based on xylose isomerase (XI), both genes
XYLA coding for XI and XYL3 coding for xylulokinase were expressed on a multicopy
plasmid pRS426GPD. In order to increase the activity of xylulokinase, the XYL3 gene
from Pichia stipitis was expressed in addition to the endogenous XKS1, since it was
reported to have higher activity [17]. Moreover, PsXYL3 was also reported to have
higher specific activity on xylulose than xylitol, avoiding any possible toxic xylitol-5P
production [57]. The PsXYL3 was amplified from the P. stipitis (ATCC 58376) genome
using PCR and inserted into pRS416GPD behind the TDH3 promoter. The TDH3p-
PsXYL3-CYCHt expression construct was then cloned into pRS426GPD at the Kpn I site,
resulting in pRS426GPD-GPDXYL3 (Figure 2-6).
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F1 ORI
TTP APr
T CYC
. - pRS426GPD-GPDXYL3
PM B1
PsXYL3
P Lac
T3P
Xba l1 Spe I P GPD
P GPD T CYC
Kpi I(4)
Figure 2-6. Cloning of PsXYL3
For the single site insertion, the TDH3p-PsXYL3-CYCft expression construct
could have two orientations but only the sense structure (same orientation for the two
THD3 promoters) was achieved.
The gene XYLA for XI from Piromyces sp. E2 was used for the construction of a
xylose metabolic pathway as it was the only reported XYLA that could be functionally
expressed in S. cerevisiae. Since the original source (Piromyces sp. E2 ATCC 76762) of
the XYLA gene had been discontinued, the XYLA was codon optimized and synthesized
(see Appendix), and then cloned into plasmid pRS426GPD-GPDXYL3 at the Spe I/ Hind
III sites to yield pRS426GPDXYLA-GPDXYL3 (Figure 2-7, called pRS426-XYLA3 for
short in further discussion).
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Figure 2-7. Plasmid pRS426-XYLA3
2.3.4 Xylose metabolic pathway based on XR-XDH
To construct the fungal redox xylose metabolic pathway, XYL1 coding for XR and
XYL2 coding for XDH from P. stipitis (ATCC 58376) were expressed under strong
constitutive TDH3 promoter, and put on the multiple copy plasmid pRS426 together with
PsXYL3. XYLJ and XYL2 genes were amplified from the P. stipitis (ATCC 58376)
genome using PCR and inserted into pRS416GPD behind the TDH3 promoter. XYL1-
CYCt and TDH3p-XYL2 were then PCR amplified from the plasmids and ligated by Pst
I (Figure 2-8). The ligation product was further amplified using PsXYLl-F-Spe I and
PsXYL2-R-Hind III primers, digested accordingly and ligated into plasmid pRS426GPD-
GPDXYL3 constructed above at the Xba I/ Hind III sites to yield pRS426GPDXYL1-
GPDXYL2- GPDXYL3 (Figure 2-8, named pRS426XYL]23 for short).
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Figure 2-8. Cloning of XYL1-XYL2-XYL3
2.3.5 Xylose-utilizing strains construction and characterization
H131 was then transformed with pRS426-XYLA3 and pRS426-XYL123,
separately, to achieve xylose-utilizing strains H131-XYLA31 and H131-XYL123. After
transformation, single colonies were isolated from selective SDG plate with uracil drop-
out. The specific growth rates of H131-XYLA31 and H131-XYL123 in SDX liquid
medium were 0.031 0.022 h-' and 0.081±0.052 h-1 under aerobic condition. As a control,
H131 showed no growth on xylose under similar conditions within an extended period.
After transformation, the xylose reductase/xylitol dehydrogenase (XYL1-XYL2)
pathway resulted in a higher growth rate on pentose sugar than the combination of the
xylose isomerase (XYLA) pathway. Similar results have been observed in the literature
45
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when comparing the two xylose metabolic pathways [101]. Heterologous expression of
xylose isomerase in S. cerevisiae has been proved to be very difficult and was successful
only when combined with extensive adaptation protocols [19, 45]. Therefore, further
evolution of the xylose-utilizing strains was necessary to improve their performance.
2.3.6 Verification of genes integration and transformation
The successful cloning was verified through PCR (data not shown). For
heterologous genes (XYLA, PsXYLJ, PsXYL2, PsXYL3 and PsTAL]) the existence of the
genes in the engineered strain were confirmed, while for endogenous TKL1, RPE1 and
RKI1 primer pairs spanning gene ORF and chromosome context were used to verify the
proper integration. The transcription of overexpressed genes was checked through qRT-
PCR using the endogenous housekeeping gene ACT] as reference, as shown in Figure 2-9.
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7F mE0 H 131 -XYLA3I
C) 0
Figure 2-9. Expression of transformed genes
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The expression level of RPE], RKI1 and TKL1 were rather low for the
background strain BF264-15D growing micro-aerobically on glucose, while for the
constructed H131-XYLA31 transcription level of PPP was elevated 1 to 3 orders of
magnitude after overexpression. The heterogeneous PsXYLA, PsXYL3 and PsTAL1 were
confirmed highly expressed in the H131-XYLA31 while showing no expression in the
wild-type BF264-15D. PsXYL1 and PsXYL2 expression were not assessed by qRT-PCR
since their expression could be indirectly verified by the growth of strain H131 -XYL 123
on xylose medium. Moreover, the strain was not extensively developed due to the
difficulty in resolving the XYL1-XYL2 cofactor imbalance.
2.4 Conclusions
Xylose-utilizing strains were successfully constructed through heterologous
expression of either XI-XK (XYLA-XYL3) or XR-XDH-XK (XYL1-XYL2-XYL3) xylose
metabolic pathways, which were named H 131 -XYLA31 and H131 -XYL 123 respectively.
Pentose phosphate pathway was also enforced to facilitate a high flux of xylose
assimilation, by overexpression of the non-oxidative PPP genes. The key genes for xylose
metabolism and their transcription were verified via PCR and qRT-PCR. Both strains
showed only a slow aerobic growth rate (0.031+0.022 h-' for H131-XYLA31 and
0.081+0.052 h'for H131-XYL123) after transformation, suggesting other expression or
regulatory limit in xylose utilization.
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CHAPTER 3. Evolutionary Engineering of Xylose-utilizing
Strains
3.1 Introduction
For the yeast Saccharomyces cerevisiae, evolutionary engineering has been
extensively used to select for industrially relevant phenotypes such as an expanded
substrate range and increased stress tolerance. The approach was also applied for
achieving pentose-utilizing strains [21, 71, 74, 75], especially on those using a XI or a
bacterial arabinose pathway. In previously constructed xylose-utilizing strains, the xylose
metabolic pathways together with the over-expression of pentose phosphate pathway did
not result in efficient xylose consumption, implying that there were other expression
and/or regulatory limitations in the system. In this chapter, evolutionary engineering was
employed to obtain improved xylose-utilizing strains, in multiple stages.
Started with H131-XYLA31 (Table 3-1, XYLA-XYL3 pathway on multiple-copy
plasmid, one extra copy of non-oxidative PPP genes under strong promoters integrated
onto chromosomes), the evolution underwent three stages including aerobic sequential
batch cultivation, oxygen-limited sequential batch cultivation and anaerobic chemostat
cultivation. Strains were isolated from the evolved populations periodically for evaluation
in terms of growth and fermentation. The finally evolved strain, H131E8-XYLA31,
displayed significantly improved anaerobic growth rate (0.120±0.004 h-) and xylose
consumption rate (0.916 g-g~lh-1) in minimal medium. The performances of H131E8-
XYLA31 were comparable to those of the best reported xylose-utilizing strain RWB 218,
before any optimization of fermentation.
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3.2 Materials and Methods
3.2.1 Shake flask batch cultivation
For the growth rate measurement, cells were grown in 50 mL of SDX or YNBX
medium in a 250 -mL Erlenmeyer flask shaken at 200 rpm. Sponge plugs were used for
aerobic growth. For micro-aerobic growth, rubber stoppers (with 23G1 syringe needles to
release CO 2 pressure during fermentation) were used to block oxygen diffusion, and 100
mL of medium was used to reduce the ratio of the headspace to the aqueous phase.
Beyond these approaches, nitrogen flow at about 1 L/min was used to sparge the medium
during the inoculation and sampling for about 30 seconds, to achieve an anaerobic
condition. Initial cell growth (OD600) was used for calculation of the maximum specific
growth rate.
Sequential batch cultivation was carried out under similar aerobic or oxygen-
limited conditions in YNBX or SDX medium. Once the culture reached the stationary
phase., an inoculum was taken to start a new batch at OD600 of 0.05-0.1.
3.2.2 Chemostat cultivation
Anaerobic chemostat cultivation was carried out at 30'C in 500-mL Water
Jacketed Spinner Flasks (Bellco Glass) with a fixed working volume of 200 mL, using a
leveled effluent driven by a peristaltic pump. Cultures were grown in YNBX medium
with various xylose concentrations. After inoculation and completion of the batch phase,
chemostat cultivation was initiated by feeding YNBX to the fermentor at increasing
dilution rates. The initial dilution rate (0.02 h-) was increased stepwise every time the
culture reached a steady state. Cultures were stirred at 200 rpm. The pH was monitored
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but not maintained. The effluent broth was checked periodically by microscopic analysis
to verify the absence of contamination, and analyzed to determine biomass and
metabolite concentrations.
3.2.3 Anaerobic fermentation of xylose
For the characterization of the engineered and evolved strains, pre-cultures were
grown in YNBX. The first pre-culture (5mL in a 14-mL BD Falcon Round-Bottom Tube)
grown overnight aerobically was used to inoculate a second 50-mL inoculum in a
plugged 250-mL flask. Cells from the late exponential phase were harvested and
inoculated at an OD600 of about 0.2. Fermentation was conducted in 1.3-liter BioFlo 110
bioreactors with 1 liter of 2xYNBX with 40 g/L xylose. Temperature was set at 30 'C,
agitation was set at 200 rpm, and pH was maintained at 5.0 by automatic addition of 2N
NaOH. Anaerobic conditions were obtained by sparging ultrapure nitrogen at 1 L/min
until DO dropped to zero at the beginning of the fermentation.
3.2.4 Strains, other materials and methods
Yeast strains constructed and evolved in this chapter are summarized in Table 3-1.
Table 3-1. S. cerevisiae strains used in this chapter
S. cerevisiae Strains Characteristics
BF264-15Dau, MA Ta, leu2-3,112, ura3, arg4, TRPJ::RKIJ- RPEJ,Hl31 HIS2::TKLJ, ADEJ::PsTALJ
H131-XYL123 H131 (pRS426-XYL123), PsXYL1, PsXYL2, PsXYL3
H131 -XYLA31 H131 (pRS426-XYLA3), Piromyces XYLA, PsXYL3
H131EI-XYL123 H13 1-XYL123, isolated from aerobic sequential batch cultivation
H131EI-XYLA31 H131 -XYLA3 1, isolated from aerobic sequential batch cultivation
H131 E3-XYLA31 H 13 1El -XYLA3 1, isolated from micro-aerobic sequential batch cultivation
H131E5-XYLA31 H131 E3-XYLA3 1, isolated from anaerobic sequential batch cultivation
H131E8-XYLA31 H131E5-XYLA31, isolated from anaerobic chemostat
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For other materials and methods such as the analysis of metabolites and cell
density please refer to Chapter 2, Materials and Methods.
3.3 Results and Discussion
The engineered S. cerevisiae strains H131-XYLA31 and H131-XYL123 (Table
3-1) were used to initiate the evolution. Both strains showed slow aerobic growth on the
xylose medium, and therefore make it possible to select for faster growth on xylose.
When xylose is used as the solo carbon source, the specific growth rate should be coupled
with xylose consumption. Specifically, under oxygen-limited conditions, the growth rate
should strictly correlate with both xylose utilization and ethanol production. Moreover,
xylose as a non-preferred carbon source for S. cerevisiae may serve as a nutritional stress
and induce spontaneous mutagenesis and genomic rearrangements, which could further
accelerate the evolution process [102-104]. Given these hypotheses, the evolution was
deployed in three stages, as described in Figure 3-1 below.
KSequential batch
STAGE 1 Transformation H Aerobic
70 generations
H131El-XYLA31
Sequential batch Sequential batch
STAGE 2 YNBX H131E3-XYLA31 YNBX
Anaerobic Micro-aerobic
60 generations 60 generations
H131E5-XYLA31
Chemnostat Chemnostat
STAGE 3 YNBX, Anaerobic H131E7-XYLA31 YNBX, Anaerobic H131E8-XYLA31D=0.02-0.12 h-1 xylose = 20-10 g/l
k 60 generations 40 generations
Figure 3-1. Scheme of strain evolution
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3.3.1 Aerobic sequential batch cultivation for improved growth on xylose
The first stage of evolution was carried out through aerobic sequential batch
cultivation in the relatively rich SDX medium, for both H131-XYL123 and H131-
XYLA31. Once the batch cultivation reached the stationary phase, it was re-inoculated
into a new batch at OD 600 of 0.05-0.1. The OD 600 of the stationary phase cultivation was
typically 8~10, and therefore, each batch is approximately equivalent to 7 generations.
The evolution lasted about 70 generations, during which the specific growth rates were
monitored, as shown in Figure 3-2.
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Figure 3-2. Evolution process of strains
31-Mar 30-Apr
under aerobic condition
The H131-XYL123 harboring the heterogeneous fungal xylose metabolic
pathway adapted relatively more quickly. In about 30-40 generations, a specific growth
rate of about 0.25 h-1 was achieved on xylose (as a reference, the growth rate on glucose
-A-H131-XYL123
-- H131-XYLA31
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and similar conditions was 0.4-0.45 h-). However, the H131-XYLA31 evolution was
much slower, and within about 70 generations, a pmax of about 0.2 h- was achieved.
At the end of this stage, cells from the shake flask cultivations were streaked on
an SDX plate for isolation of single colonies according to their sizes. The selected strains
H131El-XYL123 and H131El-XYLA31 (Table 3-1) were characterized in shake flasks
in terms of micro-aerobic fermentation performance, as shown in Figure 3-3 and Figure
3-4.
Fermentations were started with SDX (2% xylose) medium. Within about 80
hours, most xylose was consumed. An extended fermentation was required to deplete
xylose due to slow assimilation of xylose under low xylose concentration, when the
xylose transport likely limits its uptake. The important characteristics of both strains with
respect to micro-aerobic fermentation were calculated and summarized in Table 3-2.
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Figure 3-3. Fermentation profiles of H131E1-XYL123
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Figure 3-4. Fermentation profiles of H131E1-XYLA31
Table 3-2. Characteristics of H131E1-XYL123 and H131E1-XYLA31 fermentation
H131E-XYL123 H13 1E-XYLA31
m6ax n
At h
A[Xylose] g/L
A[Ethanol] g/L
A[DCW] g/L
A[Xylitol] g/L
ODaverage
DCWaverage g/L
qxylose
qethanol
g-L_ h-I
g*9g h~'
g L I h 
~'
g-g11 h'
EtOH yield g/g
Biomass yield g/g
Xylitol yield g/g
Under micro-aerobic conditions, the initial growth resembles aerobic growth
since oxygen exists in the headspace of the flask and the biomass concentration is low.
0.245±0.039
73.45
18.08
4.35
1.796
2.582
4.791
1.28
0.246
0.193
0.059
0.046
0.241
0.099
0.143
0.197±0.006
73.45
14.51
3.96
1.785
0.133
4.988
1.33
0.197
0.148
0.054
0.041
0.273
0.123
0.009
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H131El-XYLA31 showed an aerobic growth rate of 0.197±0.006 h 1, about six-fold
higher than the parent strain H131-A31. H131El-XYL123 exhibited a slightly higher
pmax of 0.245±0.006 h-1 and a growth profile similar to that of H131El-XYLA31.
The specific xylose consumption rate of H131El-XYL123 is about 30% higher
than that of H131El-XYLA31, implying that the ftngal XYL1-XYL2 pathway had a
higher efficiency in xylose conversion. This finding is consistent with the quicker
adaptation of the H131-XYL123 strain. However, the ethanol productivity of H131El-
XYL123 was only about 12% higher than H131El-XYLA31, mainly due to the lower
ethanol yield and higher xylitol yield of the XYL1-XYL2 pathway.
Xylitol accumulation is an obvious disadvantage of the XYL1-XYL2 pathway,
particularly under oxygen-limited conditions, owing to the cofactor imbalance of the
redox pathway. The xylitol production and yield of H13 1El-XYL123 were 2.582 g/L and
0.143 g xylitol/g xylose, respectively, while the xylitol accumulation of the XI-based
strain--H131EI-XYL123--was only 0.13 g/L, around the detection limit. The cofactor
rebalance is involved in either the protein engineering of XR/XDH (XYL1/XYL2) or other
complex metabolic network rearrangements, and both approaches had been under
development with limited success. On the other hand, the XI (XYLA) pathway gets
around the cofactor imbalance and is shown to be successfully established in S. cerevisiae.
Therefore, further research on xylose utilization focused on the XI pathway.
3.3.2 Evolution by oxygen-limited sequential batch cultivation
The evolved population from which the H131El-XYLA31 was isolated was
further evolved micro-aerobically and then anaerobically. A similar sequential batch
cultivation setup was applied except that minimal YNBX medium was used instead of the
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SDX medium. Each batch was equivalent to about 6 generations because the OD600 of the
culture in the stationary phase was only 4~5, about half as much as that on the SDX
medium. Strains were isolated from the culture periodically to test the performance. After
about 60 generations of micro-aerobic selection, a portion of the cells from the batch was
streaked on a SDX plate for isolation of single colonies. The strain with best anaerobic
specific growth rate was isolated (H131E3-XYLA31, Table 4-2). The sequential batch
cultivation was switched to anaerobic conditions for another 60 generations. One strain
(H131E5-XYLA31, Table 4-2) was isolated using a similar approach. The selected
strains H131E3-XYLA31 and H131E5-XYLA31 were characterized in batch cultivation
with respect to anaerobic growth and fermentation on xylose, as shown in Figure
3-5/Table 3-3 and Figure 3-6/Table 3-4, respectively.
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Figure 3-5. Fermentation profiles of H131E3-XYLA31
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Table 3-3. Characteristics of H131E3-XYLA31 fermentation
pimax
At
A[Xylose]
A[Ethanol]
A[DCW]
A[Glycerol]
ODaverage
DCWaverage
qxylose
gethanol
EtOH yield
Biomass yield
Glycerol yield
h-1
h
g/L
g/L
g/L
g/L
g/L
g-L h
g-g h
g-L h
g-g h
g/g
g/g
g/g
Growth phase
0.061+0.000
76.90
22.79
9.51
1.375
0.934
3.793
1.010
0.296
0.293
0.124
0.122
0.417
0.060
0.041
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Figure 3-6. Fermentation profiles of H131E5-XYLA31
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Table 3-4. Characteristics of H131E5-XYLA31 fermentation
Growth phase Overall
pmax h 1  0.073±0.002 /
At h 50.55 88.15
A[Xylose] g/L 26.85 37.61
A[Ethanol] g/L 11.02 15.97
A[DCW] g/L 1.490 1.495
A[Glycerol] g/L 1.228 1.949
ODaverage 3.043 3.439
DCWaverage g/L 0.811 0.917
qxyiose g-L h 0.531 0.427
g-g h 0.655 0.465
getanoi g-L h 0.218 0.181
g-g 1h 1  0.269 0.198
EtOH yield g/g 0.410 0.425
Biomass yield g/g 0.055 0.040
Glycerol yield g/g 0.046 0.052
The evolved strain H131E5-XYLA31 displayed an enhanced anaerobic growth
rate on xylose 20% higher than H131E3-XYLA31. However, the final biomass
concentrations for both strains were very similar. The data from the growth phase and the
overall fermentation process were used to calculate xylose consumption, ethanol
production and yield. The xylose consumption and ethanol production rates of strain
H131E5-XYLA31 were about 2-fold compared with H131E3-XYLA31, while the
ethanol yields were similar (0.42-0.44 g/g xylose) for the two strains. Considering the
slower xylose consumption and similar biomass accumulation of the micro-aerobically
evolved H131E3-XYLA31 to compare with H131E5-XYLA31, H131E3-XYLA31 had
about a 60% higher biomass yield during the growth phase, probably due to the emphasis
on growth during the evolution with oxygen. It took about 120 hours for H131E5-
XYLA31 to consume all the xylose, and for H131E3-XYLA31 the time required was
more than 140 hours (data not shown). Both strains had similar glycerol yields (0.04-0.05
g/g xylose) and low xylitol yields (about 0.005 g/g xylose).
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3.3.3 Evolution by xylose-limited chemostat cultivation
In the third stage of evolution, the selected strain H131E5-XYLA31 underwent
continuous culture under anaerobic conditions using xylose as the limiting carbon source.
After the batch reached the stationary phase, chemostat cultivation was started by feeding
YNBX to the fermentor at an initial dilution rate of 0.02 h-1. The dilution rate was
increased stepwise (0.02 h 1) whenever the culture reached a steady state, which is
defined as a stable cell (< 5% change of OD 600) concentration for 48 hours or 3x the
retention time, whichever came first. After approximately 30 generations, the dilution
rate had been increased from 0.02 to 0.08 h- and the cell density OD 60 0 was lowered to
2~3, as compared to initial values of 4-5 in the beginning. The OD600 was maintained
around 2 while further increasing the dilution rate for another 30 generations, until the
dilution rate reached 0.12 h-1.
In order to improve the uptake of xylose at a lower titer, the xylose concentration
of the feed was reduced from 20 g/L to 15 g/L for a period equivalent to 20 generations,
and then to 10 g/L for another 20 generations. However, under 10 g/L xylose and a
dilution rate of 0.12 h-1, the cell density dropped significantly, implying that the low
extracellular xylose concentration at this level seriously impeded its transport. Therefore,
further engineering on transporters may be necessary to improve transport of xylose at a
low extracellular concentration.
In the end, the whole cell population was analyzed at a feed xylose concentration
of 15 g/L and dilution rate of 0.148 h- (the maximum dilution rate that could be used to
maintain OD>2). After the continuous culture reached a steady state at OD6 00 about 2.2,
the xylose consumption rate was 1.568 g-g h , with an ethanol yield of 0.438 g/g xylose
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(Table 3-5). A single strain was then isolated and named H131E8-XYLA31, which was
characterized in anaerobic batch cultivation for comparison with its parent strains.
H131E8-XYLA31
8
7
6
5
4D
CO40
3
2
1
0
0 20 40 60 80 100 120
Time(h)
40
35
30
253
20
15 0
x
10
5
0
Figure 3-7. Fermentation profiles of H131E8-XYLA31
Table 3-5. Characteristics of H131E8-XYLA31 fermentation
pmax
At
A[Xylose]
A[Ethanol]
A[DCW]
A[Glycerol]
ODaverage
DCWaverage
qxyiose
qethanol
EtOH yield
Biomass yield
Glycerol yield
h-1
h
g/L
g/L
g/L
g/L
g/L
g-L- h~1
g -1 -1
g-L- h-
g-g h~
g/g
g/g
g/g
Chemostat
0.148
/
6.206
2.719
<0.03
N/A
2.190
0.584
0.916
1.568
0.401
0.687
0.438
0.094
N/A
Growth phase
0.120±0.004
40.05
28.62
12.10
1.327
1.057
2.926
0.78
0.715
0.916
0.302
0.387
0.423
0.046
0.037
Overall
/
71.60
39.35
17.22
1.503
1.565
4.117
1.098
0.550
0.501
0.240
0.219
0.438
0.038
0.040
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In the batch fermentation, the xylose consumption rate of strain H13 1E8-A31 was
about 40% higher than that of H131E5-A31, while the ethanol and glycerol yields
remained about the same. It took about 80 hours for H131E8-A31 to consume all the
xylose, significantly faster than for H131E5-A31 and H131E3-A31.
3.3.4 Discussion
In the present work, evolutionary engineering was used to improve growth and
fermentation of a recombinant S. cerevisiae strain on xylose. The strain used to initiate
evolution contains the XI-XK xylose-metabolizing pathway, as well as over-expression
of the PPP. Strain performance improvements were clearly demonstrated during the
three-stage evolution. Both the anaerobic growth rate and the xylose consumption rate
significantly improved in the final evolved strain H 131 E8-XYLA3 1.
In the three-stage evolution process, different aspects were focused on during
each stage. The first aerobic stage emphasized cell growth with a relatively rich medium
(SDX). The biomass yield was as high as ~0.5 g DCW/g xylose, while the xylose uptake
rate was not high and the ethanol production was rather low. This stage aimed to validate
the xylose metabolic pathway, as well as to resolve any possible inhibition of growth
caused by the non-preferred carbon source xylose.
The purpose of the second stage of micro-aerobic/anaerobic sequential batch
cultivation was to enhance xylose assimilation, since fermentation is the major way that
cells utilize xylose under such oxygen-limited conditions, and the cell growth should
highly correlate with xylose consumption. To compare with continuous cultivation, each
sequential batch underwent various growth phases from low initial OD 600 to saturation,
which potentially allowed selection for a shorter lag phase, better growth in the stationary
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phase, or higher final biomass accumulation. Unfortunately, none of the above
phenotypes was observed in the strain H 131 E5-XYLA3 1 after the evolution, to compare
with the strain H131 E3-XYLA3 1.
To further accelerate xylose assimilation, the continuous chemostat evolution was
carried out at a situation of relatively low cell density (OD 6oo 2~3) and moderate residue
xylose concentration (9-15 g/L), which was equivalent to the fast exponential growth
phase in batch culture. Therefore, a remarkable improvement of the growth rate of
H131E8-XYLA31 was achieved during the chemostat evolution. The lag-phase of
H131E8-XYLA31 on xylose was also shorter than that of H131E3-XYLA31 and
H131E5-XYLA31; this relative brevity partially contributes to the earlier finish of
fermentation (~80 hr) than the other two strains (~120 hr and more). In the chemostat
cultivation, the xylose-limited conditions represent a strong selective pressure for
improved uptake kinetics of the growth-limiting substrate xylose. The cell populations in
chemostat cultures tend to evolve towards a higher affinity for uptake of xylose; this
tendency was reflected by the decrease in the residual xylose concentration even when
the dilution rate elevated stepwise.
In the latter phase of the evolution, the feed xylose concentration was reduced
from 20 to 15 and eventually 10 g/L in order to improve its uptake rate at a low
concentration, which helps to reduce the residual xylose in the end of each batch. As a
result, the residual xylose concentration decreased to below 5 g/L when 10 g/L was used
in the feed, which greatly slowed down the specific xylose consumption rate and also
lowered the cell density. Therefore, H131E8-XYLA31 was isolated at a feed xylose
concentration of 15 g/L and a dilution rate of 0.15 h-1. In the batch fermentation, it took
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about 35 hours for H131E8-XYLA31 to use up the last 10 g/L xylose, which is better
than H131E5-XYLA31 (~50 hours) and H131E3-XYLA31 (not used up till the end of
fermentation). This shorter period is likely due to improvement of xylose transport,
although this is not confirmed experimentally; it suggests that extensive chemostat
evolution under low feed xylose concentration (and subsequently low residual xylose
concentration) may be necessary to further improve the transport activity.
As summarized in Table 3-6, the final evolved strain, H 13 1E8-XYLA3 1, showed
a maximum anaerobic growth rate of 0.120 h-1 as well as xylose consumption rate of
0.916 g-g-'h-1 in a batch cultivation. The data were taken from the growth phase to reflect
the maximum capacity of each strain in terms of xylose consumption and ethanol
production and also to be comparable with the data in the literature. The performance of
H 131 E8-XYLA31 is similar to that of the strains RWB 217 and RWB 218, which were
constructed and evolved using similar strategies. In batch fermentation, H131E8-
XYLA31 had the same growth rate but a 25% lower xylose consumption and ethanol
productivity, with similar ethanol and xylitol yields. In chemostat cultivation, however,
the best instantaneous specific growth rate (0.148 h-1) and xylose consumption rate (1.568
g-g~1h-1) were achieved, and both were about 25% higher than the best reported xylose-
fermenting strain, RWB218. Moreover, the strain H131E8-XYLA31 had a much lower
biomass yield (0.046 g/g) than RWB218 (0.100 ± 0.003 g/g) [21], suggesting inadequate
strain construction or under-optimized fermentation conditions, which will be discussed
in Chapter 6.
Table 3-6. Characteristics of xylose-fermenting strains
Yields g/g Ethanol Xylose
Strain Strain description Fermentation condition productivity cons. rate h
Ethanol Xylitol g-g h1  g-g 1h h
H131-XYLA31 XYLA, PsXYL3, PsTALI, TKLI, Aerobic batch, SDX, N/A* N/A N/A N/A 0.031±0.022RPE1, RKIJ 2% xylose
H131El-XYLA31 Selection of H131-A3 1, aerobic Micro-aerobic batch, 0.273 <0.01 0.041 0.148 0.197+0.006
sequential batch SDX, 2% xylose
H 13 1 E3 -XYLA31 Selection of H 13 1-A3 1, micro- Anaerobic batch, O.417 <0.01 0.122 0.293 0.061±0.002
aerobic sequential batch 2xYNB, 4% xylose
H131E5-XYLA31 Selection of H13 1E3-A3 1, Anaerobic batch, O.410 <0.01 0.269 0.655 0.073±0.002
anaerobic sequential batch 2xYNB, 4% xylose
Anaerobic batch, 0.423 <0.01 0.387 0.916 0.120±0.004
Selection of H131E5-A31, 2xYNB, 4% xylose 0
H131E8-XYLA31 xylose-limited anaerobic
chemostat Anaerobic chemostat, 0.438 <0.01 0.687 1.568 0.148
1xYNB, 1.5% xylose
RW 202-AFX[ 19] Piromyces XYLA evolved isolate sntetic maiu 0.42 0.021 0.14 0.34 0.03
RWB 217[20] Piromyces XYLA, XKS1, TALI, Anaerobic batch, 0.43 0.003 0.46 1.06 0.09TKLJ, RPEJ, RKJJ, Agre3 synthetic medium
RWB 218[3, 21] Selection of RWB 217 Anerobic maiu 0.41 0.001 0.49 0.9-1.2 0.12
*N/A = not tested
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Interestingly, two independent metabolic engineering attempts to achieve xylose-
fermenting strains using similar strain construction and evolution strategies resulting in
strains with similar performance. This result implies that a limit of the xylose metabolism
may have been reached in the current strains, while some major change of a regulatory
mechanism or introduction of essential heterologous genes (like a heterologous xylose
transporter) may be necessary for further improvement.
3.4 Conclusions
In this chapter the evolutionary engineering approaches were put into practice on
the metabolically engineered S. cerevisiae strain H131-XYLA31 for improved xylose
utilization. The multiple-stage evolution includes aerobic to oxygen-limited sequential
batch cultivation and chemostat cultivation with xylose as the limiting carbon source.
Both the anaerobic growth rate and the xylose consumption rate were significantly
improved after the evolution. A final single-strain isolate H 131 E8-XYLA31 rapidly grew
on and fermented xylose anaerobically in synthetic medium, with a specific growth rate
of 0.12 h-1 and a specific xylose consumption rate exceeding 0.9 g-g-'h'. The
fermentation performances were comparable to those of the best reported strain, RWB
218. However, the biomass yield of H131E8-XYLA31 was significantly lower than the
peer strain RWB 218 regardless of the similar initial growth rate, suggesting the potential
benefit of further metabolic engineering of the strain and optimization of the fermentation
conditions.
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CHAPTER 4. Inverse Metabolic Engineering for
Identification of Key Genotypes in the
Evolutionarily Engineered Strains
4.1 Introduction
Upon successful evolutionary engineering of S. cerevisiae towards rapid xylose
utilization, the resulting strain, H131E8-XYLA31, could be used as the host for further
rational metabolic engineering. However, it is of great interest to identify the genotypes
responsible for quick xylose utilization, to further improve the strain or transfer them to a
production host with other favorable features, which is essentially inverse metabolic
engineering [105, 106]. An inverse metabolic engineering approach based on functional
complementation and high-throughput screening has been successfully applied to identify
valid gene targets for improved xylose assimilation [18].
In this research, a similar strategy of functional complementation was employed
on the evolutionarily engineered xylose-utilizing strains to identify genotypes that
promote xylose fermentation. This genotype identification was done by transforming an
unevolved S. cerevisiae strain, H131-XYLA31, with the genomic library of an evolved
strain, H13 1E5-XYLA3 1, and then screening the resulting library on a xylose medium. A
microfluidic sorting system that sensitively detects quick xylose consumption was used to
screen the library. The main target identified was the duplication of the gene XYLA,
which was confirmed by the structural analysis of the screened plasmid and the qPCR
analysis of H 13 1E5-XYLA3 1.
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4.2 Materials and Methods
4.2.1 Construction of genomic library
Genomic DNA was isolated from the target S. cerevisiae strain and partially
digested with restriction enzyme Sau3A I. Then, DNA fragments in the size range from 3
to 8 kbp were isolated from an agarose gel after electrophoresis and purified with ethanol
precipitation. Shuttle vector pRS415 [99] was used as the backbone and digested with Sal
I. Both the genomic DNA fragments and the digested vector were treated with the DNA
polymerase I Klenow Fragment (3'--+5' exo-) and the appropriate dNTPs to reduce the 5'
overhang length from 4 to 2 nucleotides to avoid self-ligation of the vector as well as
ligation among genomic DNA fragments, as shown in Table 4-1.
Table 4-1. Genomic library cloning strategy
Recognition sites After digestion After Klenow Fragment treatment
Sal I 5'-GTCGAC 5'-G 5'-GTC3'-CAGCTG 3'-CAGCT 3'-CAGCT
Sau3A I 5'-NGATCN 5'-N 5'-NGA3'-NCTAGN 3'-NCTAG 3'-NCTAG
After ligation of the fragments and the pRS415 backbone by T4 ligase, the
resulting plasmids were transformed into ElectroMAX DH5X-E (Invitrogen) and plated
on agar petri dishes with ampicillin. The colony-forming unit (CFU) was counted, and
plasmid was extracted for analysis and transformation of yeast.
4.2.2 Microfluidic high-throughput screening
This high-throughput screening platform developed by Dr. Benjamin Wang [107]
uses microfluidic droplet emulsion technology to select for strains from libraries created
for inverse metabolic engineering applications. Wang's integrated system has the
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capability to encapsulate yeast cells in monodispersed nanoliter-volume aqueous droplets
surrounded by an immiscible fluorinated oil phase, culture the cells, mix the contents of
the droplets containing cells with a fluorescent enzymatic assay, measure the resulting
fluorescence, and sort droplets based on that measurement.
100 Jim Device#1
Culture
Media
Cells Microaerobicculture
of cells off-device
Device#2
Droplet Coalescence
Reinject
Droplets /Good
w/Cells
Assay -Bad
Reagent Delay Line for Measure
AssayReaction &Sort
Figure 4-1. Schematic of the microfluidic high-throughput screening platform
In the system shown in Figure 4-1, yeast cells in phosphate buffered saline (PBS)
are initially mixed with cell culture medium. Droplets are formed by combining this
aqueous stream with two streams containing a fluorinated oil and surfactant mixture. The
0.3nL droplets formed in this device are collected in a syringe, which provides a micro-
aerobic environment when capped. The syringe is placed in an incubator for culturing.
After being cultured for a predetermined amount of time, droplets from the incubated
syringe are re-injected into a second device, where they are combined with another set of
droplets containing fluorescent enzymatic assay reagents. After droplet coalescence, the
resulting droplets flow through channels for 30 seconds to allow the assay reaction to
proceed, as shown in Figure 4-2.
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Figure 4-2. Schematic of the xylose assay reactions
The extracellular concentration of the metabolite of interest is determined by
measuring the droplet fluorescence with a laser/photomultiplier tube system. Based on
this measurement, the droplets are sorted into one of two channels. This system as
currently configured can screen approximately 1-2 clones per second so that 104 clones
can be screened in less than 3 hours.
Note: This section is derived largely from the dissertation of Dr. Benjamin Wang
[107]. For more details about the materials and methods please refer to Chapter 2 of that
dissertation.
4.2.3 Strains, plasmids, and other materials and methods
The plasmids and strains used in this chapter are summarized in Table 4-2.
Table 4-2. S. cerevisiae strains used in this chapter
Plasmids and strains Characteristics
pRS415 Shuttle vector, CEN, LEU3
pRS415-geno Genomic library of H13 1E5-A31
pRS415-geno-W2 Isolate from pRS415-geno
E. coli DH5a Cloning host
H13 1 -XYLA31 H131 (pRS426-XYLA3), Piromyces XYLA, PsXYL3
H1315-XYA31Evolutionarily engineered strain, isolated from anaerobic sequential
H131E5-XYLA31batch cultivation
H131 -XYLA3 1 -geno Hi31-XYLA31 (pRS415-geno)
S3 1 -XYLA3 1 (pRS4H15) Control strain of Hi 3 r1 -XYLA3 1 -geno
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For other materials and methods such as yeast transformation and quantitative
PCR, please refer to Chapter 2, Materials and Methods.
4.3 Results
The inverse metabolic engineering approach was attempted by complementing the
unevolved S. cerevisiae strain of H131 -XYLA3 1 with genomic DNA fragments from the
evolved strain of H13 1E5-XYLA3 1 to identify factors that promote xylose fermentation,
as described in Figure 4-3.
Evolved S. cerevisiae E- Target genesH131E5-XYLA31
Confirm0
phenotype
Prepare genomic DNA (
Unevolved S. cerevisiae
H131-XYLA3 o
Partially digest by Sau3A I /p -
Recover 3k-8k fragments E i Screen for
Extrct pasmi I gowth / xylose-uptake
Ligteto ecorand retransform limprovement
Ligate to vector
O00
Transform E.colito 00 Transform
propagate p lasmid -300,000 colonies
--500,000 colonies 0 ge
Figure 4-3. Genomic library construction and screening
4.3.1 Genomic library construction
The genomic DNA of S. cerevisiae H131E5-A31 was isolated, digested,
recovered, modified, and ligated to predigested vector pRS415 to make the genomic
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library pRS415-geno. The transformation of pRS415-geno to E. coli yielded 5x 105 CFU
on plates.
The quality of the library was assessed by blue-white screening. Based on results
of colony-counting after series dilution and replating on an X-Gal plate, about 90% of the
colonies contained inserts. The quality of the library was also checked by plasmid
digestions, which showed an average insertion size of 3-5k bps (data not shown).
The library was then transformed to H 131 -A3 land plated on an SD medium with
20 g/L glucose and leucine drop-out, to yield about 3 x 105 yeast colonies on plates.
4.3.2 Genomic library screening
Two methods were used for screening of the yeast library H 131 -XYLA3 1 -geno,
including a high-throughput microfluidic screening system, which targets xylose
consumption of each single cell, and a screening based on cell growth rate by serial sub-
culturing enrichment followed by plating on xylose medium.
The microfluidic screening approach of the genomic library is described in
Chapter 3 of Wang's thesis, Screening for High Xylose Consuming Yeast Strains [107].
One round of screening was performed to select only a portion of the droplets, which is
about 13% coverage of the library.
For the other approach based on growth rate and colony formation, after 5 rounds
of sequential batch cultivation on SDX medium, cells were plated onto SDX agar plates.
SDX agar plates tended to dry out at 30'C during incubation over one week. Therefore,
for the selection of the library, plates were incubated in a secondary semi-confined
container with free water to retain moisture. Only about 50 colonies formed over
extended incubation. However, a similar number of colonies grew on the negative control
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H131-XYLA31 (pRS415) plate, implying that either the cell grew on another carbon
source on the agar plates or other background mutations (evolution) occurred during the
extended subculturing. Sixteen larger colonies on the H 131 -XYLA3 1 -geno plates were
picked for further evaluation.
4.3.3 Validation of the selected clones
The 16 selected larger colonies from the growth screening and 8 of the faster
xylose-consuming strains isolated from the microfluidic device screening were grown on
an SDX medium to verify growth rate, which was followed by the pRS415-geno plasmid
isolation and retransformation to H131-XYLA31 to further confirm the improved
growth/xylose-assimilating phenotypes.
Five isolates from the microfluidic device screening and one from the growth
screening passed the verification. The mutant W2 isolated from the microfluidic
screening showed the highest xylose consumption rate.
6
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Figure 4-4. Xylose consumption of strain H131-A31 transformed with plasmids [1071
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The cumulative xylose consumption in the course of 4 days for the control H131-
XYLA31 (pRS415), the mutant H 131 -XYLA3 1 -geno (W2), and H131 -XYLA31 with the
retransformed W2 plasmid H131 -XYLA3 1 -geno (W2-R) was generated using biological
replicates (Figure 4-4 [107]). The retransformed W2-R strain had a xylose consumption
of 2.6g/L after 4 days of culturing compared to 4.7g/L for mutant W2, suggesting that a
background mutation also occurred in the W2 mutant.
All plasmids were prepared for further analysis of the insertion by DNA
sequencing and restriction enzyme digestion.
4.3.4 Analysis of selected mutants
Interestingly, all five plasmids displayed highly similar structures. Here, we show
the analysis of one plasmid (pRS415-geno-W2) from the microfluidic screening to
demonstrate the structure. DNA sequencing using primers complementary to the plasmid
backbone and the XYLA gene allowed for the determination that the plasmid pRS415-
geno-W2 contained at least one full ORF of the XYLA gene plus two truncated fragments
of the ORF (Figure 4-5).
Sequencing
VYYLA
Sequencing
2.2k bps
Sequencing
- ICLA XYLA XA-
N
Figure 4-5. Sequencing results of plasmid pRS415-geno-W2
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For more details about the plasmid pRS415-geno-W2, the restriction enzyme Kpn
I was used to digest the plasmid and confirm that the XYLA gene construct (TDH3p-
XYLA-CYC~t) with a size of 2.2 kbps did exist on the plasmid (Figure 4-6 and Table 4-3,
Lane 1), and likely more than one copy duplicated since the intensity of the 2.2 kbps band
was even higher than that of the 5319 bps band. As a control, digestion analysis for the
plasmid pRS415 was also performed using the same restriction enzymes (Figure 4-6,
Lanes 2, 4).
To determine the XYLA gene copy number on pRS415-geno-W2, an EcoR I digest
was performed to confirm that the total size of the plasmid was about 14 kbps (Figure 4-6,
Lane 3); therefore, three full copies of the TDH3p-XYLA-CYC1t construct were
calculated by comparing Lane 1 and Lane 3 of Figure 4-6 [(-10000+3962) -
(5319+1621+688) bps ~ 3x2.2 kbps]. The copy number was also verified by analyzing
the band intensity of Lane 1 of Figure 4-6 with software ImageJ (NIH, data not shown).
Through these analyses, the sequence of pRS415-geno-W2 was proved to have three full
XYLA gene constructs with truncated constructs flanking on each side (Figure 4-7).
~.,2k bps-
Figure 4-6. Restriction enzymes digestion of plasmid pRS415-geno-W2 and control pRS415
~1Ok bps
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Table 4-3. Restriction enzyme digestion of plasmid pRS415-geno-W2 and control pRS415
Lane 1 2 3 4 5
Restriction KpnI EcoRI
Enzyme
Plasmid pRS4 geno- pRS415 DNA ladder pRS4 geno- pRS415
10000
8000
6000
5319 5000
Fragments 2264 4400 4000 10,458 3962
(bps) 1621 1621 3000 3962 2059
688 2000
1500
1000
500
LEU2t CEN6
LEU2
LEU2p_ PMB1
xylA-trun catec
xyIA-trun catecLd
xylAtrunatedpRS415-geno-W2
CYCit 14420 3 TDH3p
J*--CYCi t
TDH3p 4 ;o
XYLA
XYLA
CYCit TDH3p
TDH3p CYCit
XYLA
Figure 4-7. Map of plasmid pRS415-geno-W2
DNA sequencing also identified a S19Y (serine to tyrosine) point mutation in the
xylose isomerase enzyme; however, the effect of the point mutation was not confirmed
(data not shown).
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4.3.5 Copy number of genes from the xylose metabolism pathway
Since pRS415-geno-W2 carries only a fragment of the H13 1E5-XYLA31 genome,
it can be expected that more tandem copies of XYLA exist in the H131E5-XYLA31
genome. Also, it is interesting to find the duplication of another key xylose metabolic
gene, XYL3, which was introduced together with XYLA.
The copy numbers of genes XYLA and XYL3 in the unevolved strain H131-
XYLA31 as well as the evolved strains H131E5-XYLA31 and H131E8-XYLA31 were
evaluated through quantitative PCR. Endogenous PGK1 was used as a reference during
the quantification, since a single copy of PGK1 per haploid genome can be assumed. The
copy number of XYLA and XYL3 per genome was calculated by comparing their relative
amounts to the PGK1 present in the same sample, as shown in Figure 4-8.
128
OXYLA
64 
-~ uXYL3
32 -------------- ---- - ------------ ---------
E 8 ---------------- -- -- ------------ ---------
0
2 - ----------- -------- -- --------- - ------
1 -- ----- - -------- -- - - --- ---- - -
16
0.5
H 131 -XYLA31 H 131 E5-XYLA31 H 131 E8-XYLA31
Figure 4-8. Copy number of genes XYLA and XYL3
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For the unevolved strain of H131-XYLA31, 1.20±0.22 and 1.53±0.68 copies of
XYLA and XYL3 per genome were found, respectively (Figure 4-8). This result is
consistent with the fact that XYLA and XYL3 were carried on the same vector at a 1:1
copy ratio. However, it is interesting to notice that the vector copy number was rather low
given that the 2p plasmid usually keeps 10-20 copies without selective pressure.
For the evolutionarily engineered strains H131E5-XYLA31 and H131E8-
XYLA3 1, a similar high copy number of XYLA (50.6±14.4 and 43.7± 1.1) was confirmed,
while XYL3 gene's copy remained low for both strains (0.91±0.12 and 1.54±0.23 copies).
A higher expression level of XYLA by multi-copy is required [20], while moderate
expression of PsXYL3 in a low copy number in addition to endogenous XKS1 provides
enough xylulokinase activity [17]. However, it is interesting to observe the enormous
difference between the XYLA and XYL3 copy numbers, given that both genes were cloned
on the same vector at a 1:1 copy ratio. The duplication of XYLA is further discussed in
Chapter 5.
4.4 Discussion
The inverse metabolic engineering approach based on functional
complementation enables discovery of dominant genotypes in the evolutionarily
engineered strains, providing a good coverage of the genomic library and a high-
efficiency screening method. The present study obtained the proper library sizes in both E.
coli and yeast (105-106), thanks to the efficient transformation protocols. The genomic
library could possibly reveal the dominant genotypes of the target strain of interest. Other
recessive genotypes in the strain may require construction of a random knock-out library.
Such a library can be easily created for E. coli by using transposons; nevertheless,
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construction of a yeast knock-out library remains quite tedious, particularly for an
evolutionarily engineered strain with a poorly characterized background.
Two approaches were applied for the screening of the library. The microfluidic-
based screening system sorts for cells encapsuled in droplets according to xylose
consumption of each single cell (or population derived from a single cell in a droplet).
The other approach, selection for faster cell growth, is based on the hypothesis that genes
that increase xylose assimilation will also promote the growth rate of transformants on a
xylose medium. In many other cases the traditional growth-rate screening would work
effectively [18, 108]; however, the "good" transformants in the genomic library
constructed in the present work displayed only a minor growth advantage, and the
screening result is barely satisfactory (1 out of 16 isolates after screening were verified to
show fast growth phenotype). This small advantage is largely because the xylose
isomerase requires the presence of multiple copies to be potent. The microfluidic-based
screening, on the other hand, was proved to be much more sensitive (5 out of 8 isolates
after screening were verified to show a fast xylose consumption phenotype and 4 contain
meaningful inserts). Nonetheless, only part of the library was sorted due to the limit of
the current screening setup. The throughput of the screening needs to be further improved
to cover the whole library in a reasonable timeframe.
The plasmid pRS415-geno-W2 isolated from the genomic library contains three
full copies of the XYLA expression construct plus two truncated copies flanking each side.
The insert was confirmed to be digested by Sau3A I and ligated in the correct Sal I site.
Other isolated plasmids contain a similar tandem duplication of XYLA, but they vary in
copy number (3~4), digestion site (2 in XYLA ORF), and orientation of insert. The size of
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the insert ranges from 8.4-10.6k bps, and it exceeds the size of DNA collected from the
gel (up to 8k bps) for the ligation. Therefore, it is possible that recombination of XYLA
constructs occurred, resulting in increased copy number during the preculture before the
microfluidic screening or sequential culture in the selection process.
From the above observation, it seems possible to acquire higher copies of tandem
gene duplication from lower copies. The hypothesis is that the duplication initiated from
the unequal crossover of the TDH3p-XYLA-CYCt - TDH3p-PsXYL3-CYC1t construct
originally on the plasmid pRS426-XYLA3 and elongated thereafter (Figure 4-9).
Sac I Kpn I
Kpn I
XYLA - TL4 sV
7~
Figure 4-9. Scheme of unequal crossover of pRS426-XYLA-XYL3
One piece of evidence supporting this hypothesis was that the Kpn I site between
the adjacent XYLA duplication after evolution was from the original pRS426-XYLA3,
between the XYLA and XYL3. Moreover, the recombination could occur more frequently
than cell mitosis, since the pRS426-XYLA3 is a multi-copy plasmid. Nevertheless,
repeated attempts to isolate the recombined plasmid pRS426-(XYLA)N-XYL3 from
evolved strains of H 131 E-XYLA3 1 were unsuccessful. Further effort to cure the pRS426
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plasmid from the H13 1E-XYLA31 based on the URA3/5-FOA counter-selection resulted
in a strain without the URA3 genotype, but retaining xylose-utilizing ability. All the facts
implied that the XYLA duplication had recombined onto the genome during the
evolutionary engineering.
The locations of XYLA in the evolved strains were confirmed through PFGE
followed by chromosome blotting, as discussed in Chapter 5. The evidence of qPCR
results and the tandem gene duplication structure on pRS415-geno-W2 strongly
suggested that the duplication and integration of gene XYLA codes for XI was a major
recombination event during the evolutionary engineering, and a high expression level of
heterologous XI is necessary for rapid xylose utilization.
4.5 Conclusions
In this chapter, we demonstrated a successful inverse metabolic engineering
approach to identify gene targets responsible for a rapid xylose metabolic phenotype. A
genomic library of evolutionary engineered H131 E5-XYLA3 1 was constructed in E. coli,
then amplified, and finally retransformed to S. cerevisiae host for screening. The
microfluidic sorting system aiming for quick xylose consumption is much more sensitive
than the screening based on growth rate, despite lower coverage of the library. The main
target identified by both types of screening is the duplication of XYLA, which was
confirmed by the structural analysis of the screened mutant and the qPCR of the strain
H131E5-XYLA31.
Two obstacles limited our search: first, the difficulty of constructing the yeast
knock-out library for identifying recessive phenotypes, and secoid, the throughput of the
microfluidic screening method for a larger library.
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the Evolutionarily Engineered Strains
5.1 Introduction
Evolutionary engineering of S. cerevisiae containing the XI-XK xylose metabolic
pathway yielded strain H131E8-XYLA31, which quickly fermnts xylose. In addition,
the inverse metabolic engineering approach was successfully employed to identify the
tandem XYLA duplication as a key genotype in the evolved strains. However, the
genotype of the evolved strains still remains unclear and more in-depth knowledge is
needed for interpreting and further improving the strain. This chapter describes the
characterizations of the engineered xylose-utilizing strains on the genomic,
transcriptional, and biochemical levels. In particular, the duplication process of XYLA
was verified since the method can be possibly used for over-expression of other genes of
interest.
The expansion of XYLA and consequently high expression level of XI were
confirmed by qPCR, blotting techniques, and enzyme activity assay. In the series of
evolved H131E-XYLA31 strains, XYLA was proved to integrate into the chromosomes
and exist in tandem gene duplication (TGD) structure. The evolution process was
successfully reproduced, and XYLA expansion could originate from different initial XYLA
constructions. The location-specific XYLA integration and duplication could also be
achieved. The XK (XYL3) form P. stipitis could be efficiently expressed in S. cerevisiae
at low copy number. Mutations on GRE3 that potentially al olish XR activity were
discovered in the evolutionarily engineered strains.
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5.2 Materials and Methods
5.2.1 Southern blot
7) Restriction digestion of genomic DNA.
The gDNA was treated as follows. The 10-pg genomic DNA was digested in 400
il total volume with 3 units of restriction enzyme (EcoR I or Xba I) per pg DNA at 37'C
overnight. Then 0.1 volume 3 M sodium acetate (pH 5.2) was added and mixed well.
Next 1 volume ice-cold 100% isoproponal was added. The solution was precipitated at -
80'C for 30 minutes and spun in a microfuge at high speed for 20 minutes. After being
aspirated, the DNA pellet was washed with 70% ethanol and spun in a microfuge at high
speed for 10 minutes. The pellet was aspirated and air-dried (or Vacufuged) for 5 minutes.
Finally, it was resuspended in 15 pl 10mM Tris pH 7.5 and 3 pl 6 x DNA-loading buffer
was added.
8) Agarose gel electrophoresis
Samples and marker were loaded into 0.8% agarose gel in TAE. They were
electrophoresed at 4 Volts/cm for 2-4 hours and then stained by SYBR gold and
photographed with a fluorescent ruler.
9) Southern transfer
Denaturation: gel was soaked in two gel volumes of 1.5 M NaCl / 0.5N NaOH for
2 x15 minutes. Neutralization: gel was soaked in two gel volumes of 1.5 M NaCl / IM
Tris-HCl (pH7.5) for 2 x15 minutes, and then in two gel volumes of transfer buffer (10 x
SSC, Saline-Sodium Citrate, 1.5 M sodium chloride and 150 mM trisodium citrate, pH
7.0) for 15 minutes.
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Transfer was set up in a large electrophoresis tray with transfer buffer (10 x SSC).
The following items (gel-sized, saturated with transfer buffer) were placed on the middle
support: Wick (3mm paper); 3 pieces of Whatman 3MM paper; Gel (upside down);
Hybond-N+ membrane (GE); 3 pieces of Whatman 3MM paper; dry 5-cm stack of paper
towels; glass plate with weight (-500 g). DNA transfer was carried out overnight.
The next day, the blotting material was taken off and the position of the wells was
marked with a very soft lead pencil. The membrane was placed on a wet paper towel
(with 2 x SSC) of equal size. The DNA was immobilized by using a Stratalinker@ UV
Crosslinker (auto crosslink mode).
10) Hybridization
The membrane was placed in a hybridization bottle with 25-ml Church buffer (1%
BSA, 1 mM EDTA, 0.5 M Na-P0 4 pH 7.2, 7% SDS), and then incubated in a
hybridization oven at 68'C for 1-2 hours. DNA probes labeled by [32P]dCTP were
prepared using the Prime-It II Random Primer Labeling Kit (Stratagene, La Jolla, CA).
The denatured probe was added to the hybridization solution. The solution was incubated
in a hybridization oven at 68'C overnight.
11) Wash
The membrane was soaked 2-3 times for 30 minutes each with 100 ml of wash
buffer (0.2 x Church buffer, 0.1% SDS) in a hybridization oven at 68'C, then for 15
minutes in 100 ml of wash buffer at room temperature.
12) Detection
After washing, the membrane was blotted with filter paper (Whatman 3MM) to
remove most of the excess moisture. Moist blots were wrapped in plastic wrap prior to
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autoradiography. The blots were exposed to a storage phosphor screen (GE) for 1 to 3
days and scan with a TyphoonTM 9400 scanner (GE).
5.2.2 Northern blot
RNA gel electrophoresis was modified from Molecular Cloning [100]. The 4uL
RNA, luL 0.2M Na-P0 4 (pH 7.0), lOuL DMSO, and 3.75uL 6M (40%) Glyoxal were
mixed and incubated at 50 degrees for one hour to denature the RNA. The gel box and
comb were treated with 3% H20 2 and 0.8% agarose gel in 10mM Na-P0 4 (pH 7.0 in
DEPC H20). The loading buffer was added to the samples and mixed well. Samples were
loaded and run at 4V/cm until bromphenol blue had migrated approximately 8 cms
(approximately 3 hours). The neutral transfer and subsequent steps were the same as with
the Southern blot.
5.2.3 Pulsed field gel electrophoresis (PFGE) and chromosome blot
Chromosomal DNA was prepared as described by Carle and Olson [109].
Chromosomes were separated on a 1% agarose gel (Bio-Rad) in a 0.5x TBE buffer at
6V/cm at 14 'C, using a Bio-Rad CHEF-DIII mapper apparatus. The following migration
conditions were used: a pulse time of 60 s for 15 hours and a pulse time of 90 s for 9
hours with an angle of 120'. The gel was stained with ethidium bromide to identify the
chromosomal pattern specific to each strain.
The PFGE gel was treated with UV irradiation using Stratalinker@ UV
Crosslinker (auto crosslink mode). The subsequent steps for the chromosome blot were
the same as for the Southern blot.
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5.2.4 XI activity assay
S. cerevisiae was grown to an exponential phase in YNBG or YNBX medium.
Cells were harvested by centrifugation for 10 min at 8,000xg and 4C. The pellet was
washed twice with chilled washing buffer (10 mM phosphate buffer, 2 mM EDTA, pH
7.5) and suspended in chilled extraction buffer (100 mM phosphate buffer, 2mM MgCl 2,
1mM dithiothreitol, pH 7.5). The suspended cells were mixed with 0.5-mm glass beads
(Sigma), vortexed at maximum rate for 1 minute, and then cooled on ice for a similar
period. This procedure was repeated for up to 10 min. The glass beads and cellular debris
were removed by centrifugation for 15 min at 15,000xg and 4'C, and the crude extract
collected was used for the enzyme assay. The total protein concentration in cell extracts
was determined using the Pierce Coomassie Protein Assay Reagent Kit (Pierce
Biotechnology, Rockford, IL) with bovine serum albumin as the standard.
XI SDH
D-xylose o D-xylulose Xylitol
NADH NAD+
Figure 5-1. Xylose isomerase assay
Xylose isomerase activity in cell extracts was determined spectrophotometrically
using a method modified from Kersters-Hiderson et al. [110]: the assay mixture (1 ml)
containing 100 mM Tris-HCl buffer (pH 7.5), 10 mM MgCl 2, 0.2 mM NADH, 2 U
sorbitol dehydrogenase (Roche), and 20 pl of cell extract was equilibrated at 300C for 5
min. The reaction was started by the addition of D-xylose to a final concentration of 200
mM. The assay was performed at 30'C for 10 min using an Ultrospec 2100 pro
UV/Visible Spectrophotometer (GE Healthcare Biosciences). An extinction coefficient at
340 nm of NADH of 6.3 mM 1cm- was used to calculate specific activity. One unit of
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xylose isomerase activity was defined as the amount of enzyme required to produce 1 PM
of xylulose per minute under the assay conditions.
5.2.5 XK activity assay
Xylulokinase activity was measured according to the method of Shamanna and
Sanderson [111].
XK
D-xylulose D-xylulose-5-P
NAD+ NADH ATP ADP
D-lactate pyruvate PEP
Figure 5-2. Xylulokinase assay
Cell extraction and protein concentration determination were done as described
above in the XI assay. The assay mixture (1 ml) containing 20mM tris-HCl (pH7.5),
2mM ATP, 0.2mM PEP, 3mM Glutathione, 0.1mM NADH, 2mM MgCl 2 , 5mM KCN
(NADH oxidase inhibitor), 5mM NaF (ATPase inhibitor), 150mg/L LDH-PK (~30U for
each enzyme), and 20uL cell extract was equilibrated at 30'C for 5 min. The reaction was
started by the addition of D-xylulose to a final concentration of 2 mM. The assay was
performed at 30'C for 10 min using an Ultrospec 2100 pro UV/Visible
Spectrophotometer (GE Healthcare Biosciences). An extinction coefficient at 340 nm of
NADH of 6.3 mM'cm- was used to calculate specific activity. One unit of xylulokinase
activity is defined as the amount of enzyme that phosphorylates 1 imol of xylulose per
minute under the assay conditions.
5.2.6 Plasmids, strains and other materials and methods
The strains and plasmids used in this chapter are summarized in Table 5-1.
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Table 5-1. Strains and plasmids used in this chapter
Strains and plasmids
S. cerevisiae strains
H131
H131 lE-XYLA31
H131E3-XYLA31
H131E5-XYLA31
H131E8-XYLA31
H131-LEU2
H131-gre3A
H142
H142-p416A
H142-p416A2
H142-p426A
H142-p4O5A2
H142-p4O6A2
H142E-p4l6A
H142E-p416A2
H142E-p426A
H142E-p4O5A2
H142E-p4O6A2
Plasmids
pRS415GPD-yECitrine
pRS415TEF-yECitrine
pRS415PGK1-yECitrine
pRS415HXT71r-yECitrine
pUCARI
pUCARI-PsXYL3
pRS416 HXT7Tr-XYLA
pRS416 HXT7T,-(XYLA) 2
pRS426GPD-XYLA
pRS405
pRS406
pRS405-(XYLA) 2
pRS406-(XYLA) 2
Characteristics
BF264-15Dau, MA Ta, leu2-3,112, ura3, arg4, TRPJ::RKIl- RPEI,
HIS2::TKLJ, ADEJ::PsTALJ
H131 -XYLA3 1, isolated from aerobic sequential batch cultivation
H 13 1-XYLA3 1, isolated from micro-aerobic sequential batch cultivation
H13 1-XYLA3 1, isolated from anaerobic sequential batch cultivation
H131 -XYLA3 1, isolated from anaerobic chemostat
H 131, leu2-3complemented by pRS405 containing LEU2
H131, gre3::LEU2
H 131, A RG4::JHXT7p-PsXYL3-CYC1t
H142 (pRS416 HXT7r,-XYLA)
H142 [pRS416 HXT71T-(XYLA)2]
H142 (pRS426GPD-XYLA)
H142 [pRS405-(XYLA) 2]
H142 [pRS406-(XYLA) 2]
H142-p416A, isolated from aerobic sequential batch cultivation
H142-p416A2, isolated from aerobic sequential batch cultivation
H142-p426A, isolated from aerobic sequential batch cultivation
H142-p405A2, isolated from aerobic sequential batch cultivation
H142-p4O6A2, isolated from aerobic sequential batch cultivation
pRS415, TDH3p- yECitrine-CYClt
pRS415, TEFlp-yECitrine-CYCJt
pRS415, PGKlp- yECitrine-CYCl t
pRS415, HXT7Trp - yECitrine-CYClt
pUC19, HindII-ARG4-HindIlI
pUCARI, HXT7Trp-PsXYL3-CYC~t
CEN/ARS ori, URA3, TDH3p-XYLA-CYC~t
CEN/ARS ori, URA3, 2 copies of HXT7rp-XYLA-CYCJt in tandem
2p ori, URA3, TDH3p-XYLA-CYC t
YIp, LEU2
YIp, URA3
LEU2, 2 copies of HXT7Trp-XYLA-CYC t in tandem
URA3, 2 copies of HXT7rp-XYLA-CYC t in tandem
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Fluorescence of yECitrine was monitored in a Hitachi F2500 Fluorescence
Spectrophotometer at excitation/emission wavelengths of 402nm/432nm, using 1-cm
cuvettes. For other materials and methods such as cell cultivation, yeast transformation,
and quantitative PCR, please refer to previous chapters.
5.3 Results and Discussion
5.3.1 Verification of tandem gene duplication of XYLA
In order to test the hypothesis of unequal crossover, which possibly led to the
tandem XYLA duplication, the XI-XK pathway was reconstructed in the PPP over-
expressing host strain, H 131. To achieve a moderate activity of xylulokinase, one copy of
PsXYL3 was integrated into the genome. The TDH3 promoter for the XYL3 gene was
replaced with a constitutive truncated IXT7 promoter [112] to avoid further
recombination with the TDH3p-XYLA-CYC1t. Carried on a low copy CEN/ARS plasmid,
the HXT7rr promoter was tested using codon-optimized GFP yECitrine [113] as a
reporter in the host H 131 E3-XYLA3 1.
As shown in Figure 5-3, the HXT7r promoter showed an expression level similar
to that of the TDH3 promoter and stronger than the other two constitutive promoters of
TEF] and PGK1. The HXT7Tr-p-PsXYL3-CYCJt construct was then cloned into pUCAR1
at the EcoR I- BamH I site, and the resulting pUCAR I-PsXYL3 was linearized with Nhe I
for transformation of H 131, resulting in strain H 142 (Table 4-2).
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Figure 5-3. Expression of yECitrine under various promoters
For the reconstruction of a xylose-metabolizing strain, H 142 containing XYL3 and
PPP genes was transformed with plasmids with XYLA (Table 4-2), resulting in the
following strains (Table 5-1):
1) H142-p4l6A, one copy of XYLA on a low-copy-number CEN/ARS plasmid;
2) H142-p416A2, two tandem copies of XYLA on a low-copy-number CEN/ARS
plasmid for verifying unequal crossover on the plasmid;
3) H142-p426A, one copy of XYLA on a 2-p multi-copy plasmid;
4) H1i42-p405A2, two tandem copies of XYLA integrated into the leu2 locus on
chromosome III of H142; and
5) H142-pRS406A2, two tandem copies of XYLA integrated into the ura3 locus
on chromosome V of H 142.
The resulting strains were evolutionarily engineered using an approach of aerobic
sequential batch cultivation similar to that described in Chapter 3, but in a rich medium
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(YPX) to accelerate the process. After about 2 weeks, substantial growth on xylose was
observed for all tested strains, and the cultivation was switched to the synthetic defined
medium SDX for another two weeks, which is equivalent to about 30 generations. The
micro-aerobic growth of the resulting strain (named H142El-vector-XYLA) was
compared with that of the previous evolutionarily engineered H131El-XYLA31 and
H131E3-XYLA31, as shown in Figure 5-4.
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Figure 5-4. Micro-aerobic growth of H131E/H142E strains
All of the newly evolved Hi 42E strains showed a growth rate between that of the
aerobically evolved H131El-XYLA31 and that of the micro-aerobically evolved
H131 E3-XYLA3 1, indicating that the new strategy of construction and evolution worked
efficiently. However, none of the newly evolved strains out-performed H 131 E5-XYLA31
(data not shown), implying that extended oxygen-limited evolution is necessary for
further improvement of the new strains.
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From none of the 3 plasmid-based strains H142E-p4l6A/p4l6A2/p426A could
the plasmid be segregated after evolution. The observation was the same as for the
H131E-XYLA31 strains. Interestingly, the H142El-p416A containing only one initial
copy also got evolved after adaption, suggesting that recombination mechanisms other
than the hypothesized unequal crossover may occur.
For the 2 XYLA integration strains of H142E-p4O5A2/p4O6A2, the locations of the
XYLA integration were verified by PCR.
CYC t
HXT7-Tr-p
XYLA
P-XYLA49
LEU2 HXT7-Tr-p XYLA CYC-t LBJ2 P-LBJ2-post-ter
Figure 5-5. (XYLA) 2 integration in LEU2 of H142-p4O5A2
In H142E-p4O5A2, primers P-XYL49 (5'-ACAAACCTCTGGTAAGCAGGA
ATTGTACGAAGCTATTGTCGCAATGTATCA) in the XYLA open reading frame and
P-LEU2-post-ter (5'-GCCCATTCTTCCATCAGATTTGGTATTGG) were used to
successfully amplify a 3.3-kbps fragment. The size of the PCR product and its
sequencing result confirmed the expected location of the XYLA integration in LEU2.
CYCI 4
HXT7-Tr.p
URA3 XYLA
P-URA3-rec-F P-XYLA49
P-URA3-pre-pro CYC1 -t \\ I XYLA HXT7-Tr-p URA3
Figure 5-6. (XYLA) 2 integration in URA3 of H142-p4O6A2
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In H142E-p4O6A2, the primer P-XYL49 and two sense primers P-URA3-pre-pro
(5'- GGTTAATGTGGCTGTGGTTTCAGGGTCC) and P-URA3-rec-F (5'-
CCGCTAAAGG CATTATCCGC) were used to amplify either a 2.2 or a 1.7 kbps
fragment. However, only a PCR product sized about 1 kbps could be achieved using
primer P-XYL49 and P-URA3-pre-pro. The sequencing result showed a structure of
truncated URA3 flanked by a retrotransposon gene Tyl sequence (Figure 5-7), suggesting
that some genome rearrangement occurred during the evolution. The structure and
location of XYLA duplication will be investigated in the following sections by Southern
and chromosome blots.
URA3 truncated Tyl truncated
Figure 5-7. Sequencing of URA3 context in H142-p4O6A2
A quantitative PCR was used to evaluate the copy numbers of XYLA in the H142E
strains, as shown in Figure 5-8.
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Figure 5-8. qPCR for XYLA copy numbers in H142/H142E strains
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As expected, elevated copy numbers (12-49) of XYLA in all of the H142E strains
were revealed, as compared with 0.9-2.4 copies in the unevolved H142 strains.
5.3.2 Southern blot
The Southern blot was run for the evolutionarily engineered H13 1E and the newly
evolved H142E strains as well as unevolved H13 1 and H142 as references.
L 5 6 7 8 9
0I
1: H131-XYLA31 Xba I
2: H131E5-XYLA31 Xba I (12=12.5xI)
3: H131-XYLA31 EcoR I
4: H131E5-XYLA31 EcoR I (14 7xI3)
5: H131-XYLA31, Xba I
6: H131E5-XYLA31, Xba 1 (I6=11.745)
7: H131E8-XYLA31, Xba I (17=12.245)
8: H142-p416A, Xba I
9: H142E-p416A, Xba 1 (19= 9.2x s)
L: DNA Ladder, from top (bps): 10k, 8k,
6k, 5k, 4k(fade), 3k, 2k, 1.5k, lk, 0.5k
Ix: intensity of band indicated in lane x
Figure 5-9. Southern blot of XYLA in H131/H142 strains
The chromosomal DNA of evolved H131E5-XYLA31 and its reference H131-
XYLA31 were digested by Xba I and EcoR I before the blot (Figure 5-9, Lanes 1-4). For
both pairs, a higher intensity (7-12.5x over reference) of the XYLA blot was observed.
Moreover, the 2.2k bps band (Lane 2) of Xba I digested H131E5-XYLA31 corresponds
to the size of the TDH3p-XYLA-CYC]t construct, which indirectly verifies the tandem
gene duplication of XYLA in the evolutionarily engineered strain, as shown in Figure 5-10.
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Figure 5-10. Structure of tandem XYLA duplication after Xba I digestions
Xba I digestion was also applied on other H131E and H142E strains. As Lane 5-7
shows, the XYLA blot intensities of H13lE5 and Hl31E8 are very similar, about 12x the
reference. This observation is consistent with the qPCR results showing that the copy
numbers of XYLA in H131E5 and H131E8 (50.6±14.4 and 43.7±1.1) are similar.
Nevertheless, there is a 4-fold systematic error between the qPCR and Southern blot.
For the new evolved H142E-p4l6A (Lane 8-9), two blots of XYLA were observed
on the evolved strain and its reference. The 19 (the sum of the two blots' intensities in
Lane 9) is approximately 9.2 times higher than I8, confirming the duplication of XYLA in
H142E-p4l6A. However, the two blots of various sizes (other than 2.2 kbps) indicate
different structures than the tandem XYLA duplication in the H 13 1E-XYLA3 1 strains.
5.3.3 Transcription of key enzymes in the xylose metabolic pathway
The transcription levels of the key xylose metabolic genes were determined
through quantitative RT-PCR, for the evolutionarily engineered strains H13lE5-
XYLA31 and H131E8-XYLA31 and control strain H131-XYLA31. The constitutively
expressed endogenous PGK1 was used as a reference.
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Figure 5-11. Transcription of the key xylose metabolic genes
The expression profiles of H131E5-XYLA31 and H131E8-XYLA31 are very
similar, and the most significant change for both evolved strains in comparison to the
reference is the high XYLA transcription level. The transcription of XYLA in H131E5/E8
are 17.1±5.8 and 13.6±7.3 times higher than that of PGK1, or 25.7+8.8 and 20.4±11.0
times higher than that of XYLA in unevolved H13 1-XYLA3 1, while the XYL3 expression
level of H 131 E5/E8 is only 2-fold higher than that of the control strain H131 -XYLA3 1.
The only difference between H131 E8 and H 131 E5 is the 2-fold higher transcription of
RPEJ and TKL1 in H 131E8.
Northern blot, another way to evaluate XYLA transcription, was run for the series
of H131 E evolutionarily engineered strains in comparison to their parent strain H 131, as
shown in Figure 5-12.
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0: H131
0 1 2 3 4 5 1: H131-XYLA31
2: H131El-XYLA31 (12= 2.1xI1)
3: H131E3-XYLA31 (13 7.9xI1)
4: H131E5-XYLA31 (14= 6.841)
5: H131E8-XYLA31 (Is = 3.0xI1)
Ix: intensity of band indicated in lane x
Figure 5-12. Northern blot results of XYLA in H131E strains
All the H131E strains showed improved XYLA transcription. Nevertheless, the
transcription level did not monotonically increase along the evolution, suggesting that the
elevated expression level of XYLA played a dominant role only during the earlier phase of
the evolution.
5.3.4 Enzymatic activity of XYLA and XYL3
In vitro XI activities of two H131 E-XYLA3 1 strains were also compared with the
parent strain of H131 -XYLA3 1. Consistent with the DNA copy number and transcription
level of XYLA, XI activity had significantly increased in the evolved isolates H131E5-
XYLA31 and H131E8-XYLA31, about 13-fold higher than that of the unevolved strain
H131-XYLA31 (Figure 5-13). No activity could be detected in strain H131 without
XYLA.
A similar comparison was done on XK, as shown in Figure 5-13. Very weak XK
activity (0.022 U/mg) could be detected in strain H131, due to the expression of the
endogenous XKS1. After overexpression of PsXYL3, the XK activity of H131 -XYLA31
was increased to 1.41±0.07 U/mg. In contrast to the elevated XI activity after
evolutionary engineering, the XK activity decreased to 0.5-0.9 U/mg for H131E5/E8-
XYLA3 1, resulting in a much more balanced XI/XK activity ratio.
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Figure 5-13. Activity of XI and XK in H131/H131E strains
All the molecular and biochemical characterizations of XYLA and XYL3
(normalized to reference strain H13 1-XYLA3 1) are summarized in Figure 5-14.
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Figure 5-14. DNA copy number, expression and activity of XI and XK in H131/H131E strains
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For XYLA, the gene copy number and expression level of both evolved strains are
8-32 times higher than the reference strain, with a good correlation of DNA, RNA and
protein activity. The only exception is the Northern blot of XYLA in H131 E8-XYLA3 1,
which could be due to inaccuracy in the experiment and lack of replication. For XYL3 the
DNA, RNA, and protein levels of the evolved strains are comparable to the reference
strain with good correlation (a system error of about 2-fold).
5.3.5 Chromosome blotting
Tandem XYLA duplication was confirmed in the evolved H 131 E strains by use of
the Southern blot and qPCR. In addition, failure to segregate plasmid-carrying XYLA after
evolutionary engineering implies that the gene may have been recombined to
chromosomal DNA. To determine the location of XYLA, pulsed field gel electrophoresis
(PFGE) was run for H131E-XYLA31 and the new evolved H142E-XYLA strains, as
shown in Figure 5-15.
In the unevolved H13 1-XYLA3 1, a very faint blot could be seen at the position of
Chr III. In H 131 El -XYLA3 1, a strong blot on Chr X suggests multiple copies of XYLA
had been recombined to the chromosome. More interestingly, H131E3/E5/E8-XYLA31
displayed a similar blot pattern on the position of Chr VI with increased size. The new
size of Chr VI is between Chr III (317 kbps) and Chr IX (440 kbps), more than 50 kbps
larger than the original size of 270 kbps. The difference of the size is consistent with the
size of multiple copies of XYLA (2.2 kbpsx30-50 copies).
The different XYLA integration locations of H131E3/E5/E8-XYLA31 and
H 131 El -XYLA31 indicate either independent evolution process of two branches or some
translocation ofXYLA between H 131 El -XYLA31 and H 131 E3-XYLA3 1.
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Figure 5-15. PFGE and chromosome blot of H131/H131E/H142E
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Figure 5-15. PFGE and chromosome blot of H131/H131E/H142E (continued)
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The H142E-p405A2 and H142E-p406A2 were confirmed to have XYLA
integrated on the LEU2 (Chr III) and URA3 (Chr V) loci as expected, while the XYLA
blot could hardly be detected in the unevolved H142-p405A2 and H142-p406A2 (not
shown).
For H142E-p405A2, the XYLA duplication structure was detected to be in Chr III
on the locus of LEU2, which was confirmed by PCR previously. The Chr III size
migrated slightly but obviously, in agreement with the minor XYLA copy number
increment determined by qPCR.
For H142E-p4O6A2 the XYLA duplication structure was detected in the Chr V
where URA3 locates, although the context of XYLA integration could not be verified by
using PCR. The Chr V size migration was about 70k bps (577k bps to ~650k bps), in
agreement with the copy number determined by qPCR (2.2k bps/copy x 32 copies ~ 70k
bps).
Although the presence of tandem XYLA duplication was not verified directly, the
evidence of chromosome blot, qPCR results, and the tandem gene duplication structure
on pRS415-geno-W2 strongly suggested that the duplication and integration of gene
XYLA was a major recombination event during the evolutionary engineering, and a high
expression level of heterologous XI is necessary for rapid xylose utilization.
5.3.6 GRE3 mutations in the evolved strains
The XI activity is inhibited by xylitol [65]. Although natural S. cerevisiae strains
do not have a specific xylose reductase (XYL1), xylose could b. reduced to xylitol with
an endogenous aldose reductase like GRE3 [63] and other putative XR [64, 114] listed in
Table 5-2.
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Table 5-2. Putative xylose reductases in S. cerevisiae
Gene Description
Aldose reductase involved in methylglyoxal, d-xylose, arabinose, and
GRE3 galactose metabolism; stress induced (osmotic, ionic, oxidative, heat shock,
starvation and heavy metals); regulated by the HOG pathway
YPR1 NADPH-dependent aldo-keto reductase
GCY1 Putative NADP* coupled glycerol dehydrogenase
YJR096W Putative xylose and arabinose reductase
YDL124W NADPH-dependent alpha-keto amide reductase
Deletion of the GRE3 gene improves efficient xylose utilization in XI-expressing
S. cerevisiae strains [66] and also reduces xylitol yields [20, 67]. However, it has been
reported that the aldose reductase encoded by the GRE3 gene belongs to a group of
generally stress-induced proteins [63] and that its deletion reduces the growth by 30%
[67]. Based on the above analysis and estimation of the xylitol effect shown in the
Appendix, the GRE3 was not knocked out during the strain construction.
The GRE3 in the evolved strains were sequenced in order to evaluate the
inhibitory effect of xylitol (GRE3 product) on xylose utilization. Interestingly, mutations
were found to either truncate the C-terminus of the GRE3 protein by 28 amino acids
(H131El-XYLA31) or switch Glul93 to Lys (H131E3/E5/E8-XYLA31), as shown in
Figure 5-16.
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Figure 5-16. Mutations of GRE3 in the evolved strains
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It can be inferred that the mutations of GRE3 lessen its xylose reductase activity
and therefore reduce the xylitol accumulation, which is favorable for xylose assimilation
since it is a competitive inhibitor of xylose isomerase.
In addition, the different gre3 mutations in H131El-XYLA31 and
H 131 E3/E5/E8-XYLA31 coincide with the different XYLA integration locations (Figure
5-15) of the two sets of strains, implying that H131El-XYLA31 and H131E3/E5/E8-
XYLA31 evolved independently in two branches.
Furthermore, the following experiments could be run to further evaluate the GRE3
effects: i) the XR activity of gre3'(E193K) and gre3'(L3000pal); ii) xylitol inhibitory
kinetics in the unevolved and evolved strains; and iii) comparison of GRE3, gre3 and
gre3' in terms of XR activity, xylitol accumulation, and growth rate.
To first validate the effect of gre3i on growth rate, two strains (H131 -LEU2 and
H131-gre3A, Table 5-1) were constructed. In the H131-gre3A a copy of LEU2 was
inserted into the GRE3 ORF at 522, and it truncated the GRE3 by about half of the amino
acid sequence. H131-LEU2 was constructed as a control that has the same genetic
background (except for LEU2 on its original locus other than in the GRE3). The growth
rates of the two strains were compared on SDG medium under micro-aerobic conditions,
as shown in Figure 5-17.
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Figure 5-17. Effect of gre3A on aerobic growth in glucose medium
The comparison of H13 1-gre3A and H13 1-LEU2 showed no difference in growth,
unlike findings in a previous report [67]. Similar results were confirmed by another set of
strains on glucose (data not shown). However, to ultimately verify the effect of GRE3, a
set of strains containing GRE3, gre3, and gre3' need to be constructed based on the
evolved xylose-fermenting strain and evaluated on xylose.
5.4 Conclusions
A high expression level of XI as a key phenotype was confirmed by quantitative
PCR, blotting and hybridization techniques, and enzyme activity assay. The tandem gene
duplication (TGD) of XYLA was proved in the series of evolved H131 E-XYLA3 1 strains.
The TGD structure was translocated onto one or more chromosomes during the early
stage of the evolutionary engineering. However, the TGD is not the only way to achieve
high XI expression. The evolution process was successfully reproduced in a different
background H142, and XYLA expansion could originate from a different initial XYLA
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construction, whether by integration or on different types of plasmids. The location-
specific XYLA integration and duplication could be achieved, although the structure might
be subject to other genomic rearrangements.
The XK (XYL3) form P. stipitis could be efficiently expressed in S. cerevisiae,
and the low copy number of PsXYL3 promoted by a strong promoter should be enough to
support the high flux of xylose assimilation. Mutations on GRE3 that potentially abolish
XR activity were discovered in the evolutionary engineered strains, supporting the
hypothesis that the elimination of XR activity was favorable for xylose fermentation by
reducing the production of by-product xylitol and hence alleviating inhibition to XI.
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CHAPTER 6. Optimization of Fermentation and Other
Metabolic Engineering of Xylose-fermenting S.
cerevisiae Strains
6.1 Introduction
Successful evolutionary engineering of S. cerevisiae resulted in strain of H131 E8-
XYLA3 1, which showed comparable fermentation performance to the best-reported
strain, RWB-218 [3, 21], under a typical yeast cultivation conditions. Since the
cultivation conditions may not be optimal for the anaerobic xylose fermentation,
optimization of the conditions was expected to improve the fernentation performance of
the evolutionarily engineered strain. Moreover, as one of the best xylose-utilizing strains,
H13 1E8-XYLA3 1 could be used as the host for further rational metabolic engineering.
In this chapter, fermentation condition including media, strictly anaerobic setup
and chemostat cultivation were studied to further explore the best performance of the
engineered strain. After restoring the auxotrophic markers arg4 and leu2 (primarily leu2)
and supplementing the anaerobic growth factors (ergosterol and Tween 80) to the media,
the newly engineered strain H153E10-XYLA31 showed a greatly improved anaerobic
growth rate of 0.199 h~1 and specific xylose consumption rate o' 1.647 g-g-'h-1, 65% and
37% higher than those of the best reported xylose-fermenting strain RWB 218,
respectively. In addition, several genes that improve xylose utilization or cell growth
were introduced to the engineered strain, including an NADP-dependent glyceraldehyde-
3-phosphate dehydrogenase (gapN), some other heterogeneous xylose isomerase and a
series of putative xylose transporters.
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6.2 Materials and Methods
6.2.1 Plasmids and strains
Plasmids used in this chapter are summarized in Table 6-1 and yeast strains
constructed in this chapter are summarized in Table 6-2.
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pUCAR1
pUCARI-gapN
pRS405
pRS405-(XYLA) 2
pRS406-(XYLA) 2
Heterologous XIs
pRS426HXT7Tr-PXYLA
pRS426HXT7T,-TTHXYLA
pRS426HXT7Tr-EcXYLA
pRS426HXT7Tr-BTHXYLA
pRS426HXT7Tr-AthXYLA
pRS426HXT7Tr-BsXYLA
pRS426HXT7Tr-SrXYLA
pRS426HXT7Tr-XcaXYLA
Putative xylose transporters
p424-TEF-DhSUT2
p424-TEF-DhSUT3
p424-TEF-CaSUT2
p424-TEF-PsXUT4
p424-TEF-PsSUT1
p424-TEF-PsSUT2
p424-TEF-DhSUT1
p424-TEF-CaSUTI
p424-TEF-CgSUT1
p424-TEF-PsXUT6
p424-TEF-PsXUT5
p424-TEF-TrXLT1
Table 6-1. Plasmids used in this chapter
Characteristics
pUC 19, HindII-ARG4-HindII
pUCARi, BamH I-TDH3p-gapN-CYC t -EcoR I
YIp, LEU2
LEU2, 2 copies of HXT7r,.p-XYLA-CYC~t in tandem
URA3, 2 copies of HXT7Trp-XYLA-CYC~t in tandem
2 ori, URA3, Piromyces XYLA
2 ori, URA3, Thermus thermophilus XYLA
2 ori, URA3, E.coli XYLA
2 ori, URA3, Bacteroides thetaiotaomicron XYLA
2 ori, URA3, Arabidopsis thaliana XYLA
2 ori, URA3, B.subtilisXYLA
2 ori, URA3, Streptomyces rubiginosus XYLA
2 ori, URA3, Xanthomonas campestris Xy/A2
Debaryomyces hansenii SUT2
Debaryomyces hansenii SUT3
Candida albicans SUT2
Pichia stipitis XUT4
Pichia stipitis SUTJ
Pichia stipitis SUT2
Debaryomyces hansenii SUTJ
Candida albicans SUTJ
Candida glabrata, SUT
Pichia stipitis XUT6
Pichia stipitis XUT5
Trichoderma reesei XL Ti
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Table 6-2. S. cerevisiae strains used in this chapter
S. cerevisiae Strains Characteristics
H131E3-XYLA31 H13 1E-XYLA3 1, isolated from micro-aerobic sequential batch cultivation
H131E10-XYLA31 Similar to H 13 1E8-XYLA3 1, isolated from anaerobic chemostat 2 weekslater than H131E8-XYLA3 1
H145E1O-XYLA31 H 13 1E O-XYLA3 1, arg4 complemented by pUCARI containing ARG4
H146E10-XYLA31 H13 1E1O-XYLA3 1, leu2-3complemented by pRS405 containing LEU2
H153E1O-XYLA31 H146EIO-XYLA3 1, arg4 complemented by pUCARi containing ARG4
H131E5-XYLA31-ARG4 H13 1E5-XYLA3 1, arg4 complemented by pUCARi containing ARG4
H141E5-XYLA31 H13 1E5-XYLA3 1, pUCAR1-gapN
H142 H 131, ARG4:: HXT7p-PsXYL3-CYC1t
H142-XYLAs H142, pRS426HXT7T,-XYLAs, XYLAs listed in Table 6-1
H142E-XYLAs H 142-XYLAs, evolutionary engineered by aerobic sequential batch
cultivation
FPL-YSX3C[17] MAT _a, trpl-112, leu2 ::LEU2-TDH3p-XYL1, ura3::URA3- TDH3p -XYL2, Ty3::NEO-XYL3
YSX3-SUTs FPL-YSX3C, with putative xylose transporters listed in Table 6-1
6.2.2 Anaerobic fermentation of xylose
The condition of anaerobic fermentation is described in Chapter 3. In addition, to
achieve strict anaerobic condition, cultures were stirred at 300 rpm and sparged with 0.5
L/min nitrogen (Airgas, Ultra high purity grade, <lppm oxygen). And the medium was
supplemented with 200 pL/L of silicone antifoam as well as with the anaerobic growth
factors ergosterol (0.01 g/L) and Tween 80 (0.42 g/L) dissolved in ethanol in 1000x.
6.3 Results and Discussion
6.3.1 Medium comparison
Yeast nitrogen base (YNB) is used as a base medium for preparation of minimal
and synthetic defined yeast media, which contains basically salts, vitamins and trace
elements. To evaluate the effect of YNB and other supplemental media, a series of media
were tested using H13 1E3-XYLA3 1 under micro-aerobic condition and 2% xylose unless
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otherwise indicated. The growth and xylose consumption after 24 hours were compared
in Figure 6-1.
25
mOD60C in 24 hrs
OXylose consumption in 24 hrs (g/L)
20 -------------------------------------------------------
15 -----------------------------------
10 -------- ---------------------------------
5 --- - - --- - --
0
Figure 6-1. Fermentation of H131E3-XYLA31 on different media
Additional YNB did not appreciably contribute to the growth. On top of YNB, a
supplement of 1-5x CSM (mixture of essential amino acids and nucleobases) improved
the growth and xylose consumption by about 2-fold, implying that amino acid synthesis
under oxygen-limited condition could be one limiting factor. Furthermore, 1-10 g/L YE
(yeast extract) greatly improves growth by up to 3-fold and hence xylose utilization by up
to 5-fold, suggesting that some growth factor was deficient in the minimal YNB media
and could be supplemented by the addition of complex YE, which contains most essential
nutrients for yeast growth.
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6.3.2 Complement of arg4 and leu2
The evolutionarily engineered strain H131E1O-XYLA31 still contains two
auxotrophic markers, arg4 and leu2, and requires L-arginine and L-leucine in the medium.
To evaluate the performance of the strain on the minimal medium without Arg and Leu,
the two genes were complemented by YIp pRS405 and pUCARi (Table 6-1), separately.
H131E1O-XYLA31 was first transformed with Cla I linearized pUCARi and
selected on Arg medium to yield H145E1O-XYLA31. Meanwhile, H131E1O-XYLA31
was also transformed with Afl II digested pRS405 and selected on Leu medium to yield
H146E1O-XYLA31. H146E1O-XYLA31 was then transformed with Cla I linearized
pUCARi to yield H153E1O-XYLA31 (Table 6-2). The aerobic growth profiles of the
three new constructed strains were compared with their parent strain H 131 E O-XYLA3 1
on 2xYNBX medium (with 2x arginine and/or leucine if necessary) to verify the effect of
ARG4 and LEU2 on growth, as shown in Figure 6-2.
12
--- H131E10 (arg4, Ieu2)
-A--H145E10 (arg4, LEU2)
10 
-- H146E10 (ARG4, Ieu2)
--- H153E10 (ARG4, LEU2)
8 -------- -- - ------ ---------- - - - - - - - - - -
6 --
0
4 --
2 --
0
0 10 20 30 40
Time(h)
Figure 6-2. Effect of ARG4 and LEU2 on aerobic growth
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The successful restoration of the ARG4 gene eliminates the requirement of
arginine supplement in the medium but didn't change the growth profile significantly,
when comparing the performances of H131E10 with H146E10, or H145E10 with
H153E10.
Surprisingly, the restoration of LEU2 not only fixed the deficient in the leucine
biosynthesis, but also increased the pmax by 30% and elevated the final biomass by 3-fold,
when comparing the strains H145E/H153E (LEU2) with H131E/H146E (leu2). It had
been reported that the amount of leucine provided in commonly used synthetic media
(like the YNB used in this study) is limiting for growth of leucine-requiring strains, and
supplementing synthetic media with a higher leucine concentration is recommend [115].
Nevertheless, the leucine concentration still limited the growth even though it had been
increased to 200mg/L, 2x the concentration of normal SD media. In addition, studies
have demonstrated that leucine was also correlative with tolerance to ethanol [116].
Therefore, a complement of LEU2 solves both problems and dramatically boosts growth
on xylose.
The performance of the prototrophic H153E10-XYLA31 in terms of anaerobic
fermentation was evaluated in a bioreactor in 2xYNBX (4%) medium, to compare with
that of H 131 E8-XYLA3 1 under similar condition (fermentation results from Chapter 3),
as shown in Figure 6-3 and Table 6-3.
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Figure 6-3. Comparison of H131E8-XYLA31 and H153E10-XYLA31
H131E8-XYLA31: (OOD00, LiXylose, A Ethanol)
H153E1O-XYLA31: (*OD6oo, EXylose, AEthanol)
Table 6-3. Characteristics of H131E8-XYLA31 and H153E10-XYLA31 fermentation
H131E8-XYLA31 H153E10-XYLA31
Growth phase Overall Growth phase Overall
pmax h~1 0.120±0.004 0.177±0.009
At h 40.05 71.60 19.85 29.70
A[Xylose] g/L 28.62 39.35 34.02 36.19
A[Ethanol] g/L 12.10 17.22 13.75 14.69
A[DCW] g/L 1.327 1.503 1.869 1.968
A[Glycerol] g/L 1.057 1.565 2.114 2.134
Final OD600  5.540 7.960
Average OD600 2.926 4.117 3.780 4.675
DCWaverage g/L 0.78 1.098 1.008 1.336
qxylose g-LI h~ 0.715 0.550 1.714 1.219
gg1 h~1 0.916 0.501 1.700 0.912
gethanol g-L h~1 0.302 0.240 0.693 0.495
g-gh~' 0.387 0.219 0.687 0.370
Ethanol yield g/g 0.423 0.438 0.404 0.406
Biomass yield g/g 0.046 0.038 0.055 0.054
Glycerol yield g/g 0.037 0.040 0.062 0.059
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The newly constructed strain H153E10-XYLA31 finished the 37 g/L xylose in
about 37 hours, twice as fast as H131E8-XYLA31 (40 g/L xylose in 80 hours), thanks to
the 47.5% faster growth, 43% higher final biomass and 120% higher specific xylose
consumption rate. The xylose was almost depleted when the growth stopped, and likely
limited further biomass accumulation. Therefore, better biomass accumulation could be
achieved if sufficient carbon source xylose is provided.
Furthermore, H153E10-XYLA31 has 42% higher biomass yield and 8% lower
ethanol yield. It was suspected that oxygen leaked into the system and led to better
growth and lower fermentation efficiency.
To address the above issues, batch fermentation was carried out with a higher
initial xylose concentration of 80g/L and carefully insulated from oxygen diffusion. The
results are shown in Figure 6-4 and Table 6-4.
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--- OD600 - 50,
o4
4 *-Xylose 
-t4W 
- 40
03 -h-Ethanol 0
- 30 W
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Time(h)
Figure 6-4. Fermentation of H153E10-XYLA31 with 8% xylose
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Table 6-4. Characteristics of H153E10-XYLA31 fermentation with 8% xylose
Growth phase Overall
smax hI 0.
At h
A[Xylose] g/L
A[Ethanol] g/L
A[DCW] g/L
A[Glycerol] g/L
ODaverage
DCWaverage g/L,
qxylose g-L h'
g-g_ h- I
gethanol g-L h I
g1- h I
Ethanol yield g/g
Biomass yield g/g
Glycerol yield g/g
Under anaerobic conditions, H153E1
202±0.009
24.15
26.08
10.83
1.103
1.530
2.547
0.679
1.080
1.590
0.448
0.660
0.415
0.042
0.059
O-XYLA31
/
74.80
69.94
30.99
1.369
2.799
4.332
1.155
0.935
0.809
0.414
0.359
0.443
0.020
0.040
rapidly finished 71 g/L xylose
within 75 hours at overall ethanol yield of 0.443. The initial growth (9max = 0.202±0.009
h-1) and the specific xylose productivity in growth phase (1.590 g-g h ) were also very
good. Nonetheless, the biomass accumulation stopped at OD600 about 6 when the residual
xylose of more than 20 g/L should not limit the growth. The final cell density is only
about a half of that of the same strain on the same medium under aerobic condition
(H153E10-XYLA31 in Figure 6-2). The restrained growth could be due either to a
deficiency of some growth factor under the oxygen-limited condition or to some stress
caused by accumulation of certain metabolites.
6.3.3 Strictly anaerobic fermentation with growth factors ergosterol and Tween 80
Ergosterol and Tween 80 are important anaerobic growth factors [117-119], and
are routinely used under strictly anaerobic conditions where culture is sparged with pure
nitrogen. To testify the ability of H153E10-XYLA31 to ferment under strictly anaerobic
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condition, and also to verify the effect of anaerobic growth factors ergosterol and Tween
80, the fermentation profile of H153E10-XYLA31 with the two anaerobic growth factors
and sparged with N2 was compared with fermentation results without the factors and N2,
as shown in Figure 6-5 and Table 6-5.
With the anaerobic growth factors, the specific growth rate and biomass yield
were both about 20% higher. In addition, the overall xylose consumption rate showed a
30% improvement. As a result, the duration of the fermentation was reduced by 20%.
Sparging with nitrogen didn't significantly affect the growth and fermentation, but caused
lower ethanol yield due to the ethanol evaporation and inefficient condensation. Like
previous fermentation results of H153E10-XYLA31 on 4% xylose, the xylose was
depleted when the cell was still in growth phase, and hence limited the growth.
To address the above issues, 80 g/L xylose was used to initiate the fermentation.
Also, the anaerobic conditions in our previous fermentation setup were rather strict since
cultivation were purged with ultra-pure N2 at the beginning of each fermentation, and the
diffusion of 02 into the system was minimal due to the slightly positive pressure in the
fermenter caused by CO 2 production. Thus, the fermentation profile of H153E10-
XYLA31 with the two anaerobic growth factors was compared with fermentation results
without the factors (from Figure 6-4 and Table 6-4), and combined into Figure 6-6 and
Table 6-6.
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Figure 6-5. Effect of strictly anaerobic condition with ergosterol and Tween 80
With N2 sparging, ergosterol (10mg/L) and Tween 80 (0.42g/L): (*OD00, EXylose, AEthanol)
Without N2 sparging, ergosterol or Tween 80: (OOD600 , ElXylose, A Ethanol)
Table 6-5. Characteristics of H153E10-XYLA31 fermentation under strictly anaerobic condition with
ergosterol and Tween 80
No N2 sparging or growth N2 sparging, l0mg/L ergosterol
factors and 0.42g/L Tween80
Growth phase Overall Growth phase Overall
max h-1 0.177±0.009 / 0.215±0.004 /
At h 19.85 29.70 20.10 24.20
A[Xylose] g/L 34.02 36.19 36.98 40.91
A[Ethanol] g/L 13.75 14.69 13.76 14.80
A[DCW] g/L 1.869 1.968 2.363 2.717
A[Glycerol] g/L 2.114 2.134 2.512 2.670
Final OD600  7.96 10.52
ODaverage 3.780 4.675 3.832 4.945
DCWaverage g/L 1.008 1.336 1.022 1.413
qxyiose g-L h 1.714 1.219 1.840 1.690
gg h 1.700 0.912 1.801 1.196
qethanol g-L h 0.693 0.495 0.684 0.611
g-g h- 0.687 0.370 0.670 0.433
Ethanol yield g/g 0.404 0.406 0.372 0.362
Biomass yield g/g 0.055 0.054 0.064 0.066
Glycerol yield g/g 0.062 0.059 0.068 0.065
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Figure 6-6. Effect of ergosterol and Tween 80 on H153E10-XYLA31 fermentation
With ergosterol (10mg/L) and Tween 80 (0.42g/L): (*OD600, .Xylose, A Ethanol)
Without ergosterol or Tween 80: (OOD600, oXylose, A Ethanol)
Table 6-6. Characteristics of H153E10-XYLA31 fermentation with ergosterol and Tween 80
No ergosterol and Tween80 10mg/L ergosterol and0.42g/L Tween80
Growth phase Overall Growth phase Overall
a. h-1 0.202±0.009 / 0.199±0.010 /
At h 24.15 74.80 24.40 47.85
A[Xylose] g/L 26.08 69.94 47.20 81.06
A[Ethanol] g/L 10.83 30.99 20.00 35.47
A[DCW] g/L 1.103 1.369 2.441 3.061
A[Glycerol] g/L 1.530 2.799 2.546 3.520
Final OD600  5.420 11.7
ODaverage 2.547 4.332 4.403 7.594
DCWaverage g/L 0.679 1.155 1.174 2.025
qxyiose g-L h1  1.080 0.935 1.935 1.694
g-g h' 1.590 0.809 1.647 0.837
qethanol g-LI h 0.448 0.414 0.820 0.741
g-g h' 0.660 0.359 0.698 0.366
Ethanol yield g/g 0.415 0.443 0.424 0.438
Biomass yield g/g 0.042 0.020 0.052 0.038
Glycerol yield g/g 0.059 0.040 0.054 0.043
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With the supplement of ergosterol and Tween 80, H153E1 O-XYLA3 1 was able to
finish 81 g/L xylose in about 48 hours, significantly faster than the same strain without
the growth factors (70 g/L xylose in 75 hours). The initial growth rates, specific xylose
consumption rates and ethanol productivities are almost identical for strain under the two
conditions, as well as the yields of ethanol and glycerol. The only difference is the nearly
twice higher biomass production with growth factors added, which led to about 80%
higher volumetric xylose consumption rate and ethanol productivity. Xylose was no
longer a limit of growth since the culture entered the stationary phase when a sufficient
amount of xylose remained.
6.3.4 Expression of other heterologous XIs
Expression of quite a few heterologous XIs from various organisms had been
attempted in S. cerevisiae, with very limited success[45]. The successful expression of
Piromyces XYLA in S. cerevisiae [47] is a milestone after 25 years of elaboration. XI
from anaerobic fungus Orpinomyces [22], and bacterium Clostridium phytofermentans
[24] have also been successfully expressed in S. cerevisiae. However, all the XIs could
only enable a very low initial growth rate and further metabolic and evolutionary
engineering were required to increase the xylose utilization. According to the current
understanding of the XI expression, it is promising to revisit some of the unsuccessfully
expressed XIs, adding another powerful tool of codon/expression optimization for S.
cerevisiae.
The XIs from E.coli, Bacillus subtilis, Bacteroides thetaiotaomicron, Thermus
thermophiles, Streptomyces rubiginosus, Arabidopsis thaliana and Xanthomonas
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campestris (see Appendix for sequences) were picked for expression in S. cerevisiae, to
represent each cluster shown in Figure 6-7.
XYLA Therrnotoga neapolitana (0.1645)
XYLA Bacillus subtilis X02795.1 (0.1865)
XYLA Arabidopsis thaliana (0.2390)
XYLA E.coli (0.2537)
XYLA Bacteroides thetaiotaoicron (0.0334)
XYLA Bacteroides vulgatus (0.0396)
XYLA Orpinonyces sp. ukk1 (0.0286)
XYLA Pirorryces sp. E2 (0.0263)
XYLA1 Xanthonnas carrpestris (0.0076)
'XYLA2 Xanthormonas carrpestris (0.0081)
XYLA Therrrius thermophilus (0.1978)
XYLA Streptomyces rubiqinosus (0.2141)
Figure 6-7. Clustering of XI
All the genes are codon/expression optimized and synthesized before being
cloned to multiple copy plasmid pRS426HXT7Tr-p (Table 6-1). The constructed plasmids
were then transformed to H142 (PPP and XYL3 overexpressed) and evolutionarily
engineered through aerobic sequential batch cultivation in a rich medium, similar to the
process described in Section 5.3.1.
After about 4 weeks of evolution, only the Bacteroides thetaiotaomicron XYLA
showed adequate XI activity to support growth on xylose, other than previously proved
Piromyces XYLA. The aerobic growth profile of H142E-BthXYLA compared with
H142E-PXYLA and H13 1E1-XYLA31 is shown in Figure 6-8.
The newly evolved H142E-BthXYLA showed similar aerobic growth as H142E-
PXYLA (newly evolved strain as a control), and slightly better than the previously
engineered H131El-XYLA31. Not surprisingly, the B. thetaiotaomicron XYLA shares
about 80% amino acid sequence homology with Piromyces XYLA. A qPCR revealed
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31.2±2.7 copies of BthXYLA in H142E-BthXYLA, implying that BthXYLA also needs to
be overexpressed to support growth of the host on xylose, similar to the Piromyces XYLA.
5.0
-*- H142E-PXYLA
--- H142E-BthXYLA
4.0 - -- H131E1-XYLA31
3.0 -- - --
0
0 2.0 
--
1.0 --
0.0
0 10 20 30 40 50 60 70
Time(h)
Figure 6-8. Aerobic growth of S. cerevisiae containing Bacteroides thetaiotaomicron XYLA
6.3.5 NADP-dependent glyceraldehyde-3 -phosphate dehydrogenase (gapN)
A previous study had shown that anaerobic growth factor ergosterol can greatly
boost growth on xylose medium, as well as more complex media with yeast extracts.
These observations suggest insufficient biosynthesis of certain factors under anaerobic
condition. One hypothesis is that the high flux of xylose catabolism saturates the non-
oxidative branch of the pentose phosphate pathway, and therefore represses the oxidative
PPP where cytosol NADPH is produced. A lack of NADPH can cause deficiency of
amino acid and steroid (like ergosterol) synthesis and consequently slower growth, which
could be alleviated by supplementing with ergosterol or yeast extract.
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To test this hypothesis, a NADP-dependent non-phosphorylating glyceraldehyde
3-phosphate dehydrogenase (gapN) from Streptococcus mutants was expressed in
H13 1E5-XYLA3 1. The gapN pathway is shown in Figure 6-9.
Glycolysis
-Glyceraldehyde-3-P
- NAD*+Pi
NADH TDH,2,3 gapN
NAD ,, NADP*
Glyceraldehyde-1,3-P NADPH
ADPGlycerol A PGKJ
ATP
Glycerate-3-P
Pyruvate
Figure 6-9. NADP-dependent non-phosphorylating G3P dehydrogenase pathway
It has been reported that by diverting some G3P from wild-type GAPD pathway,
the cell could make more NADPH and less NADH and ATP, consequently result in 50%
less glycerol and 3% more ethanol [120].
gapN from Streptococcus mutants was cloned into YIp pUCARI, resulting in
pUCAR1-gapN (Table 6-1). H131E5-XYLA31 was then transformed with Hpa I
digested pUCAR1-gapN to make strain H141E5-XYLA31 (Table 6-2). H131E5-
XYLA31 transformed with empty pUCAR1 was used as control. The fermentation
profiles of the two strains are shown in Figure 6-10.
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Table 6-7. Characteristics of H141E5-XYLA31
H131E5-XYLA31-ARG4
Control
pmax h-I 0.073±0.002
At h 117.15
[Xylose] g/L 39.54
Ethanol] g/L 17.85
[DCW] g/L 1.399
Glycerol] g/L 1.949
nal OD600  5.420
Daverage 3.974
CWaverage g/L 1.060
qxyiose g-L h 0.338
g-g h 0.319
gethanol g-L h 0.152
g-g h 0.144
anol yield g/g 0.451
mass yield g/g 0.035
cerol yield g/g 0.049
fermentation
H141E5-XYLA31
gapN
0.077±0.003
117.15
39.54
17.51
1.646
1.485
6.340
4.423
1.179
0.337
0.286
0.149
0.127
0.443
0.042
0.038
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Figure 6-10. Effect of gapN on xylose fermentation
H141E5-XYLA31 (gapN): (*OD6 00 , .Xylose, A Ethanol)
H131E5-XYLA31-ARG4 (control): (OOD600, nXylose, AEthanol)
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The expression of gapN provided marginal improvement on xylose fermentation,
reducing glycerol production by 25% and increasing final biomass by 20%, but didn't
change xylose consumption rate or ethanol productivity significantly. pUCAR1-gapN
was also transformed to the better evolved H141 El 0-XYLA3 1, but again no significant
improvement of xylose fermentation could be observed, although glycerol production
was reduced by 20% (data not shown).
6.3.6 Expression of heterologous xylose transporters
As discussed in Chapter 1, inefficient xylose transport could be a limiting step in
xylose assimilation by S. cerevisiae. Xylose utilization has been greatly improved after
successful metabolic engineering, which makes the xylose transport more likely the
bottleneck of the system.
Twelve putative transporters from 5 natural xylose-utilizing strains (Candida
albicans, Candida glabrata, Debaryomyces hansenii, Pichia stipitis and Trichoderma
reesei) were selected according to sequence homology. They were separately cloned into
shuttle vector pRS424 (Table 6-1) and the plasmids were transformed into yeast. Before
the H131 strain was successfully constructed, the putative xylose transporters were tested
in a legacy strain YSX3 (Table 6-2).
The 12 strains together with the control strain underwent a sequential batch
cultivation on selective SD media for 3 rounds, and 1% xylose was used instead of
regular 2% to further increase the selection pressure. After the selection, the mixed
culture was diluted appropriately and plated on SDX (1%) for screening. The larger
colonies were picked to segregate the plasmids for transporters sequencing. The result
was confirmed by retransforming plasmids to YSX3, and two transformants containing
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DhSUT1 (from Debaryomyces hansenii) and CgSUT] (from Candida glabrata) displayed
an advantage in aerobic growth on xylose, as shown in Figure 6-11.
0.16 30o Specific growth rate
oXylose consumption
0.15 NXylito production 25
0.14 20
S0.13 15
* x
0.12 10 0
CO 0.11 5
0.1 0
Figure 6-11. Performance of strain with selected transporters
The YSX3 transformed with DhSUT] and CgSUT1 showed 2-4 times higher
xylitol production and 30-90% higher xylose consumption than the control strain. The
contribution of the transporters on xylose consumption was not as significant as that of
PsTAL1 (a PPP gene). The effect of the transporters is to be further validated in the newly
engineered H153E10-XYLA31, in which the limit of xylose transport could be more
prominent.
6.3.7 Chemostat cultivation of H153E10-XYLA31
To explore the maximum fermentation capacity of the strain as well as the
maximum specific growth rate, strain H153E10-XYLA31 underwent chemostat in
minimal media with sufficient xylose. The bioreactor setup was as described previously,
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with the addition of anaerobic growth factors ergosterol and Tween 80. The dilution rate
was increased stepwise by 0.02 h-1, once the chemostat reached a steady state. The results
at dilution rate of 0.1-0.2 h-I are shown in Table 6-8.
Table 6-8. Characteristics of H141E5-XYLA31 in chemostat
D h-I1  0.098 0.118 0.137 0.157 0.176 0.196
[Xylose]Feed g/L 52.692 45.392 44.472 42.951 41.089 42.723
[Xylose]Effluent g/L 23.090 25.122 29.159 34.362 33.856 38.629
A[Xylose] g/L 29.602 20.269 15.313 8.589 7.233 4.094
[Ethanol] Feed g/L 0.708 0.708 0.708 0.758 0.854 0.628
[Ethanol]Effluent g/L 14.251 9.243 6.541 3.765 3.246 1.969
A[Ethanol] g/L 13.543 8.535 5.833 3.007 2.392 1.341
A[Glycerol] g/L 1.350 0.951 0.713 0.422 0.371 0.139
OD600 4.120 3.193 2.655 1.797 1.490 0.978
DCW g/L 1.099 0.851 0.708 0.479 0.397 0.261
qxylose g-L h 2.915 2.391 2.104 1.347 1.275 0.801
gg h 2.654 2.808 2.972 2.812 3.210 3.075
gethanol g-L h 1.334 1.007 0.801 0.472 0.422 0.262
gg h 1.214 1.182 1.132 0.984 1.062 1.007
Ethanol yield g/g 0.458 0.421 0.381 0.350 0.331 0.328
Biomass yield g/g 0.037 0.042 0.046 0.056 0.055 0.064
Glycerol yield g/g 0.046 0.047 0.047 0.049 0.051 0.034
At dilution rate 0.1 h-',
consumed to produce ethanol at
significant
very good
amount (56%) of
yield (0.456 g/g).
xylose in feed was
The specific xylose
consumption rate and ethanol productivity reached 2.654 g-g'h'and 1.214 g-g~ h',
respectively, which is about 60% better than the performance in batch cultivation and is
the highest ever observed in the research. With the increase of the dilution rate, the
specific xylose consumption rate and ethanol productivity were even higher. Nevertheless,
the consumed xylose and ethanol production dropped dramatically due to the rapid
decline of biomass. In addition, the ethanol yield also fell monotonically with increasing
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biomass yield. The results diminished the practical significance of the high specific
fermentation rate in the chemostat cultivation.
6.3.8 Discussion
As summarized in Table 6-9, the final metabolic and evolutionary engineered
strain H153E1O-XYLA31 showed a maximum anaerobic growth rate of 0.199 h-1, 65%
better than that of H131E8-XYLA31 before optimization or the best reported strain RWB
218. Xylose consumption rate of H153E10-XYLA31 was 1.647 g-g~1h-' in batch
fermentation, 80% higher than before optimization and 37% higher than RWB 218, with
same level of ethanol yield (data were taken from the growth phase to match the
condition in the literature). In chemostat cultivation of H153E10-XYLA31, the peak
xylose consumption rate reached 2.654 g-g~ h-1 at a dilution rate of 0.1 h-1, 60% higher
than in the batch cultivation of the same strain.
The evolved strain performs well at elevated sugar concentrations (80 g/L);
however the biomass yield was still relatively low (0.038 g/g) when the carbon source
was not limiting. A similar final OD 60 0 of around 10 was also achieved under aerobic and
anaerobic condition, implying that the anaerobic growth factors ergosterol and Tween 80
are not the limiting factors any more. Additional optimization of the medium (such as
phosphate and nitrogen source) and metabolic engineering of the strain toward better
tolerance to stresses may be necessary to further improve the growth and fermentation.
The fermentation performance of strain H153E10-XYLA31 is superior to any
other reported strain to the best of our knowledge. Further metabolic engineering toward
mixed sugar fermentation and successful transfer of fermentation performance to
industrial strains and conditions should be the key issues to stress in future research.
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Table 6-9. Characteristics of recombinant S. cerevisiae strains
Yields g/g qEthanol qxyose Pmax
Strain Strain description Fermentation condition Ethanol Xylitol g-g h g-g h h
H131-XYLA31 XYLA, PsXYL3, PsTAL1, Aerobic batch, SDX, 2% xylose N/A* N/A N/A N/A 0.031±0.022TKLJ, RPEJ, RKIJ
Selection ofH 31- Micro-aerobic batch, SDX, 2%
H131El-XYLA31 XYLA3 1, aerobic xylose 0.273 <0.01 0.041 0.148 0.197±0.006
sequential batch
Selection ofH131- Anaerobic batch, 2xYNB, 4%H131
H 13 1E3-XYLA31 XYLA3 1, micro-aerobic xylose
sequential batch
Selection of H131- Anaerobic batch, 2xYNB, 07
H131E5-XYLA31 XYLA3 1, anaerobic xylose
sequential batch
Anaerobic batch, 2xYNB, 4% 0.423 <0.0 1 0.387 0.916 0.120±0.004
Selection ofH13 1- xylose
H13 1E8-XYLA31 XYLA3 1, xylose-limited
anaerobic chemostat Anaerobic chemostat, 1 xYNB, 0.438 <0.01 0.687 1.568 0.148
1.5% xylose
Anaerobic batch, 2xYNB, 8% 0.424 <0.0 1 0.698 1.647 0.199±0.010
H 13 1E8-XYLA3 1, with xylose, ergosterol and Tween 80
H153E10-XYLA31 complement of ARG4 and
LEU2 Anaerobic chemostat, 2xYNB, % 0458 <0.01 1.214 2.654 0.098
xylose, ergosterol and Tween 80
Piromyces XYLA evolved Anaerobic batch, synthetic medium 0.42 0.021 0.14 0.34 0.03
RW 22-AF[19] isolate
RWB 21 7[20] TKL, RPEJ, TKI, Agre3 Anaerobic batch, synthetic medium 0.43 0.003 0.46 1.06 0.09
RWB 218 [3, 21] Selection of RWB 217 Anaerobic batch, synthetic medium 0.41 0.001 0.49 1.2 0.12
*N/A e rnot tested
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6.4 Conclusions
The restoration of the auxotrophic markers arg4 and leu2 (primarily leu2) in
H 131 El 0-XYLA31 greatly boosted aerobic growth on minimal medium. The anaerobic
growth can be further improved by supplementing the anaerobic growth factors
(ergosterol and Tween 80) or complex medium gradient yeast extract. Under the
optimized conditions, the engineered strain H153E 1 0-XYLA3 1 showed a anaerobic ptma
of 0.199 h-1 and specific xylose consumption rate of 1.647 g-g-lh-1 in batch fermentation,
65% and 37% higher than those of the best reported xylose-fermenting strain RWB 218,
respectively. In chemostat cultivation, the specific performance of H153E10-XYLA31
was 60% better than that of the same strain in the growth phase of batch cultivation,
although a significant amount of xylose was left unconsumed in the effluent.
The strictly anaerobic condition realized by sparging ultra-pure nitrogen didn't
affect the fermentation performance, although the ethanol yield was leveled down due to
evaporation. Expression of NADP-dependent G3P dehydrogenase (gapN) was able to
reduce glycerol production by 25%, but led to only marginal improvement in anaerobic
growth. Xylose isomerase from bacterium Bacteroides thetaiotaomicron was successfully
expressed in S. cerevisiae, resulting in a xylose-utilizing strait equivalent to similarly
constructed H131 El -XYLA3 1. Heterologous expression of putative xylose transporters
(SUTs) showed a promising result in a host (YSX3) far inferior to the newly engineered
strain H153E10-XYLA31. Therefore, more significant results can be expected through
further study of the SUTs in H153E10-XYLA31, where sugar transport is more likely the
bottleneck of xylose assimilation.
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As discussed throughout this work, a central goal of this thesis has been to enable
and improve the utilization of xylose by S. cerevisiae, for production of bioethanol and
potentially other chemicals. To achieve superior xylose-fermenting strains, both rational
and combinatorial metabolic engineering approaches were applied for the construction,
adaption and characterization of the strains.
7.1 Conclusions
Xylose-utilizing strains were successfully constructed through the heterologous
expression of either the XI-XK (XYLA-XYL3) or the XR-XDH-XK (XYL1-XYL2-XYL3)
xylose metabolic pathways as well as the non-oxidative pentose phosphate pathway,
resulting in strains H 131 -XYLA31 and H 131 -XYL123, respectively. Both strains showed
slow but significant aerobic growth (pmax= 0.031±0.022 h~1 for H131-XYLA31 and
0.081±0.052 h'for H131-XYL123) after pathway construction.
The engineered strain carrying the redox XR-XDH pathway showed substantial
accumulation of the by-product, xylitol, due to the intrinsic cofactor imbalance of the
pathway. Therefore, evolutionary engineering approaches were put into practice mainly
on the XI-based strain H131-XYLA31 for improved xylose utilization. After multiple
stages of evolution including aerobic to oxygen-limited sequential batch cultivation,
followed by xylose-limited anaerobic chemostat cultivation, both the anaerobic growth
rate and the xylose consumption rate of the evolved strain were significantly improved.
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The finally isolated strain, H 131 E8-XYLA3 1, rapidly grew and fermented xylose under
anaerobic conditions, with a specific growth rate of 0.12 h-1 and a specific xylose
consumption rate exceeding 0.9 g-g lh~1. The evolutionary engineering approach was
again proven to be a powerful tool for obtaining improved properties in the target strain,
such as efficient substrate utilization in this study.
Further modification of restoring the auxotrophic markers arg4 and leu2
(primarily leu2) in H131E10-XYLA31 greatly boosted its aerobic growth on a minimal
medium. In addition, the anaerobic growth can be dramatically improved by
supplementing the anaerobic growth factors, ergosterol and Tween 80. After optimization
of the metabolically and evolutionarily engineered strain, H153E10-XYLA31, an
anaerobic specific growth rate of 0.199 h- and a specific xylose consumption rate of
1.647 g-g-'h-1 were achieved in batch fermentation, 65% and 37% higher than those of the
best reported xylose-fermenting strain RWB 218 [3, 21], respectively. The ethanol yield
was as high as 0.438 g/g and the xylitol accumulation was negligible. In addition, the
specific performance was 60% better in chemostat cultivation than in the growth phase of
batch cultivation, although a significant amount of xylose left unconsumed in the effluent.
A successful inverse metabolic engineering approach was demonstrated to
identify gene targets responsible for the phenotype of rapid xylose assimilation. A
genomic library of the evolutionarily engineered H131E5-XYLA31 was constructed and
amplified in E. coli, then transformed to the S. cerevisiae host for screening. A high
throughput screening system is the key factor of such inverse metabolic engineering. The
microfluidic sorting system aiming for quick xylose consumption is much more sensitive
than the screening based on growth rate, despite lower coverage of the library. The main
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genotype identified in the evolved strain is the duplication of XYLA. The genotype was
verified by the structural analysis of the plasmid selected after the screening, and qPCR
of the genomic DNA from the evolved strain, H131 E5-XYLA3 1.
A high expression level of XI was confirmed by molecular biology techniques
including quantitative PCR, blotting and hybridization and enzyme activity assay. The
tandem gene duplication (TGD) of XYLA was proved in the series of evolved H131E-
XYLA31 strains. And the TGD structure was translocated onto one or more
chromosomes during the early phase of the evolution. However,'the TGD is not the only
way to achieve high XI expression. The evolution process was successfully reproduced in
a different background H142 where XYLA expansion could originate from different initial
XYLA construction, whether through chromosomal integration or on different types of
plasmids. The site-specific XYLA integration and duplication could also be achieved,
although the structure might be subject to other genomic rearrangement.
The XI from bacterium Bacteroides thetaiotaomicron was successfully expressed
in S. cerevisiae, resulting in a xylose-utilizing strain equivalent to the similarly
constructed and evolutionary engineered H 131 El -XYLA3 1. A XI with higher specific
activity in S. cerevisiae is still desirable, yet none of other XIs expressed in S. cerevisiae
showed significantly better specifications.
The XK (XYL3) form P. stipitis could be efficiently expressed in S. cerevisiae,
and low copy number of PsXYL3 promoted by strong promoter should be sufficient to
support a high flux of xylose assimilation.
Mutations on GRE3 that potentially abolish XR activity were discovered in the
evolutionarily engineered strains, supporting the hypothesis that the elimination of XR
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activity was favorable for xylose utilization by reducing the production of xylitol and
hence alleviating the inhibition of XI activity caused by xylitol.
The strictly anaerobic conditions realized through sparging ultra-pure nitrogen did
not affect the fermentation performance, although the ethanol yield was leveled down due
to ethanol evaporation caused by gas flow.
The expression of an NADP-dependent G3P dehydrogenase (gapN) was able to
reduce glycerol production by 25%, but led to only marginal improvement in anaerobic
growth.
Heterologous expression of putative xylose transporters (SUTs) showed
promising results in a host (YSX3) with much lower xylose assimilation rate than the
newly engineered H153E1O-XYLA31. Therefore, more significant results can be
expected through further study of the SUTs in H153E1 O-XYLA3 1, where sugar transport
is more likely the bottleneck of xylose metabolism.
The fermentation performance of the strain H153E1O-XYLA31 is superior to any
other reported strain to the best of our knowledge. Further metabolic engineering toward
successful transfer of fermentation performance to industrial strains and conditions
should be the key issue to stress in future research.
7.2 Recommendations and future work
After intensive metabolic engineering, the xylose fermentation performance of the
strain H153E 1 O-XYLA3 1 has been greatly improved and is no longer a true bottleneck in
the fermentation of hemicellulose hydrolysates. However, this does not imply that further
improvement is either impossible or undesirable.
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As we proposed and preliminarily tested, the xylose transport may remain a rate-
limiting step of xylose assimilation, since the downstream pathway has been adequately
engineered. Particularly, at low extracellular xylose concentration or when fermenting on
mixed sugar, a high-specific xylose transport system will be necessary for efficient sugar
utilization. Expression of heterologous (putative) xylose transporters from native xylose-
utilizing strains (preferable fungi) is still the most feasible strategy, despite the limited
success after decades of effort. Upon the discovery of effective xylose transporters, more
engineering such as mutagenesis and gene shuffling could be used to further improve the
capacity and specificity of the xylose transporters. In addition, extensive evolutionary
engineering may be another potential approach to adapt and enhance the endogenous
sugar transporters, when carried out using a low xylose concentration as the selective
pressure.
Mixed sugar fermentation is another challenge for the rapid and complete
utilization of hemicellulose hydrolysates, mainly due to the effect of Carbon Catabolite
Repression (CCR). Expression of a xylose-specific transport may alleviate the CCR and
therefore promote the co-utilization of hexoses and pentoses. Also, evolutionary
engineering may be required to improve the strains in terms of mixed sugars fermentation.
The XIs from Piromyces and some other fungi or bacteria have been proved to
support efficient xylose assimilation. However, a very high expression level of the
enzyme is required, implying a low specific activity of the XIs expressed in S. cerevisiae.
Therefore, efforts either to search for XIs with better properties or to engineer the current
XIs could be favorable to higher xylose-assimilation efficiency and lower metabolic
burden of abundant XI synthesis.
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The expression of an NADP-dependent G3P dehydrogenase (gapN) showed
reduced glycerol production and marginal improvement in anaerobic growth, when
integrated into the chromosome and expressed in parallel with the endogenous G3P
dehydrogenase (TDH1,2,3). It can be expected that a fine-tuned expression of gapN
together with TDH may further change the NADPH/NADH ratio, resulting in better
growth and lower concentration of byproduct glycerol.
The inverse metabolic engineering approach serves as a useful tool to identify the
genotypes of an evolutionarily engineered strain; however, two obstacles limited its
application in current research. The first was the difficulty in construction of a knockout
yeast library. The genomic library could only represent the dominant mutations, while for
identification of recessive phenotypes a knockout library is required. Knockout libraries
can be efficiently generated using transposon in bacteria, but hardly in yeast. It is possible
to prepare and fragment the genomic DNA of target strain, apply the transposon insertion
in vitro and retransform the DNA back to the target strain to generate a knockout library.
However, the efficiency of transposon insertion and transformation must be remarkably
improved for good quality of the library. The second obstacle was the throughput of the
microfluidic screening method. The microfluidic device which coalesces, detects, and
sorts droplets is currently the throughput bottleneck since it can only sort up to 104
droplets in one hour while the droplet formation rate of the cell encapsulation device is
106 droplets in the same amount of time. By optimizing the sorting device, libraries with
sizes of 105 or higher could be screened, which represents a better coverage of the yeast
genome for an overexpression or knockout library.
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Appendix
A.1. Heterologous xylose isomerases
Piromyces sp. E2 xylose isomerase
PROTEIN LENGTH = 437
MAKEYFPQIQKIKFEGKDSKNLAFHYYDAEKEVMGKKMKDWLRFAMAWWHTLCAEGADQFGGGTKSFPWNE
GTDAIEIAKQKVDAGFEIMQKLGIPYYCFHDVDLVSEGNSIEEYESNLKAVVAYLKEKQKETGIKLLWSTAN
VFGHKRYMNGASTNPDFDVVARAIVQIKNAIDAGIELGAENYVFWGGREGYMSLLNTDQKREKEHMATMLTM
ARDYARSKGFKGTFLIEPKPMEPTKHQYDVDTETAIGFLKAHNLDKDFKVNIEVNHATLAGHTFEHELACAV
DAGMLGSIDANRGDYQNGWDTDQFPIDQYELVQAWMEIIRGGGFVTGGTNFDAKTRRNSTDLEDIIIAHVSG
MDAMARALENAAKLLQESPYTKMKKERYASFDSGIGKDFEDGKLTLEQVYEYGKKNGEPKQTSGKQELYEAI
VAMYQ*
DNA LENGTH = 1314 (codon optimized)
ATGGCTAAAGAGTACTTCCCACAGATTCAGAAGATAAAGTTCGAGGGCAAAGATTCTAAAAACCCTTTGGCT
TTCCACTACTATGATGCAGAGAAGGAAGTCATGGGAAAGAAAATGAAGGATTGGTTGAGATTTGCTATGGCT
TGGTGGCATACTTTGTGTGCTGAAGGTGCAGACCAGTTCGGCGGTGGCACTAAGTCTTTTCCTTGGAATGAG
GGTACTGATGCCATTGAAATCGCCAAACAAAAGGTAGACGCTGGTTTTGAGATCATGCAGAAGTTGGGCATC
CCTTATTACTGTTTTCACGATGTCGATTTGGTGAGTGAAGGCAATAGTATAGAGGAATACGAGTCTAACTTA
AAGGCAGTCGTTGCCTATTTGAAGGAGAAGCAAAAGGAAACTGGTATCAAATTGTTGTGGAGTACTGCTAAC
GTCTTCGGCCACAAAAGATACATGAACGGTGCTTCTACTAATCCAGACTTTGATGTAGTCGCTAGAGCTATA
GTCCAGATTAAGAATGCTATCGACGCCGGAATTGAGTTGGGAGCTGAGAACTATGTTTTTTGGGGAGGTAGG
GAAGGCTATATGTCTTTGTTGAATACTGACCAGAAGAGAGAGAAAGAACACATGGCAACAATGTTAACTATG
GCAAGAGATTACGCAAGGAGTAAGGGCTTTAAGGGCACTTTTTTGATTGAACCTAAGCCTATGGAACCAACT
AAACACCAATATGATGTTGACACTGAAACAGCCATCGGTTTCTTGAAGGCCCACAACTTGGATAAAGATTTT
AAGGTAAACATTGAGGTCAATCACGCCACCTTGGCCGGTCACACTTTCGAACATGAATTGGCTTGTGCTGTT
GATGCTGGAATGTTGGGTTCTATTGATGCAAATAGAGGCGATTATCAGAATGGTTGGGATACTGATCAATTT
CCAATCGACCAATACGAATTGGTTCAAGCCTGGATGGAAATCATAAGAGGTGGTGGCTTTGTAACTGGTGGA
ACTAACTTCGATGCCAAAACAAGAAGAAACTCCACTGACTTGGAGGATATCATTATTGCTCACGTTTCCGGT
ATGGATGCAATGGCCAGGGCCTTGGAGAACGCTGCTAAGTTGTTACAAGAATCCCCCTACACTAAGATGAAG
AAAGAGAGGTACGCATCATTCGATTCTGGAATCGGCAAGGATTTTGAGGACGGAAAGTTGACTTTAGAGCAG
GTTTATGAGTACGGTAAAAAGAATGGCGAGCCTAAACAAACCTCTGGTAAGCAGGAATTGTACGAAGCTATT
GTCGCAATGTATCAATAA
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50 Oligonucleotides synthesized
1 ATGGCTAAAGAGTACTTCCCACAG 24
2 CTTTGCCCTCGAACTTTATCTTCTGAATCTGTGGGAAGTACTCTTTAGCCA 51
3 CAGAAGATAAAGTTCGAGGGCAAAGATTCTAAAAACCCTTTGGCTTTCCAC 51
4 ATGACTTCCTTCTCTGCATCATAGTAGTGGAAAGCCAAAGGGTTTTTAGAA 51
5 ACTATGATGCAGAGAAGGAAGTCATGGGAAAGAAAATGAAGGATTGGTTGA 51
6 GTATGCCACCAAGCCATAGCAAATCTCAACCAATCCTTCATTTTCTTTCCC 51
7 TGCTATGGCTTGGTGGCATACTTTGTGTGCTGAAGGTGCAGACCAGTTCGG 51
8 CTCATTCCAAGGAAAAGACTTAGTGCCACCGCCGAACTGGTCTGCACCTTC 51
9 GCACTAAGTCTTTTCCTTGGAATGAGGGTACTGATGCCATTGAAATCGCCA 51
10 TGATCTCAAAACCAGCGTCTACCTTTTGTTTGGCGATTTCAATGGCATCAG 51
11 GGTAGACGCTGGTTTTGAGATCATGCAGAAGTTGGGCATCCCTTATTACTG 51
12 TCACTCACCAAATCGACATCGTGAAAACAGTAATAAGGGATGCCCAACTTC 51
13 ACGATGTCGATTTGGTGAGTGAAGGCAATAGTATAGAGGAATACGAGTCTA 51
14 AGGCAACGACTGCCTTTAAGTTAGACTCGTATTCCTCTATACTATTGCC 49
15 ACTTAAAGGCAGTCGTTGCCTATTTGAAGGAGAAGCAAAAGGAAACTGGTA 51
16 GTTAGCAGTACTCCACAACAATTTGATACCAGTTTCCTTTTGCTTCTCCTT 51
17 TCAAATTGTTGTGGAGTACTGCTAACGTCTTCGGCCACAAAAGATACATGA 51
18 CAAAGTCTGGATTAGTAGAAGCACCGTTCATGTATCTTTTGTGGCCGAAGA 51
19 GGTGCTTCTACTAATCCAGACTTTGATGTAGTCGCTAGAGCTATAGTCCAG 51
20 AATTCCGGCGTCGATAGCATTCTTAATCTGGACTATAGCTCTAGCGACTAC 51
21 AATGCTATCGACGCCGGAATTGAGTTGGGAGCTGAGAACTATGTTTTTTGG 51
22 AAAGACATATAGCCTTCCCTACCTCCCCAAAAAACATAGTTCTCAGCTCCC 51
23 GAGGTAGGGAAGGCTATATGTCTTTGTTGAATACTGACCAGAAGAGAGAGA 51
24 GTTAACATTGTTGCCATGTGTTCTTTCTCTCTCTTCTGGTCAGTATTCAAC 51
25 AAGAACACATGGCAACAATGTTAACTATGGCAAGAGATTACGCAAGGAGTA 51
26 TCAATCAAAAAAGTGCCCTTAAAGCCCTTACTCCTTGCGTAATCTCTTGCC 51
27 GCTTTAAGGGCACTTTTTTGATTGAACCTAAGCCTATGGAACCAACTAAAC 51
28 TGTTTCAGTGTCAACATCATATTGGTGTTTAGTTGGTTCCATAGGCTTAGG 51
29 ACCAATATGATGTTGACACTGAAACAGCCATCGGTTTCTTGAAGGCCCACA 51
30 TCAATGTTTACCTTAAAATCTTTATCCAAGTTGTGGGCCTTCAAGAAACCG 51
31 ACTTGGATAAAGATTTTAAGGTAAACATTGAGGTCAATCACGCCACCTTGG 51
32 CAAGCCAATTCATGTTCGAAAGTGTGACCGGCCAAGGTGGCGTGATTGACC 51
33 CACTTTCGAACATGAATTGGCTTGTGCTGTTGATGCTGGAATGTTGGGTTC 51
34 CTGATAATCGCCTCTATTTGCATCAATAGAACCCAACATTCCAGCATCAAC 51
35 TGATGCAAATAGAGGCGATTATCAGAATGGTTGGGATACTGATCAATTTCC 51
36 CTTGAACCAATTCGTATTGGTCGATTGGAAATTGATCAGTATCCCAACCAT 51
37 ATCGACCAATACGAATTGGTTCAAGCCTGGATGGAAATCATAAGAGGTGGT 51
38 AAGTTAGTTCCACCAGTTACAAAGCCACCACCTCTTATGATTTCCATCCAG 51
39 GCTTTGTAACTGGTGGAACTAACTTCGATGCCAAAACAAGAAGAAACTCCA 51
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40 AGCAATAATGATATCCTCCAAGTCAGTGGAGTTTCTTCTTGTTTTGGCATC 51
41 CTGACTTGGAGGATATCATTATTGCTCACGTTTCCGGTATGGATGCAATGG 51
42 CAACTTAGCAGCGTTCTCCAAGGCCCTGGCCATTGCATCCATACCGGAAAC 51
43 CTTGGAGAACGCTGCTAAGTTGTTACAAGAATCCCCCTACACTAAGATGAA 51
44 AATCGAATGATGCGTACCTCTCTTTCTTCATCTTAGTGTAGGGGGATTCTT 51
45 AAAGAGAGGTACGCATCATTCGATTCTGGAATCGGCAAGGATTTTGAGGAC 51
46 CATAAACCTGCTCTAAAGTCAACTTTCCGTCCTCAAAATCCTTGCCGATTC 51
47 GAAAGTTGACTTTAGAGCAGGTTTATGAGTACGGTAAAAAGAATGGCGAGC 51
48 AATTCCTGCTTACCAGAGGTTTGTTTAGGCTCGCCATTCTTTTTACCGTAC 51
49 ACAAACCTCTGGTAAGCAGGAATTGTACGAAGCTATTGTCGCAATGTATCA 51
50 TTGATACATTGCGACAATAGCTTCG 25
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Thermus thermophilus xylose isomerase
PROTEIN LENGTH = 387
MYEPKPEHRFTFGLWTVGNVGRDPFGDAVRERLDPVYVVHKLAELGAYGVNLHDEDLIPRGTPPQERDQIVR
RFKKALDETGLKVPMVTANLFSDPAFKDGAFTSPDPWVRAYALRKSLETMDLGAELGAEIYVVWPGREGAEV
EATGKARKVWDWVREALNFMAAYAEDQGYGYRFALEPKPNEPRGDIYFATVGSMLAFIHTLDRPERFGLNPE
FAHETMAGLNFVHAVAQALDAGKLFHIDLNDQRMSRFDQDLRFGSENLKAAFFLVDLLESSGYQGPRHFDAH
ALRTEDEEGVWAFARGCMRTYLILKERAEAFREDPEVKELLAAYYQEDPAALALLGPYSREKAEALKRAELP
LEAKRRRGYALERLDQLAVEYLLGVRG*
DNA LENGTH = 1164 (Expression optimized)
ATGTATGAACCCAAACCCGAACATAGATTTACATTTGGACTTTGGACAGTAGGAAATGTTGGTAGAGATCCA
TTCGGTGACGCAGTTAGAGAGAGATTAGATCCAGTTTATGTTGTTCACAAATTGGCTGAATTAGGCGCATAT
GGTGTTAATTTACATGATGAAGATTTAATTCCCAGAGGTACACCCCCACAAGAAAGAGACCAAATTGTAAGA
AGATTTAAAAAAGCACTAGACGAAACAGGACTAAAAGTACCAATGGTAACAGCAAATTTATTTTCAGACCCC
GCTTTCAAAGATGGAGCATTCACTTCTCCCGATCCGTGGGTTAGAGCTTATGCCTTGAGAAAAAGTTTAGAA
ACAATGGATTTGGGTGCAGAATTAGGAGCAGAAATATACGTTGTATGGCCAGGAAGAGAAGGAGCAGAAGTA
GAGGCAACAGGAAAAGCAAGAAAGGTGTGGGATTGGGTAAGGGAAGCCCTAAATTTTATGGCTGCTTATGCT
GAAGATCAAGGATACGGATATAGATTCGCACTAGAACCAAAACCGAACGAGCCAAGAGGTGATATATATTTT
GCTACAGTCGGTTCTATGTTGGCATTTATACATACGTTAGACAGGCCTGAAAGATTCGGATTGAACCCAGAA
TTTGCACACGAAACAATGGCCGGATTAAACTTTGTACACGCTGTTGCTCAAGCCTTAGACGCTGGTAAATTA
TTTCACATAGACCTAAATGACCAAAGAATGTCACGTTTCGACCAAGATTTAAGATTTGGTTCAGAGAATTTA
AAAGCTGCATTTTTCCTAGTAGATTTATTGGAATCAAGTGGTTATCAAGGACCAAGACATTTTGACGCACAC
GCACTAAGAACTGAAGATGAAGAAGGGGTTTGGGCCTTTGCCAGAGGTTGCATGAGAACGTATTTAATACTT
AAAGAAAGAGCCGAAGCATTTAGAGAAGATCCAGAAGTTAAAGAATTGTTAGCTGCCTACTACCAAGAAGAC
CCAGCTGCACTAGCATTACTAGGACCGTATTCAAGAGAAAAAGCTGAAGCATTAAAAAGAGCCGAATTACCA
TTAGAAGCAAAGAGAAGAAGAGGTTACGCATTAGAAAGATTAGACCAATTAGCTGTAGAATATTTATTAGGA
GTCAGGGGATAA
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E. coli xylose isomerase
PROTEIN LENGTH = 440
MQAYFDQLDRVRYEGSKSSNPLAFRHYNPDELVLGKRMEEHLRFAACYWHTFCWNGADMFGVGAFNRPWQQP
GEALALAKRKADVAFEFFHKLHVPFYCFHDVDVSPEGASLKEYINNFAQMVDVLAGKQEESGVKLLWGTANC
FTNPRYGAGAATNPDPEVFSWAATQVVTAMEATHKLGGENYVLWGGREGYETLLNTDLRQEREQLGRFMQMV
VEHKHKIGFQGTLLIEPKPQEPTKHQYDYDAATVYGFLKQFGLEKEIKLNIEANHATLAGHSFHHEIATAIA
LGLFGSVDANRGDAQLGWDTDQFPNSVEENALVMYEILKAGGFTTGGLNFDAKVRRQSTDKYDLFYGHIGAM
DTMALALKIAARMIEDGELDKRIAQRYSGWNSELGQQILKGQMSLADLAKYAQEHHLSPVHQSGRQEQLENL
VNHYLFDK*
DNA LENGTH = 1323 (Expression optimized)
ATGCAAGCTTATTTTGATCAATTAGACAGAGTCAGATACGAAGGATCAAAATCATCAAACCCATTAGCATTT
AGACATTATAACCCTGATGAATTAGTATTGGGAAAGAGAATGGAAGAACATCTAAGATTTGCAGCTTGCTAT
TGGCACACTTTTTGTTGGAACGGTGCAGATATGTTTGGGGTGGGTGCATTCAATAGACCATGGCAACAACCC
GGAGAAGCTTTAGCTTTGGCAAAGAGAAAAGCCGACGTGGCCTTTGAATTTTTTCACAAACTTCATGTTCCA
TTTTACTGTTTCCATGACGTAGATGTTTCACCCGAAGGTGCATCATTGAAGGAATATATAAACAACTTTGCT
CAGATGGTTGATGTATTAGCTGGTAAACAAGAGGAATCCGGAGTAAAATTATTATGGGGGACAGCGAATTGC
TTTACTAATCCAAGATATGGTGCAGGCGCTGCTACAAATCCAGACCCTGAAGTATTCTCATGGGCAGCTACT
CAAGTCGTTACCGCAATGGAAGCTACGCACAAATTAGGCGGCGAAAATTATGTTTTATGGGGGGGAAGAGAA
GGTTATGAAACTTTATTAAATACAGATTTAAGACAAGAAAGAGAACAATTAGGACGTTTTATGCAAATGGTG
GTAGAACATAAACACAAAATCGGATTTCAAGGAACATTATTAATCGAACCAAAACCACAAGAGCCAACCAAA
CACCAATATGATTACGACGCAGCAACAGTTTACGGATTTTTAAAACAATTTGGGTTAGAAAAGGAAATAAAA
TTGAATATAGAAGCAAATCACGCAACATTAGCAGGACATTCTTTTCATCATGAAATTGCCACCGCTATCGCA
CTTGGTTTATTTGGCAGTGTTGACGCAAATAGAGGAGATGCACAATTAGGATGGGATACTGACCAATTTCCA
AACTCCGTTGAAGAAAATGCATTGGTTATGTATGAGATCTTGAAGGCTGGGGGATTTACAACTGGGGGATTA
AATTTCGATGCTAAAGTTAGAAGGCAATCTACTGATAAATACGATTTATTTTACGGACACATAGGAGCAATG
GATACAATGGCTTTAGCTTTAAAAATCGCTGCAAGAATGATAGAAGATGGCGAATTAGATAAGAGAATAGCA
CAAAGATATTCAGGCTGGAACAGTGAATTAGGACAACAAATTTTAAAAGGGCAAATGTCACTAGCAGACTTA
GCGAAATATGCACAAGAACACCATTTATCACCCGTGCATCAATCTGGTAGACAAGAACAATTAGAAAATTTG
GTAAATCATTATCTATTTGACAAATAA
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Bacteroides thetaiotaomicron xylose isomerase
PROTEIN LENGTH = 438
MATKEFFPGIEKIKFEGKDSKNPMAFRYYDAEKVINGKKMKDWLRFAMAWWHTLCAEGGDQFGGGTKQFPWN
GNADAIQAAKDKMDAGFEFMQKMGIEYYCFHDVDLVSEGASVEEYEANLKEIVAYAKQKQAETGIKLLWGTA
NVFGHARYMNGAATNPDFDVVARAAVQIKNAIDATIELGGENYVFWGGREGYMSLLNTDQKREKEHLAQMLT
IARDYARARGFKGTFLIEPKPMEPTKHQYDVDTETVIGFLKAHGLDKDFKVNIEVNHATLAGHTFEHELAVA
VDNGMLGSIDANRGDYQNGWDTDQFPIDNYELTQAMMQ IIRNGGLGTGGTNFDAKTRRNSTDLEDIFIAHIA
GMDAMARALESAAALLDESPYKKMLADRYASFDGGKGKEFEDGKLTLEDVVAYAKTKGEPKQTSGKQELYEA
ILNMYC*
DNA LENGTH = 1317 (Expression optimized)
ATGGCTACAAAAGAATTCTTTCCGGGAATCGAAAAAATAAAGTTTGAAGGTAAAGATTCAAAAAACCCAATG
GCTTTTAGATATTATGATGCTGAAAAGGTAATAAACGGAAAAAAAATGAAAGACTGGTTGAGATTTGCTATG
GCTTGGTGGCATACATTATGCGCTGAAGGTGGGGATCAATTCGGGGGTGGGACGAAACAATTCCCTTGGAAC
GGTAATGCAGACGCAATTCAAGCGGCTAAGGATAAAATGGATGCAGGGTTTGAATTTATGCAAAAAATGGGC
ATTGAATACTATTGTTTCCACGACGTTGATTTAGTAAGTGAAGGGGCATCAGTAGAAGAATATGAAGCTAAC
CTTAAAGAAATCGTTGCATACGCAAAACAAAAGCAGGCTGAAACTGGTATAAAATTGTTATGGGGAACAGCT
AACGTTTTCGGACATGCCAGATATATGAATGGTGCAGCTACCAACCCAGATTTTGATGTCGTTGCAAGAGCT
GCTGTACAAATCAAAAATGCGATAGATGCTACAATAGAACTAGGAGGAGAAAATTACGTTTTTTGGGGAGGA
AGAGAAGGGTACATGTCATTACTTAATACGGATCAAAAAAGAGAAAAGGAACACTTAGCCCAAATGTTAACA
ATTGCAAGAGATTACGCAAGAGCAAGAGGATTTAAAGGAACATTTTTAATAGAACCAAAACCGATGGAACCA
ACTAAACATCAATACGACGTAGACACTGAAACAGTTATAGGTTTCCTAAAAGCACACGGACTAGATAAGGAT
TTTAAAGTTAATATAGAAGTGAACCATGCAACTTTAGCTGGACATACATTCGAACATGAGCTAGCGGTAGCA
GTCGATAATGGAATGCTAGGATCTATAGATGCTAATAGAGGAGATTACCAAAACGGCTGGGACACTGATCAA
TTCCCTATTGATAACTATGAATTAACACAAGCAATGATGCAAATAATTAGGAATGGCGGCTTAGGGACAGGA
GGAACAAATTTTGATGCGAAAACTAGAAGAAACTCGACGGATTTAGAAGATATATTTATAGCGCATATTGCT
GGAATGGATGCAATGGCTCGTGCACTGGAATCTGCTGCGGCACTATTAGACGAATCGCCATACAAAAAAATG
CTTGCCGATAGATACGCTTCATTTGACGGGGGGAAAGGAAAAGAATTTGAAGATGGTAAATTGACACTAGAA
GATGTTGTTGCTTACGCTAAGACTAAAGGAGAACCAAAACAAACTTCAGGAAAACAAGAATTATATGAAGCA
ATTTTGAATATGTATTGTTAA
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Arabidopsis thaliana xylose isomerase
PROTEIN LENGTH = 477
MKKVEFFMLLLCFIAASSLVSADPPTCPADLGGKCSDSDDWQGDFFPEIPKIKYEGPSSKNPLAYRWYNAEE
EILGKKMKDWFRFSVAFWHTFRGTGGDPFGAATKYWPWEDGTNSVSMAKRRMRANFEFLKKLGVDWWCFHDR
DIAPDGTTLEESNKNLDEVIELAKELQKGSKIKPLWGTAQLFLHPRYMHGGATSSEVGVYAYAAAQVKKAME
VTHYLGGENYVFWGGREGYQTLLNTDMGRELDHLARFFEAAVAYKKKIGFKGTLLIEPKPQEPTKHQYDWDA
ATAANFLRKYGLIDEFKLNIECNHATLSGHTCHHELETARINGLLGNIDANTGDAQTGWDTDQFLTDVGEAT
MVMMSVIKNGGIAPGGFNFDAKLRRESTDVEDLFIAHISGMDTMARGLRNAVKILEEGSLSELVRKRYATWD
SELGKQIEEGKADFEYLEKKAKEFGEPKVSSAKQELAEMIFQSAM*
DNA LENGTH = 1434 (Expression optimized)
ATGAAAAAAGTCGAATTTTTTATGTTATTATTATGTTTTATAGCAGCGTCTAGTTTGGTTTCAGCAGACCCA
CCTACTTGTCCTGCAGATTTAGGAGGCAAATGTTCAGATTCAGATGATTGGCAAGGTGATTTTTTTCCAGAA
ATACCGAAAATTAAGTATGAAGGTCCTTCGAGCAAAAATCCCCTAGCATACAGATGGTATAATGCAGAAGAA
GAGATATTGGGCAAAAAAATGAAAGATTGGTTTAGGTTTTCAGTCGCTTTCTGGCATACATTTAGAGGCACA
GGTGGTGATCCCTTTGGCGCAGCTACGAAATATTGGCCCTGGGAAGACGGAACAAATAGTGTTAGTATGGCT
AAAAGGAGAATGAGGGCAAATTTTGAATTTTTGAAAAAACTTGGAGTTGATTGGTGGTGTTTTCACGACAGA
GATATCGCACCAGACGGGACAACATTAGAGGAATCGAATAAAAATTTAGATGAAGTTATTGAATTAGCAAAA
GAACTACAAAAAGGGAGTAAAATAAAACCACTATGGGGAACAGCACAATTATTCTTACATCCTCGTTACATG
CATGGAGGTGCAACATCATCAGAAGTCGGAGTTTACGCATATGCAGCCGCACAAGTTAAGAAAGCGATGGAA
GTTACACATTATTTAGGAGGTGAAAATTATGTATTTTGGGGTGGAAGAGAAGGTTATCAAACATTGTTAAAC
ACAGATATGGGCAGAGAATTGGATCATTTAGCAAGATTTTTCGAAGCCGCAGTTGCCTACAAGAAAAAAATC
GGATTTAAAGGAACTTTATTAATTGAACCAAAACCACAAGAGCCAACAAAACATCAATACGATTGGGATGCT
GCCACTGCCGCGAATTTTTTGAGAAAGTATGGGTTAATCGACGAATTTAAATTAAATATAGAATGTAATCAT
GCTACATTGTCCGGCCACACATGCCACCATGAATTAGAAACAGCAAGGATTAATGGATTATTGGGTAACATA
GATGCTAATACAGGTGACGCACAAACAGGATGGGATACAGATCAATTTCTTACAGATGTAGGTGAAGCTACA
ATGGTTATGATGTCAGTTATTAAAAATGGGGGAATCGCACCAGGGGGATTTAATTTCGATGCAAAATTAAGA
AGGGAAAGTACAGACGTAGAGGATTTATTTATTGCACACATATCAGGTATGGATACTATGGCTAGAGGTTTA
AGAAATGCAGTCAAGATATTGGAAGAAGGCTCACTATCAGAATTAGTTAGAAAAAGGTACGCAACATGGGAT
TCGGAATTAGGAAAACAGATAGAAGAAGGTAAAGCAGATTTTGAATACTTAGAAAAAAAGGCAAAGGAATTC
GGTGAACCTAAAGTAAGCTCAGCAAAACAAGAATTGGCCGAAATGATATTTCAAAGTGCTATGTAA
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Bacillus subtilis xylose isomerase
PROTEIN LENGTH = 440
MAQSHSSSVNYFGSVNKVVFEGKASTNPLAFKYYNPQEVIGGKTMKEHLRFSIAYWHTFTADGTDVFGAATM
QRPWDHYKGMDLARARVEAAFEMFEKLDAPFFAFHDRDIAPEGSTLKETNQNLDIIVGMIKDYMRDSNVKLL
WNTANMFTNPRFVHGAATSCNADVFAYAAAQVKKGLETAKELGAENYVFWGGREGYETLLNTDLKFELDNLA
RFMHMAVDYAKEIEYTGQFLIEPKPKEPTTHQYDTDAATTIAFLKQYGLDNHFKLNLEANHATLAGHTFEHE
LRMARVHGLLGSVDANQGHPLLGWDTDEFPTDLYSTTLAMYEILQNGGLGSGGLNFDAKVRRSSFEPDDLVY
AHIAGMDAFARGLKVAHKLIEDRVFEDVIQHRYRSFTEGIGLEITEGRANFHTLEQYALNNKTIKNESGRQE
RLKPILNQ*
DNA LENGTH = 1323 (Expression optimized)
ATGGCTCAATCTCATTCTAGTTCAGTTAACTATTTTGGAAGCGTAAACAAAGTGGTTTTCGAAGGGAAAGCT
TCCACTAATCCTTTAGCATTTAAATATTATAATCCTCAAGAAGTAATCGGCGGAAAAACGATGAAAGAGCAT
TTGCGATTTTCTATTGCCTATTGGCATACATTTACTGCTGATGGCACAGACGTTTTTGGAGCAGCTACAATG
CAAAGACCATGGGATCACTATAAAGGCATGGATCTAGCTAGGGCAAGAGTAGAAGCAGCATTTGAGATGTTT
GAAAAACTAGATGCACCATTTTTTGCTTTTCATGATCGAGATATTGCACCAGAAGGAAGTACGTTAAAAGAG
ACAAATCAAAATTTAGATATTATCGTGGGCATGATTAAGGATTACATGAGAGATAGCAACGTTAAGTTATTA
TGGAATACTGCAAACATGTTTACGAACCCCCGTTTCGTCCATGGAGCCGCGACTTCTTGTAATGCAGATGTG
TTTGCGTATGCTGCAGCACAAGTAAAAAAAGGGTTAGAAACAGCAAAAGAGCTTGGCGCCGAGAACTATGTA
TTTTGGGGCGGCCGTGAAGGATACGAAACATTGTTAAATACCGATTTAAAATTTGAGCTTGATAATTTGGCG
AGATTTATGCATATGGCAGTAGATTATGCGAAGGAAATCGAGTATACAGGGCAGTTTTTGATTGAACCAAAA
CCAAAAGAGCCGACCACCCATCAATATGATACAGATGCAGCAACAACCATTGCCTTTTTGAAGCAATATGGC
TTAGACAATCATTTTAAATTAAATCTAGAAGCCAATCATGCCACATTAGCCGGGCATACATTCGAACATGAA
TTACGCATGGCAAGAGTACATGGTCTTCTTGGATCTGTTGATGCGAACCAGGGTCATCCTCTTTTAGGCTGG
GACACGGATGAATTTCCCACAGATTTATATTCTACGACATTAGCAATGTACGAAATCCTGCAAAATGGCGGC
CTTGGAAGCGGTGGCTTAAACTTTGACGCGAAGGTCAGAAGATCTTCTTTTGAGCCTGATGATTTAGTATAT
GCCCATATTGCAGGGATGGATGCATTTGCAAGAGGATTGAAAGTAGCCCACAAATTAATCGAAGATCGTGTG
TTTGAAGATGTGATTCAACATCGTTATCGCAGTTTTACTGAAGGAATTGGTCTTGAAATTACAGAAGGAAGA
GCTAATTTCCATACTCTTGAGCAATATGCGCTAAATAATAAAACAATTAAAAATGAATCTGGAAGACAGGAG
CGATTAAAACCTATATTGAACCAATAA
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Streptomyces rubiginosus xylose isomerase
PROTEIN LENGTH = 388
MNYQPTPEDRFTFGLWTVGWQGRDPFGDATRRALDPVESVRRLAELGAHGVTFHDDDLIPFGSSDSEREEHV
KRFRQALDDTGMKVPMATTNLFTHPVFKDGGFTANDRDVRRYALRKTIRNIDLAVELGAETYVAWGGREGAE
SGGAKDVRDALDRMKEAFDLLGEYVTSQGYDIRFAIEPKPNEPRGDILLPTVGHALAFIERLERPELYGVNP
EVGHEQMAGLNFPHGIAQALWAGKLFHIDLNGQNGIKYDQDLRFGAGDLRAAFWLVDLLESAGYSGPRHFDF
KPPRTEDFDGVWASAAGCMRNYLILKERAAAFRADPEVQEALRASRLDELARPTAADGLQALLDDRSAFEEF
DVDAAAARGMAFERLDQLAMDHLLGARG*
DNA LENGTH = 1167 (Expression optimized)
ATGAATTATCAACCTACACCCGAAGACAGATTTACGTTTGGACTGTGGACGGTTGGATGGCAAGGTAGAGAT
CCCTTTGGAGACGCCACAAGAAGAGCTTTAGACCCAGTTGAGAGTGTAAGAAGATTGGCAGAATTAGGTGCA
CATGGTGTTACTTTTCATGACGACGACCTTATTCCATTCGGATCCAGTGATAGTGAAAGAGAAGAACATGTA
AAAAGATTTAGACAAGCTTTAGATGATACAGGTATGAAGGTTCCGATGGCTACTACAAATTTGTTTACTCAT
CCCGTATTTAAAGATGGTGGATTTACAGCTAACGACCGTGATGTTAGAAGATACGCTTTAAGGAAAACTATT
AGAAATATTGACTTAGCAGTTGAATTAGGTGCAGAAACTTACGTTGCCTGGGGCGGTAGAGAAGGTGCCGAA
TCTGGTGGGGCAAAAGATGTAAGAGATGCTTTGGATAGAATGAAAGAGGCCTTCGATTTATTGGGCGAATAT
GTTACCTCACAAGGCTATGATATTAGATTTGCAATCGAACCAAAACCAAATGAACCAAGAGGAGATATTTTA
CTACCGACAGTCGGACATGCATTAGCATTTATAGAGAGATTAGAAAGACCAGAACTTTATGGTGTAAATCCA
GAGGTAGGACACGAACAAATGGCAGGACTAAATTTTCCACATGGCATAGCACAAGCATTGTGGGCAGGCAAA
TTATTTCACATAGACTTAAACGGACAAAATGGTATCAAATATGACCAAGACTTAAGATTCGGAGCAGGAGAT
TTGAGAGCAGCATTTTGGTTGGTAGATTTATTAGAAAGTGCAGGTTATTCAGGCCCTAGACATTTTGATTTT
AAACCCCCAAGAACAGAAGATTTTGATGGAGTTTGGGCTTCAGCAGCAGGATGTATGAGAAATTATCTAATT
TTGAAAGAGAGAGCAGCAGCATTTAGAGCCGATCCAGAAGTTCAAGAAGCCTTAAGAGCAAGTAGACTAGAT
GAATTAGCAAGACCAACAGCAGCAGACGGATTACAAGCGTTATTGGATGATCGTTCAGCTTTCGAAGAATTC
GACGTAGACGCAGCGGCAGCAAGAGGTATGGCATTTGAAAGATTAGATCAATTAGCAATGGATCACTTACTA
GGAGCTAGGGGTTAA
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Xanthomonas campestris xylose isomerase
PROTEIN LENGTH = 446
MSNTVFIGAKEYFPGIGKIGFEGRDSDNPLAFKVYDANKQVAGKTMAEHLRFAVAYWHSFCGNGADPFGPGT
RAYPWDVGNTALARAEAKSDAAFEFFTKLGVPYYCFHDIDLAPDADDIGEYENNLKHMVGIAKQRQADTGVK
LLWGTANLFSHPRYMNGASTNPDFNVVARAAVQVKAAIDATVELGGENYVFWGGREGYACLHNTQMKREQDN
MARFLTLARDYGRAIGFKGNFLIEPKPMEPMKHQYDFDSATVIGFLRQHGLDQDFKLNIEANHATLSGHSFE
HDLQVASDAGLLGSIDANRGNPQNGWDTDQFPTDLYDTVGAMLVVLRQGGLAPGGLNFDAKVRRESSDPQDL
FLAHIGGMDAFARGLEVADALLTSSPLETWRAQRYASFDSGAGADFANGTSTLADLATYAAGKGEPTQLSGR
QEAYENLINQYLTR*
DNA LENGTH = 1341 (Expression optimized)
ATGTCCAACACAGTTTTCATTGGTGCAAAAGAATATTTTCCGGGAATAGGTAAGATTGGATTCGAAGGTAGA
GACTCTGACAACCCTTTAGCATTTAAAGTTTATGACGCAAACAAACAAGTTGCGGGGAAAACTATGGCGGAA
CATTTAAGATTTGCAGTCGCATATTGGCATTCATTTTGTGGTAACGGTGCTGATCCATTTGGTCCAGGTACG
AGGGCTTACCCATGGGACGTTGGAAACACTGCACTTGCTAGAGCCGAGGCGAAATCTGATGCCGCTTTTGAA
TTTTTTACTAAATTAGGTGTACCATACTATTGCTTTCATGATATAGATTTAGCCCCAGATGCGGATGATATA
GGCGAATACGAAAATAATCTAAAACACATGGTTGGAATTGCAAAACAAAGACAAGCGGATACAGGTGTAAAA
TTATTATGGGGAACTGCTAACTTATTCTCACATCCAAGGTATATGAACGGTGCTAGCACTAATCCAGATTTT
AATGTTGTTGCAAGAGCTGCAGTACAAGTTAAAGCAGCCATAGATGCTACTGTTGAATTAGGAGGAGAGAAT
TACGTTTTTTGGGGTGGTAGGGAAGGATATGCATGTTTACACAATACACAAATGAAAAGAGAACAGGACAAT
ATGGCAAGGTTTTTAACATTAGCTAGAGATTATGGTAGAGCGATAGGATTTAAAGGTAACTTTTTGATAGAA
CCAAAACCGATGGAGCCTATGAAACATCAGTATGACTTCGATTCAGCTACTGTTATAGGATTTTTGAGACAG
CACGGCTTAGATCAAGATTTTAAATTAAACATAGAGGCAAATCACGCAACCCTATCAGGACATTCTTTTGAA
CATGATTTACAAGTTGCTTCAGATGCAGGGTTATTAGGATCAATTGACGCAAACAGAGGAAATCCACAAAAC
GGATGGGATACAGATCAATTTCCTACAGATTTATATGATACAGTTGGGGCGATGTTAGTAGTTTTAAGACAA
GGTGGACTAGCTCCCGGTGGTTTAAATTTCGACGCTAAAGTAAGAAGAGAAAGTAGCGATCCACAAGATTTG
TTTTTAGCACATATTGGCGGTATGGATGCTTTTGCAAGAGGATTAGAAGTAGCTGACGCTTTATTAACCAGT
TCACCATTAGAGACTTGGAGGGCACAAAGATACGCATCTTTTGATTCAGGCGCAGGAGCTGACTTTGCAAAT
GGCACTTCTACTCTAGCGGATCTAGCCACGTACGCTGCAGGAAAAGGAGAACCAACACAATTAAGCGGTAGA
CAAGAAGCATATGAAAATCTAATAAATCAATATTTGACCAGATAA
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A.2. Putative xylose transporters
Putative transporters were selected using BLAST depending on sequence
homology. The gene name, strain resource, Genbank accession number and primers used
for cloning of each gene are listed in following table.
Table A-1. Putative xylose transporters
Gene name
PsXUT4
SUTI P-PsXUT4-F
P-PsXUT4-R
Ps-SUT1
SUT2 P-PsSUT1-F
P-PsSUTI-R
Ps-SUT2
SUT3 P-PsSUT2-F
P-PsSUT2-R
DhSUT1
SUT4 P-DhSUT1-F
P-DhSUT1-R
DhSUT2
SUT5 P-DhSUT2-F
P-DhSUT2-R
DhSUT3
SUT6 P-DhSUT3-F
P-DhSUT3-R
CaSUTI
SUT7 P-CaSUT1-F
P-CaSUTI-R
CaSUT2
SUT8 P-CaSUT2-F
P-CaSUT2-R
CgSUT1
SUT9 P-CgSUT1-F
P-CgSUT1-R
TrXLT1
SUT1O P-TrXLTI-F
P-TrXLT1-R
Strain, Genbank Accession Number
Primers used for cloning
Pichia stipitis, XM_001386678
ATTCTAGATGTCTTCGTTATTGACTAACG
TTCTCGAGTTATTCCATCTCATTCAACTTGT
Pichia stipitis, XM_001387861
TTACTAGTATGTCTTCTCAAGATATTCCTT
TACTCGAGTTAAACATGTTCGTCAACA
Pichia stipitis, AF072808
TTTCTAGATGTCCTCACAAGATTTACCCT
TTCTCGAGCTAAACTTGCTCTTGCTCTT
Debaryomyces hansenii, CBS767, XM_458532
AATCTAGATGGGTTTAGAAGATAATGCG
TACTCGAGTTAGACTGAAGTGGTTTCAAT
Debaryomyces hansenii, CBS767, XM_457669
AATCTAGATGACCAATACAGAACCAAATA
TTCTCGAGTTACTCCTGTCTTTTATCTTCA
Debaryomyces hansenii, CBS767, XM459306
TATCTAGATGTTTAAGCAGGAGAATGGAA
TACTCGAGCTATACTTGTTCATCAGAAGGT
Candida albicans SC5314, XM_715292
AATCTAGATGAGTGCAAATATCCAAGCT
ATCTCGAGTTAAACGGAATTTTCATCAA
Candida albicans SC5314, XM_710040
TATCTAGATGTCAGAATTGACTGAACTT
ATCTCGAGCTATTGTTGTAATAATCTACTT
Candida glabrata CBS138, XM_444845
ATACTAGTATGATCAGCGGCCCTAAGGAA
TACTCGAGTCAATTTCTTGAGAATACTCT
Trichoderma reesei, AY818402
ACTCTAGATGTATCGGATTTGGAACATAT
TACTCGAGTTAGACCTTTTCTTCGTGCT
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Restriction
enzyme site
Xba I
Xho I
Spe I
Xho I
Xba I
Xho I
Xba I
Xho I
Xba I
Xho I
Xba I
Xho I
Xba I
Xho I
Xba I
Xho I
Spe I
Xho I
Xba I
Xho I
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PsXUT5
SUTI 1 P-PsXUT5-F
P-PsXUT5-R
ScHXT7
SUT12 ScHXT7-F
ScHXT7-R
PsXUT6
SUT13 P-PsXUT6-F
P-PsXUT6-R
ScHXT5
SUT14 P-ScHXT5-F
P-ScHXT5-R
Ps-XUT3
SUT15 P-PsXUT3-F
P-PsXUT3-R
CaSUT3
SUT16 P-CaSUT3-F
P-CaSUT3-R
Pichia stipitis, XM_001385925
TAACTAGTATGACGGAAAGAAGCATTGG
AACTCGAGTTACTTCTTTGTATTAACAAC
S. cerevisiae, Z31692
TTACTAGTATGTCACAAGACGCTGCTATTG
ATCTCGAGTTATTTGGTGCTGAACATTCT
Pichia stipitis, XM_001386552
TTACTAGTATGTCCAGTGTTGAAAAAAGT
TTCTCGAGTTAGCTGATGTTTTCGACAT
S. cerevisiae, X77961
AAACTAGTATGTCGGAACTTGAAAACGC
ATCTCGAGATTATTTTTCTTTAGTGAACAT
Pichia stipitis, XM_001387101
AAATACTAGTATGAGAGAAGTTGGTATTCTTGATGT
TG
TTTTCTCGAGTTATTCTGACATTTCAATCGAGTTGC
Candida albicans, XM_714504
AAAAACTAGTATGTCCTCAACTAATTCAACAG
AATACTCGAGTTAAACGTGTTCCTCTGTTGG
Bold: restriction enzyme recognition sequence
Underline: start or stop codon
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Spe I
Xho I
Spe I
Xho I
Spe I
Xho I
Spe I
Xho I
Spel
XhoI
Spel
XhoI
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A.3. Xylitol inhibitory effect estimation
E+S , ES E+ P
Ki
El
Assumption: competitive inhibition
vo-Vmax S/(Km,+ S) where Km'= Kmx(1 + I/Ki)
From literatures:
Km 20-50mM
Ki~ 5-15mM
From literatures and experiments:
S(xylose) 100mM
I (xylitol) = 1-10mM
Estimated results:
w/o inhibitor: vo = 0.66vma
w/ inhibitor I = 1mM: Km' = 70mM; vo,= 0.59vmax =0.88vo
w/ inhibitor I = 10mM: Kn' =15OmM; vo, = 0.4vmax =0.6vo
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